1

RAJ S. PRUTHI MD, MHA, FACS

Curriculum Vitae

Education

2015-17 University of North Carolina, Chapel Hill, North Carolina

Masters of Health Administration (M.H.A.)

1994-98 Stanford University, Stanford, California

Residency, Urology

1995-96 Stanford University, Stanford, California

Fellow, Prostate cancer and ultrasonography, Dept. of Urology

1993-94 Stanford University, Stanford, California

Residency, General Surgery

1992-93 Stanford University, Stanford, California

Internship, General Surgery

1988-92 Duke University School of Medicine, Durham, North Carolina

M.D., May, 1992

1984-88 Stanford University, Stanford, California

B.S. in Biology and B.A. in Economics with Honors, June, 1988

Board Certification/Licensure

American Board of Urology (12919), 2002, recertification 2009

Louisiana State Board of Medical Examiners (13229R), 1999

North Carolina Medical Board (98-00667), 1998

Drug Enforcement Agency (BP4105929), 1993

Professional Experience

01/2017- Present Department of Urology, UNC School of Medicine, Chapel Hill, NC

Department Chair, John Rhodes Distinguished Professor of Urology

(tenure)

7/2013 –01/2017 Department of Urology, UNC School of Medicine, Chapel Hill, NC

Department Chair, Professor of Urology (tenure)

5/2011 – 06/2013 Division of Urology, UNC School of Medicine, Chapel Hill, NC

Division Chief, Professor of Surgery (tenure)

01/2011-05/2011 Division of Urology, UNC School of Medicine, Chapel Hill, NC

Division Chief, Associate Professor of Surgery (tenure)

5/2006 – 01/2011 Division of Urology, UNC School of Medicine, Chapel Hill, NC

2

Associate Professor of Surgery (tenure)

4/2000 – 5/2006 Division of Urology, UNC School of Medicine, Chapel Hill, NC

Assistant Professor of Surgery

4/1999 – 4/2000 Dept. of Urology, LSU Medical Center, Shreveport, Louisiana

Assistant Professor of Urology

8/1998 – 4/1999 Kinston Urological Associates, Kinston, North Carolina

Private Practice of Urology

Honors/Awards

UNC Health Care and Faculty Physicians Award for Carolina Care Excellence 2018

“Best Doctors in America” 2018

“Best Doctors in America” 2017

“Best Doctors in America” 2016

UNC Health Care and Faculty Physicians Award for Carolina Care Excellence 2016

“Bests Doctors in America” 2015

UNC Health Care and Faculty Physicians Award for Carolina Care Excellence 2015

“Best Doctors in America” 2014

“Best Doctors in America” 2013

Castle and Connolly’s “America’s Top Doctors” 2012

Faculty Teaching Award (“Attending of the Year), Division of Urologic Surgery, 2011-2012

Castle and Connolly’s Best Doctors in America 2010-2011

America’s Top Doctors for Cancer, 2010-2011

“Best Doctors in North Carolina”, 2010

2009 Best Reviewer for Prostate Cancer Articles – Journal of Urology, May 2010

North Carolina Urology Seminar - Third Prize, Research, 2008

“Best Doctors in America”, 2003-04, 2004-2005, 2005-2006, 2006-2007, 2007-2008, 2011-2012

Faculty Teaching Award (“Attending of the Year), Division of Urologic Surgery, 2006-07

“Best Doctors in North Carolina”, 2004-2005, 2005-2006, 2006-2007

North Carolina Urology Seminar - Second Prize, Research, 2006

North Carolina Urology Seminar - First Prize, Research 2005

North Carolina Urology Seminar - Second Prize, Case Report, 2005

North Carolina Urology Seminar – Third Prize, Case Report, 2004

North Carolina Urology Seminar – First Prize, Research, 2004

North Carolina Urology Seminar – Second Prize, Research, 2003

North Carolina Urology Seminar – Third Prize, Case Report, 2002

North Carolina Urology Seminar – First Prize, Research, 2002

Excellence in Teaching Award, University of North Carolina School of Medicine, 2002

Excellence in Teaching Award, University of North Carolina School of Medicine, 2001

T. Leon Howard Pyelogram Conference – Second Prize, SEAUA Meeting, 2001

North Carolina Urology Seminar – Third Prize, Case Report, 2001

Faculty Teaching Award (“Attending of the Year”), Division of Urologic Surgery, 2000-01

Northern California Resident’s Competition -- First Prize, U.C.S.F., 1997

Northern California Resident’s Competition -- Second Prize, U.C. Davis, 1996

Northern California Resident’s Competition -- First Prize, Stanford University, 1995

Merck ph Prize, Duke University, 1992

Pathology Research Scholar Award, Duke University, 1990-1991

American Liver Foundation Research Scholarship, Duke University, 1990-1991

3

Thomas J. Watson Scholarship, Stanford University, 1984-1988

Jordan Scholar, Stanford University, 1984-1985

Bibliography

Book Chapters

Smith AB, Nix J, and Pruthi RS (2017). “Complications of Robotic Cystectomy” in

Complications of Urologic Surgery, 5th ed, Taneja S and Shah O (Eds), Elsevier, p. 594-596.

Pruthi RS (2017). “Commentary on Robotic Radical Cystectomy” in Hinman’s Atlas of Urologic

Surgery, 4e, Smith J, Howards S, Preminger G, Dmochowski R (Eds.), Elsevier, p. 594-596.

Kallingal GJ, Smith AB, Parekh, Pruthi RS (2015). “Laparoscopic/Robotic Radical Cystectomy

and Urinary Diversion- Clinical Trials” in Bladder Cancer: Diagnosis and Clinical Management, Lerner S, Sternberg C, Schoenberg M, (Eds.), Wiley-Blackwell, p. 167-176.

Ferguson JE 3rd, Woods ME, Pruthi R. (2015) Radical cystectomy: laparoscopic, open & partial. In: Pelvic Cancer Surgery: Modern Breakthroughs and future advances. (155-164). Springer-

Verlag New York.

Nix, J, Pruthi RS. (2014) Robot-Assisted Anterior Pelvic Exenteration for Bladder Cancer in

the Female. Robotic Surgery of the Bladder. Castle and Pruthi (Eds). . (63-76) Springer,

Springer New York Heidelberg Dordrecht London.

Woods ME, Pruthi RS. (2014) Inguinal lymphadenopathy. The 5-Minute Urology Consult 3rd ed. (230-232). Gomella, Leonard G, Lippincott Williams & Wilkins. Wolters-Kluwer, China.

Smith A, Pruthi RS (2014). “Ureter & Renal Pelvis, SCC” in The 5-Minute Urology Consult, 3rd

Ed., (544-797) Gomella, Leonard G, Lippincott Williams & Wilkins. Wolters-Kluwer. China.

Smith A, Pruthi RS. (2013) “Chapter 24: Prostate Cancer Counterpoint,” in Patient Surveillance

after Cancer Treatment (Current Clinical Oncology), Johnson F, et al. (Eds.). (403-410),

Springerlink. New York, NY.

Castle EP, Pruthi RS, Woods ME. (2013) Male Robot-Assisted Cystectomy. Robotic Urology

2nd ed. Hubert John and Peter Wiklund (Eds). (145-152). Springer; Springer-Verlag New York.

David C. Johnson, MD, Raj S. Pruthi, & Michael E. Woods (2013) Perioperative Chemotherapy

When to Use it, What to Use and Why in S. S. Chang (Ed.). Diagnosis, Evaluation, and Treatment of Non-Muscle Invasive Bladder Cancer (pp. 183-195). Philadelphia, Pennsylvania:

Elsevier.

Badrinath Konety, Willem Oosterlinck, Sam Chang, Sigurdur Gudjonsson, Raj Pruthi, Mark

Soloway, Eduardo Solsona, Paul Sved. (2012) Low Grade Ta Urothelial Carcinoma of the

Bladder. In M. Soloway, &S Khoury (Eds.), Bladder Cancer (2nd ed., pp. 233-246). Paris-France:

Springer.

4

Pearson M., Pruthi R.S. Quality of Life in men undergoing radical prostatectomy for prostate

cancer. In Handbook of Disease Burdens and Quality of Life Measures. V. Preedy (Ed.) 2010.

Springer, New York, pp 2877-2885.

Ramirez M., Pruthi R.S., deVere-White R. Pelvic Lymphadenectomy. In Glenn’s Urologic

Surgery (7th edition). Graham S. and Keane T. (Eds.) 2009. Lippincott Williams, pp 179-194.

Fielding J., Pruthi R.S. Imaging of nephrolithiasis, urinary tract infections and their

complications. In Evidence-Based Imaging: Optimizing Imaging in Patient Care Medina, L.

Santiago; Blackmore, C. Craig (Eds.) 2006. Springer, New York, pp 542-552.

In Press/Submitted

Manvar A, Pruthi RS, Wallen EM, Nielsen ME. Epidemiology. In The Textbook of Prostate

Cancer. Ashutosh Tewari (ed). 2011. Springer.

Ferguson JE, Pruthi RS, Wallen EM, Nielsen ME. Racial Disparities and the Global Picture. In

The Textbook of Prostate Cancer. Ashutosh Tewari (ed). 2011. Springer.

Smith A, Nielsen ME, Wallen EM, Pruthi RS. Patient Surveillance after Prostate Cancer

Treatment. In Patient Surveillance After Cancer Treatment. Johnson F, Virgo K, Margenthaler J,

et al (Eds.). 2011. Springer. 7 typed pages.

Nix J, Nielsen ME, Wallen EM, Pruthi RS. Robotic anterior exenteration in females: Technique,

current status and outcomes. In Robotic in Genitourinary Surgery. Menon M and Hemal A.

(Eds.) 2011. (511-522) Springer.

Journal Articles (refereed)

1. Parekh DJ, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, Weizer AZ, Konety

BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A,

Kibel AS, Shemanski L, Pruthi RS, Montgomery JS, Weight CJ, Sharp DS, Chang SS,

Cookson MS, Gupta GN, Gorbonos A, Uchio EM, Skinner E, Venkatramani V, Soodana-

Prakash N, Kendrick K, Smith JA Jr, Thompson IM. Robot-assisted radical cystectomy

versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label,

randomised, phase 3, non-inferiority trial. Lancet. 2018 Jun 23;391(10139):2525-2536.

2. McCormick BJ, Deal A, Borawski KM, Raynor MC, Viprakasit D, Wallen EM, Woods ME,

Pruthi RS.Implementation of medical scribes in an academic urology practice: an analysis of

productivity, revenue, and satisfaction. World J Urol. 2018 Apr 10. doi: 10.1007/s00345-

018-2293-8. [Epub ahead of print]

3. Smith AB, Meyer AM, Meng K, Nielsen ME, Pruthi R, Wallen E, Woods M, Tan HJ.

4. The relationship of travel distance with cystectomy access and outcomes. Urol Oncol. 2018

Jun;36(6):308.e1-308.e9. doi: 10.1016/j.urolonc.2018.03.005. Epub 2018 Mar 19.

5. Daneshmand S, Patel S, Lotan Y, Pohar K, Trabulsi E, Woods M, Downs T, Huang W,

Jones J, O'Donnell M, Bivalacqua T, DeCastro J, Steinberg G, Kamat A, Resnick M, Konety

B, Schoenberg M, Jones JS; Flexible Blue Light Study Group Collaborators. Efficacy and

5

Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of

Bladder Cancer: A Phase III, Comparative, Multicenter Study. J Urol. 2018

May;199(5):1158-1165.

6. Spencer ES, Lyons MD, Pruthi RS. Patient Selection and Counseling for Urinary Diversion.

Urol Clin North Am. 2018 Feb;45(1):1-9.

7. Casilla-Lennon MM, Choi SK, Deal AM, Bensen JT, Narang G, Filippou P, McCormick B,

Pruthi R, Wallen EM, Tan HJ, Woods M, Nielsen M, Smith AB. Financial Toxicity in

Bladder Cancer Patients- Reasons for Delay in Care and Effect on Quality of Life. J Urol.

2018 May;199(5):1166-1173

8. Tilki D, Chandrasekar T, Capitanio U, Ciancio G, Daneshmand S, Gontero P, Gonzalez J,

Haferkamp A, Hohenfellner M, Huang WC, Linares Espinós E, Lorentz A, Martinez-

Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik S, Palou J,

Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Vera-

Donoso C, Zigeuner R, Libertino JA, Evans CP. Impact of lymph node dissection at the time

of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from

the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Urol

Oncol. 2018 Feb;36(2):79.e11-79.e17. doi: 10.1016/j.urolonc.2017.10.008. Epub 2017 Nov

10.

9. McGrath JS, Pruthi RS. Surgery: Enhanced recovery after cystectomy: cocktails, culture, or

consistency? Nat Rev Urol. 2017 Nov;14(11):648-649.

10. Pham MN, Deal AM, Ferguson JE 3rd, Wang Y, Smith AB, Nielsen ME, Pruthi RS, Woods

ME. Contemporary survival trends in penile cancer: Results from the National Cancer

Database. Urol Oncol. 2017 Dec;35(12):674.e1-674.e9. doi: 10.1016/j.urolonc.2017.08.009.

Epub 2017 Sep 4.

11. Smith AB, Crowell K, Woods ME, Wallen EM, Pruthi RS, Nielsen ME, Lee CT. Functional

Outcomes Following Radical Cystectomy in Women with Bladder Cancer: A Systematic

Review. Eur Urol Focus. 2017 Feb;3(1):136-143.

12. Langston JP, Duszak R Jr, Orcutt VL, Schultz H, Hornberger B, Jenkins LC, Hemingway J,

Hughes DR, Pruthi RS, Nielsen ME. The Expanding Role of Advanced Practice Providers in

Urologic Procedural Care. Urology. 2017 Aug;106:70-75.

13. McCormick BJ, Pruthi RS.The Present and Future Challenges Facing Urology Departments

at Academic Health Centers. Urology. 2017 Jun;104:25-30.

14. Filippou P, Pruthi RS. Trends in Prostate Cancer Screening Following Changes Made by the

US Preventative Services Task Force; Are we turning back the clock? JAMA Surg. 2016

Nov. 2. [Epub ahead of print]. PMID:27806148

15. Mager R, Daneshmand S, Evans CP, Palou J, Martínez-Salamanca JI, Master VA,

McKiernan JM, Libertino JA, Haferkamp A; International Renal Cell Carcinoma-Venous

Thrombus Consortium, Haferkamp A, Capitanio U, Carballido JA, Chantada V, Chromecki

T, Ciancio G, Daneshmand S, Evans CP, Gontero P, González J, Hohenfellner M, Huang

WC, Koppie TM, Libertino JA, Espinós EL, Lorentz A, Martínez-Salamanca JI, Master VA,

McKiernan JM, Montorsi F, Novara G, O'Malley P, Pahernik S, Palou J, Moreno JL, Pruthi

6

RS, et al. Renal Cell Carcinoma with inferior vena cava involvement: Prognostic effect of

tumor thrombus consistency on cancer specific survival. J Surg. Oncol. 2016 Nov; 114(6)

:764-768. PMID: 27562252.

16. McKibben MJ, Kirby EW, Langston J, Raynor MC, Nielsen ME, Smith AB, Wallen EM,

Woods, Pruthi RS. Projecting the Urology Workforce over the Next 20 Years. Urology.

2016 Dec; 98:21-26. PMID: 27491965.

17. Johnson DC, Pruthi RS. Urinary Reconstruction after Radical Cystectomy. J Urol. 2016 Oct;

196(4):979-80. PMID: 27424815.

18. Azhar RA, Bochner B, Catto J, Goh AC, Kelly J, Patel HD, Pruthi RS, Thalmann GN, Desai M.

Enhanced Recovery after Urological Surgery: A Contemporary Systematic Review of Outcomes,

Key Elements, and Research Needs. Eur Urol. 2016 Jul;70(1) :176-87. PMID: 26970912.

19. Johnson DC, Meuller DE, Dunn MW, Smith AB, Woods ME, Wallen EM, Pruthi RS.,

Nielsen ME. Integrating patient preferences into treatment decisions for men with prostate

cancer at the point of care. J Urol. 2016 Dec; 196(6): 164-1644. PMID: 27346032.

20. Janda G, Deal A, Yang H, Nielsen M, Smith A, Pruthi RS, et al. Single –Institution

Experience with Robotic Partial Nephrectomy for Renal Masses Greater than 4cm.

a. J Endourology 2016 Apr;30(4):384-9.PMID: 26597172.

21. Spencer ES, Deal AM, Pruthi NR, Gonzalez CM, Kirby EW, Langston J, McKenna PH,

McKibben MJ, Nielsen ME, Raynor MC, Wallen EM, Woods ME, Pruthi RS, Smith AB. Gender

Differences in Compensation, Job Satisfaction and other practice patterns in urology. J Urol.

2016 Feb;195(2):450-5.PMID: 26384452

22. Matulewicz RS, Brennan J, Pruthi RS, Kundu SD, Gonzalez CM, Meeks JJ. Radical

Cystectomy Perioperative Care Redesign. Urology 2015 Dec: 86 (6) : 1076-86. PMID:

26384452.

23. Rose TL, Deam AM, Basch E, Godley PA, Rathmell Wk, Kim WY, Whang YE, Dunn MW,

Wang A, Checn RC, Nielsen ME, Pruthi RS, et.al. Neoadjuvant chemotherapy

administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of

transitions between academic and community settings. Urol. Oncol. 2015 Sep;33 (9): 386

PMID: 26122712.

24. Johnson DC, Riggs SB, Nielsen ME, Matthews JE, Woods ME, Wallen EM, Pruthi RS,

Smith AB. Nutritional predictors of complications following radical cystectomy. World

Journal of Urology. 2015 Aug; 33(8): 1129-37. PMID: 25240535

25. Nguyen HG, Tilki D, Dall'Era MA, Durbin-Johnson B, Carballido JA, Chandrasekar

T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J,Haferkamp

A, Hohenfellner M, Huang WC, Linares Espinós E, Mandel P, Martinez-Salamanca

JI, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik S,Palou J, Pruthi RS, et. al.

Cardiopulmonary bypass has No significant impact on Survival in patients undergoing

nephrectomy and level III-IV inferor vena cava thrombectomy: multi-institutional analysis. J

Urol 2015. Aug; 194 (2) : 304-8. PMID: 25797392

7

26. McMillan DT, Viera AJ, Matthews J, Raynor MC, Woods ME, Pruthi RS, Wallen EM,

Nielsen ME, Smith AB. Resident involvement and experience as predictive factors for peri-

operative outcomes following robotic prostatectomy. World J Urol. 2015 Jun;33(6):793-9

PMID: 24985554.

27. Janda GM, Woods ME, Pruthi RS. Practical tips for safe and efficient robotic cystectomy.

Curr Urol Rep. 2015 Jun;16 (6):37. PMID 25917231.

28. Smith ND, Castle EP, Gonzalgo ML, Svatke RS, Weizer AZ, Montgomery JS, Pruthi RS,

et.al. The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial

update. BJU Int. 2015 Feb; 115(2): 198-205 PMID: 25626182.

29. Johnson DC, Vukina J, Smith AB, Meyer AM, Wheeler SB, Kuo TM, Woods ME, Raynor

MC, Wallen EM, Pruthi RS, Nielsen ME. Preoperative misclassified, surgically removed

benign renal masses: a systematic review and United States population-level burden

estimate. J Urol. 2015 Jan; 193(1) 30-5. PMID: 25072182.

30. Hautmann RE, Herr HW, Pruthi RS, Aron M. Robotic radical cystectomy—is the diversion

the Achilles’ heel? J Urol. 2014 Dec; 192 (6): 1601-3. PMID: 25245487.

31. Fifer GL, Raynor MC, Selph P, Woods ME, Wallen EM, Viprakasit D, Nielsen ME, Smith

A, Pruthi RS. Robotic ureteral reconstruction distal to the Ureteropelvic junction; a large

single institution clinical series with short-term follow up. J Endourol. 2014 Dec;28 (12)

:1424-8. PMID: 25230048.

32. Smith AB, Deal AM, Woods ME, Wallen EM, Pruthi RS, Chen RC, Milowsky MI, Nielsen

ME. Muscle-invasive bladder cancer: evaluating treatment and survival in the National

Cancer Data Base. BJU Int. 2014 Nov; 114(5):719-26. PMID: 24325202.

33. Daneshmand S, Schuckman AK, Bochner BH, Cookson MS, Downs TM, Gomella LG,

Grossman HB, Kamat AM, Konety BR, Lee CT, Pohar KS, Pruthi RS, et al. Nat Rev. Urol.

2014 Oct; 11(10):589-96. PMID: 25245244.

34. Johnson DC1, Nielsen ME, Matthews J, Woods ME, Wallen EM, Pruthi RS, Milowsky

MI, Smith AB. Neoadjuvant chemotherapy for bladder cancer does not increase risk of

perioperative morbidity. BJU Int. 2014 Aug; 114 (2) 221-8. PMID: 24274722.

35. Smith J, Pruthi RS, McGrath J. Enhanced recovery programs for patients undergoing radical

cystectomy. Nat Rev Urol. 2014 Aug; 11(8): 437-44. PMID: 25023593.

36. Raynor MC, Pruthi RS. Postoperative ileus after radical cystectomy: looking for answers to

an age-old problem. Eur Urol. 2014 Aug; 66 (2):273-4. PMID: 24746972.

37. Smith AB, Deal AM, Yu H, Boyd B, Matthews J, Wallen EM, Pruthi RS, et al. Sarcopenia

as a predictor of complications and survival following radical cystectomy.

J Urol. 2014 Jun; 191(6):1714-20. PMID 24423437

38. Selph JP, Whited WM, Smith AB, Matthews J, Pruthi RS, et al. Metabolic Syndrome as a

Predictor for Postoperative Complications after Urologic Surgery. Urology 2014

May;83(5):1051-9. PMID 24656508.

8

39. Martínez-Salamanca JI1, Linares E, González J, Bertini R, Carballido JA, Chromecki

T, Ciancio G, Daneshmand S, Evans CP, Gontero P, Haferkamp A,Hohenfellner M, Huang

WC, Koppie TM, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi

F, Nguyen HG, Novara G, Pahernik S, Palou J, Pruthi RS, et al. Lessons learned from the

International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Curr Urol

Rep 2014 May; 15 (5): 404. PMID: 24682884.

40. Pruthi RS, Raynor MC. Enhanced recovery programmes : an important step towards going

lean in healthcare. BJU Int. 2014 May;113 (5) :685-6. PMID: 24717058.

41. Langston JP, Kirby EW, Nielsen ME, Smith AB, Woods ME, Wallen EM, Pruthi RS.

Economic Impact of Training and Career Desions in Urologic Surgery. J Urol. 2014 Mar;

191(3):755-60. PMID: 24096119.

42. Ahmed K, Khan SA, Hayn MH, Agarwal PK, Badani KK, Balbay MD, Castle EP, Dasgupta

P, Ghavamian R, Guru KA, Hemal AK, Hollenbeck BK, Kibel AS, Menon M, Mottrie A,

Nepple K, Pattaras JG, Peabody JO, Poulakis V, Pruthi RS, et al. Analysis of Intracorporeal

Compared with Extracorporeal Urinary Diversion After Robot-assisted Radical Cystectomy:

Results from the International Robotic Cystectomy Consortium. Eur Urol 2014

Feb;65(2):340-7. PMID: 24183419.

43. Gallagher SA, Smith AB, Matthews JE, Potter CW, Woods ME, Raynor M, Wallen EM,

Kimryn Rathmell W, Whang YE, Kim WY, Godley PA, Chen RC, Wang A, You C,

Barocas DA, Pruthi RS, Nielsen ME, Milowsky MI. Roadmap for the development of the

University of North Carolina at Chapel Hill Genitourinary OncoLogy Database-UNC

GOLD. Urol Oncol. 2014 Jan;32(1):32. PMID 23434424.

44. Nielsen ME, Smith AB, Meyer AM, Kuo TM, Tyree S, Kim WY, Milowski MI, Pruthi RS,

Milikan RC. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder

in the United States: 1988 to 2006. Cancer. 2014 Jan 1;120(1):86-95. PMID: 24122346.

45. Langston JP, Kirby EW, Nielsen ME, Smith AB, Woods ME, Wallen EM, Pruthi RS.

Economic Impact of Training and Career Decisions in Urologic Surgery. J Urol. 2014 Mar;

191(3):755-60. PMID: 24096119.

46. Smith AB, Deal AM, Woods ME, Wallen EM, Pruthi RS, Chen RC, Milowsky MI, Nielsen

ME. Muscle-Invasive bladder cancer: Evaluating treatment and survival in the National

Cancer Data Base. BJU Int. 2014 Nov;114(5):719-26.BJU Int. 2013 Dec 11. PMID:

24325202.

47. Pruthi RS, Neuwahl S, Nielsen ME, Fraher E. Recent Trends in the Urology Workforce in

the United States. Urology.2013 Nov;82(5):987-93 PMID: 24055244.

48. Raynor MC, Pruthi RS. Postoperative Ileus: Time for an Evidence-based Consensus. Eur

Urol. 2013 Oct.;64(4):589-9.

49. Smith AB, Pruthi RS. Phase II study of everolimus in metastatic urothelial cancer. BJU Int.

2013 Aug;112(4):427-8.

9

50. Smith AB, Woods ME, Raynor MC, Nielsen ME, Wallen EM, Pruthi RS. Prevention and

management of complications following robot-assisted radical cystectomy: lessons learned

after > 250 consecutive cases. World J Urol. 2013 Jun; 31 (3) :441-6. PMID: 2329032.

51. Johnson DC, Pruthi RS, Woods ME. Perioperative chemotherapy: when to use it, what to

use, and why. Urol Clin North Am. 2013 May;40(2):183-95. PMID: 23540777.

52. Marshall SJ, Hayn MH, Stegemann AP, Agarwal PK, Badani KK, Balbay MD, Dasgupta P,

Hemal AK, Hollenbeck BK, Kibel AS, Menon M, Mottrie A, Nepple K, Pattaras JG,

Peabody JO, Poulakis V, Pruthi RS, Palou Redorta J, Rha KH, Richstone L, Schanne F,

Scherr DS, Siemer S, Stöckle M, Wallen EM, Weizer AZ, Wiklund P, Wilson T, Woods M,

Guru KA. Impact of surgeon and volume on extended lymphadenectomy at the time of

robot-assisted radical cystectomy: results from the International Robotic Cystectomy

Consortium (IRCC). BJU Int. 2013 Jun;111(7):1075-80. PMID: 23442001.

53. Johnson D, Castle E, Pruthi RS, Woods ME. Robotic intracorporeal urinary diversion: ileal

conduit. J Endourol. 2012 Dec;26(12):1566-9. PMID: 23102129.

54. Burger M, Oosterlinck W, Konety B, Chang S, Gudjonsson S, Pruthi R, Soloway M,

Solsona E, Sved P, Bajuk M, Brausi MA, Cheng C, Comperat E, Dinney C, Otto W, Shah J,

Thürof J, Witjes JA. ICUD-EAU International Consultation on Bladder Cancer 2012: Non-

Muscle-Invasive Urothelial Carcinoma of the Bladder. Eur Urol.2013 Jan;63(1):36-

44.PMID: 22981672.

55. Song L, Chen RC, Bensen JT, Knafl GJ, Nielsen ME, Farnan L, Wallen EM, Michel M,

Pruthi RS, Mohler JL, Godley PA. Who Makes the decision regarding the treatment of

clinically localized prostate cancer-the patient or physician?: results from a population-based

study. Cancer. 2012 Jul 11. [Epub ahead of print

56. Chen RC, Rosenman JG, Hoffman LG, Chiu WK, Wang AZ, Pruthi RS, et al. Phase I study

of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT)

and androgen-deprivation therapy (ADT) for high-risk prostate cancer.

BJU Int. 2012 Sep 27. [Epub ahead of print]

57. Mmeje CO, Nunez-Nateras R, Nielsen ME, Pruthi RS, Smith A, Wallen EM, Humphreys

MR, Woods ME, Castle EP. Oncologic outcomes for lymph node-positive urothelial

carcinoma patients treated with robot assisted radical cystectomy: With mean follow-up of

3.5 years. Urol Oncol. 2012 Apr 23. [Epub ahead of print]

58. Nielsen ME, Smith AB, Pruthi RS, Guzzo TJ, Amiel G, Shore N, Lotan Y. Reported use of

intravesical therapy for non-muscle-invasive bladder cancer (NMIBC): results from the

Bladder Cancer Advocacy Network (BCAN) survey. BJU Int. 2012 Apr 4. [Epub ahead of

print]

59. Ferguson JE 3rd, Goyal RK, Raynor MC, Nielsen ME, Pruthi RS, Brown PM, Wallen EM.

Cost Analysis of Robot-Assisted Laparoscopic Versus Hand-Assisted Laparoscopic Partial

Nephrectomy. J Endourol. 2012 Apr 26. [Epub ahead of print]

60. Smith AB, Raynor M, Amling CL, Busby JE, Castle E, Davis R, Nielsen M, Thomas R,

Wallen EM, Woods M, Pruthi RS. Multi-institutional analysis of robotic radical cystectomy

10

for bladder cancer: perioperative outcomes and complications in 227 patients. J

Laparoendosc Adv Surg Tech A. 2012 Jan;22(1):17-21. Epub 2011 Dec 5.

61. Brannon AR, Haake SM, Hacker KE, Pruthi RS, Wallen EM, Nielsen ME, Rathmell WK.

Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup

and identifies gender influences on tumor biology. Eur Urol. 2012 Feb;61(2):258-68. Epub

2011 Oct 18.

62. Manvar AM, Rathmell WK, Ferguson J, Pruthi RS, Nielsen ME, Wallen EM, Nolan N,

Raynor MC. Carcinoma in a Cadaveric Transplant Kidney. Urology. 2011 Oct 18. [Epub

ahead of print] No abstract available.

63. Smith AB, Raynor MC, Pruthi RS. Peri- and postoperative outcomes of robot-assisted

radical cystectomy (RARC). BJU Int. 2011 Sep;108(6 Pt 2):969-75. doi: 10.1111/j.1464-

410X.2011.10456.x. Review.

64. Raynor MC, Lavien G, Nielsen M, Wallen EM, Pruthi RS. Elimination of preoperative

mechanical bowel preparation in patients undergoing cystectomy and urinary diversion. Urol

Oncol. 2011 Jun 28. [Epub ahead of print]

65. Whang YE, Armstrong AJ, Rathmell WK, Godley PA, Kim WY, Pruthi RS, Wallen EM,

Crane JM, Moore DT, Grigson G, Morris K, Watkins CP, George DJ. A phase II study of

lapatnib, a dual EGFR and HER-2 tyrosine kinase inhibitor in patients with castration-

resistant prostate cancer. Urol Oncol, 2011 Mar 9. Epub ahead of print.

66. Coward RM, Smith A, Raynor M, Nielsen M, Wallen EM, Pruthi RS. Feasibility and

outcomes of robotic-assisted laparoscopic radical cystectomy for bladder cancer in older

patients. Urology. 2011 May;77(5):1111-4. Epub 2011 Feb 18

67. Manvar AM, Wallen EM, Pruthi RS, Nielsen ME. Prognostic value of CA 125 in

transitional cell carcinoma of the bladder. Expert Rev Anticancer Ther, 2010; 10(12):1877-

81.

68. Davis JW, Castle EP, Pruthi RS, Ornstein DK, Guru KA. Robot-assisted radical

cystectomy: An expert panel review of the current status and future direction. Urol Oncol,

2010 Sept-Oct; 28(5):480-6. Epub 2010 Mar 5

69. Hayn MH, Hellenthal NJ, Hussain A, Andrews PE, Carpentier P, Castle E, Dasgupta P,

Davis R, Thomas R, Khan S, Kibel A, Kim H, Manoharan M, Menon M, Mottrie A,

Ornstein D, Peabody J, Pruthi R, Palou Redorta J, Vira M, Schanne F, Stricker H, Wiklund

P, Wilding G, Guru KA. Does previous robot-assisted radical prostatectomy experience

affect outcomes at robot-assisted radical cystectomy? Results from the International

Robotic Cystectomy Consortium. Urology. 2010 Aug 13. Epub ahead of print.

70. Hayn MH, Hussain A, Mansour AM, Andrews PE, Carpentier P, Castle E, Dasgupta P,

Rimington P, Thomas R, Kahn S, Kibel A, Kim H, Manoharan M, Menon M, Mottrie A,

Ornstein D, Pruthi R, Palou Redorta J, Richstone L, Schanne F, Stricker H, Wiklund P,

Chandrasekhar R, Wilding GE, Guru KA. Reply from authors re: Urs E, Studer, Laurence

Collette. The learning curve of robot-assisted radical cystectomy: Does it meet expectations?

Eur Urol 2010 Aug; 58(2):204-6. Epub 2010 June 15; No abastracts available.

11

71. Pruthi RS, Nielsen M, Heathcote S, Wallen EM, Rathmell WK, Godley P, Whang Y,

Fielding J, Schultz H, Grigson G, Smith A, Kim W. A phase II trial of neoadjuvanant

erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy:

clinical and pathological results. BJU Int, 2010 Aug; 106(3):349-56. Epub 2010 Jan 19.

72. Hellenthal NJ, Hussain A, Andrews PE, Carpentier P, Castle E, Dasgupta P, Kaouk J, Khan

S, Kibel A, Kim H, Manoharan M, Menon M, Mottrie A, Ornstein D, Palou J, Peabody J,

Pruthi R, Richstone L, Schanne F, Stricker H, Thomas R, Wiklund P, Wilding G, Guru KA.

Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the

International Robotic Cystectomy Consortium. BJU Int, 2010 June 18. Epub ahead of print.

73. Swords K, Wallen E, Pruthi RS. The impact of race on prostate cancer detection and choice

of treatment in men undergoing a contemporary extended biopsy approach. Urol Oncol.

2010 May-Jun; 28(3):280-4. Epub 2008 Dec 12.

74. Pruthi RS, Nix J, McRackan D, Hickerson A, Nielsen ME, Raynor M, Wallen EM. Robotic-

assisted laparoscopic intracorporeal urinary diversion. Eur Urol, 2010 Jun; 57(6):1013-21.

Epub 2010 Jan 9.

75. Hellenthal NJ, Hussain A, Andrews PE, Carpentier P, Castle E, Dasgupta P, Kaouk J, Kahn

S, Kibel A, Kim H, Manoharan M, Menon M, Mottrie A, Ornstein D, Palou J, Peabody J,

Pruthi R, Richstone L, Schanne F, Stricker H, Thomas R, Wiklund P, Wilding G, Guru KA.

Surgical margin status after robot-assisted radical cystectomy: Results from the

International Robotic Cystectomy Consortium. J Urol, 2010; 184(1):87-91. Epub 2010

May 15.

76. Raynor MC, Pruthi RS. Robot-assisted surgery: applications in urology. Open Access J

Urol, 2010 May; 2010(2):85-89.

77. Hayn MH, Hussain A, Mansour AM, Andrews PE, Carpentier P, Castle E, Dasgupta P,

Rimington P, Thomas R, Khan S, Kibel A, Kim H, Manoharan M, Menon M, Mottrie A,

Ornstein D, Peabody J, Pruthi R, Redorta JP, Richstone L, Schanne F, Stricker H, Wiklund

P, Chandresekhar R, Wilding GE, Guru KA. The learning curve of robot-assisted radical

cystectomy: Results from the International Robotic Cystectomuy Consortium. Eur Urol,

2010; 58(2):197-202. Epub ahead of print 2010 Apr 23.

78. Cowey CL, Amin C, Pruthi RS, Wallen EM, Nielsen ME, Grigson G, Watkins C, Nance

KV, Crane J, Jalkut M, Moore DT, Kim WY, Godley PA, Whang YE, Fielding JR, Rathmell

WK. Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell

carcinoma. J Clin Oncol, 2010 Mar 20; 28(9):1502-7. Epub 2010 Feb 16

79. Brannon AR, Reddy A, Seller M, Arreola A, Moore DT, Pruthi RS, Wallen EM, Nielsen

ME, Liu H, Nathanson KL, Ljungberg B, Zhao H, Brooks JD, Ganesan S, Bhanot G,

Rathmell WK. Molecular stratification of clear cell renal cell carcinoma by consensus

clustering reveals distinct subtypes and survival patterns. Gene Cancer, 2010 Feb 1;

1(2):152-163.

80. Rathmell WK, Pruthi R, Wallen E. Neoadjuvant treatment of renal cell carcinoma. Urol

Oncol, 2010 Jan-Feb; 28(1):69-73. Review.

12

81. Nix J, Smith A, Kurpad R, Nielsen ME, Wallen EM, Pruthi RS. Prospective randomized

controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative

and pathologic results. Eur Urol, 2010 Feb; 57(2):196-201. Epub 2009 Oct 20.

82. Pruthi RS, Nielsen M, Nix J, Smith A, Schultz H, Wallen E. Robotic radical cystectomy for

bladder cancer: surgical and pathological outcomes in 100 consecutive cases. J Urol, 2010

Feb; 183(2):510-4. Epub 2009 Dec 14.

83. Smith A, Kurpad R, Lal A, Nielsen M, Wallen E, Pruthi RS. Cost analysis of robotic versus

open radical cystectomy for bladder cancer. J Urol, 2010 Feb; 183(2):505-9. Epub 2009

Dec 14.

84. Pruthi RS, Nielsen M, Smith A, Nix J, Kurpad R, Schultz H, Wallen E. Fast track program

in patients undergoing radical cystectomy: results in 362 consecutive cases. J of Amer College of Surgeons, 2010 Jan; 210(1):93-99. Epub 2009 Oct 28.

85. Smith AB, Nielsen ME, Wallen EM, Pruthi RS. Current status of robot-assisted radical

cystectomy. Curr Opin Urol, 2010 Jan; 20(1):60-4. Review.

86. Raynor M, Pruthi R. Robot-assisted surgery: applications in urology. Open Access J of

Urology. 2010 May, vol 2;85-89.

87. Kim WY, Whang YE, Pruthi RS, Baggstrom MQ, Rathmell WK, Rosenman JG, Wallen

EM, Goyal LK, Grigson G, Watkins C, Godley PA. Neoadjuvant docetaxel/estramustine

prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate

cancer: A phase II trial. Urol Oncol, 2009 Dec 21; epub ahead of print.

88. Mishel MH, Germino BB, Lin L, Pruthi RS, Wallen EM, Crandell J, Blyler D. Managing

uncertainty about treatment decision making in early stage prostate cancer: a randomized

clinical trial. Patient Educ Couns, 2009 Dec; 77(3):349-59. Epub 2009 Oct 9.

89. Kouba E, Lentz A, Wallen E, Pruthi R. Clinical use of serum CA-125 levels in patients

undergoing radical cystectomy for transitional cell carcinoma of the bladder. Urol Oncol,

2009 Sep-Oct;27(5):486-90. Epub 2008 Jun 16.

90. Pruthi RS, Lentz AC, Sand M, Kouba E, Wallen EM. Impact of marital status in patients

undergoing radical cystectomy for bladder cancer. World J Urol, 2009 Aug; 27(4):573-6.

Epub 2009 Feb 15.

91. Pruthi RS, Belsante J, Kurpad R, Nielsen ME, Wallen EM. Robotic cystectomy and the

Internet: Separating fact from fiction. Urol Oncol, 2009 July 2. Epub ahead of print.

92. Kurpad R, Kim W, Rathmell WK, Godley P, Whang Y, Fielding J, Smith L, Pettiford A,

Schultz H, Nielsen M, Wallen E, Pruthi R. A multidisciplinary approach to the management

of urologic malignancies: does it influence diagnostic and treatment decisions? Urol Oncol.

2009 Jul2. Epub ahead of print.

93. Pruthi RS, Wallen EM. Current status of robotic prostatectomy: Promises fulfilled. J Urol,

2009 Jun; 181(6):2420-1. Epub 2009 Apr 15. No abstract available.

13

94. Wright TM, Brandon AR, Gordan JD, Milels AJ, Mitchell C, Chen S, Espinosa I, van de

Rijn M, Pruthi R, Wallen E, Edwards L, Nusse R, Rathmell WK. Ror2, a developmentally

regulated kinase, promotes tumor growth potential in renal cell carcinoma. Oncogene, 2009;

28(27):2513-23. Epub 2009 May 18.

95. Satia JA, Walsh JF, Pruthi RS. Health behavior changes in white and African American

prostate cancer survivors. Cancer Nurs, 2009 Mar - Apr; 32(2):107-17.

96. Pruthi RS, Wallen EM. Robotic-assisted laparoscopic pelvic lymphadenectomy for bladder

cancer: a surgical atlas. J Laparoendosc Adv Surg Tech A, 2009 Feb; 19(1):71-4.

97. Pruthi RS, Stefaniak H, Hubbard JS, Wallen EM. Robotic anterior pelvic exenteration for

bladder cancer in the female: outcomes and comparisons to their male counterparts. J

Laparoendsc & Adv Surg Tech A. 2009 Feb; 19(1):23-7

98. Pruthi RS, Swords K, Schultz H, Carson CC, Wallen E. The impact of obesity on the

diagnosis of prostate cancer using a modern extended biopsy scheme. J Urol, 2009 Feb;

181(2):574-7; discussion 578. Epub 2008 Dec 13.

99. Kimple RJ, Wallen EM, Pruthi R, Marks LB. A simple algorithm to assess patient

suitability for Calypso-see implantation for four-dimensional prostate localization. J Appl

Clin Med Phys, 2009; 11(1):3107.

100. Coward R, Simhan J, Pruthi R, Carson C. Racial differences in hypogonadal

improvement and prostate-specific antigen in hypogonadal men treated with testosterone

replacement therapy. J of Mens Hlth, 2009; 6(3):233.

101. Pruthi RS, Smith A, Wallen E. Evaluating the learning curve for robotic-assisted

laparoscopic radical cystectomy. J Endourol, 2008 Nov; 22(11):2469-74.

102. Amin C, Wallen E, Pruthi RS, Calvo BF, Godley PA, Rathmell WK. Preoperative

tyrosine kinase inhibition as an adjunct to debulking nephrectomy. Urology, 2008 Oct;

72(4):864-8. Epub 2008 Aug 5.

103. Pruthi RS, Stefaniak H, Hubbard JS, Wallen E. Robot-assisted laparoscopic anterior

pelvic exenteration for bladder cancer in the female. J Endourol, 2008 Oct; 22(10):2397-

402. Discussion 2402. Epub 2008 Jul 11.

104. Pruthi RS, Wallen E. Is robotic radical cystectomy an appropriate treatment for bladder

cancer? Short-term oncologic and clinical follow-up in 50 consecutive patients. Urol, 2008

Sep; 72(3):617-20; discussion 620-2. Epub 2008 Jun 30.

105. Rathmell K, Amin C, Cowey C, Pruthi RS, Wallen E, Khandani A. Neoadjuvant therapy

with sorfenib for locally advanced renal cell carcinoma (RCC). Urol, Epub 2008 Aug 4.

106. Kouba E, Wallen E, Pruthi RS. Management of ureteral obstruction due to advanced

malignancy: optimizing therapeutic and palliative outcomes. J Urol, 2008 Aug;180(2):444-

50. Epub 2008 Jun 11.

14

107. Pruthi RS, Wallen E. Surgery in Motion: Robotic-assisted laparoscopic radical

cystoprostatectomy. Eur Urol (paper and video). Eur Urol, 2008 Feb; 53(2):310-22. Epub 2007

Mar 28.

108. Hall MC, Chang SS, Dalbagni G, Pruthi R.S., Schellhammer P., Seigne J, Skinner EC,

Wolf JS. Treatment principles for nonmuscle invasive bladder cancer: A review of the

updated AUA guidelines. Contemporary Urology, 2008; 8-14.

109. Pruthi RS, Baldwin N, Bhalani V, Wallen E. Conservative management of patients with

low-risk superficial bladder cancer. J Urol, 2008 Jan; 179(1):87-90; discussion 90. Epub

2007 Nov 12.

110. Hall MC, Chang SS, Dalbagni G, Pruthi RS, Schellhammer P, Seigne J, Skinner EC,

Wolf JS. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta,

T1, and Tis). J Urol, 2007 Dec; 178:2314-30. Review. No abstract available.

111. Kouba E, Wallen E, Pruthi RS. Gum chewing stimulates recovery of bowel function in

patients undergoing cystectomy and urinary diversion. Urology, 2007 Dec; 70(6):1053-6.

112. Kouba E, Sands M, Lentz A, Wallen E, Pruthi RS. Incidence and risk factors of stomal

complications in patients undergoing radical cystectomy with ileal conduit urinary diversion

for bladder cancer. J Urol, 2007 Sep; 178(3 Pt 1):950-4. Epub 2007 Jul 16.

113. Pruthi RS, Wallen E. Robotic-assisted laparoscopic radical cystoprostatectomy:

operative and pathologic outcomes. J Urol, 2007 Sep; 178(3):814-8. Epub 2007 Jul 16.

114. Kouba E, Sands M, Lentz A, Wallen E, Pruthi RS. A comparison of the Bricker versus

Wallace ureteroileal anastomosis in patients undergoing urinary diversion for bladder

cancer. J Urol, 2007 Sep; 178(3 Pt 1):945-8; discussion 948-9. Epub 2007 Jul 16.

115. Miller J, Smith A, Kouba E, Wallen E, Pruthi RS. Prospective evaluation of short-term

impact and recovery of health-related quality of life (HRQOL) in men undergoing robotic-

assisted laparoscopic radical prostatectomy vs. open radical prostatectomy. J Urol, 2007

Sep; 178(3 Pt 1):854-8; discussion 859. Epub 2007 Jul 16.

116. Wallen E, Pruthi RS, Joyce GF, Wise M. The burden of kidney cancer in America: the

urologic diseases of America project. J Urol, 2007 Jun; 177:2006-18; discussion 2018-9.

117. Kouba E, Smith A, Derksen JE, Gunn K, Wallen E, Pruthi RS. Efficacy and safety on en

bloc ligation of the renal hilum during laparoscopic nephrectomy. Urology, 2007 Feb;

69(2):226-9. Epub 2007 Jan 31.

118. Kouba E, Smith A, McRackan D, Wallen E, Pruthi RS. Watchful waiting for solid renal

masses: insight into the natural history and the results of delayed intervention. J Urol, 2007

Feb; 177(2):466-70; discussion 470.

119. McLaughlin S, Shephard J, Wallen E, Maygarden S, Carson CC, Pruthi RS. Comparison

of the clinical and pathologic staging in patients undergoing radical cystectomy for bladder

cancer. Int Braz J Urol, 2007 Jan-Feb; 33(1):25-31; discussion 31-2.

15

120. Kouba E, Evans A, Gaston KE, Lavelle JP, Pruthi RS. From simple urinary tract infection to

transitional cell carcinoma of the bladder: evaluation of patients with irritative voiding symptoms.

Issues in Urology, 2007; pp. 43-48.

121. Kouba E, Hubbard JS, Wallen E, Pruthi RS. Incisional hernia in a 12 mm non-bladed trocar site

following laparoscopic nephrectomy. Urol Int, 2007; 79 (3):276-9.

122. Pruthi RS, Hubbard JS, Kouba E, Wallen EM. Androgen-independent prostate cancer treated

with resection of the solitary metastatic site. Urol Int, 2007; 79(4):371-3.

123. Kouba E, Wallen E, Pruthi RS. Uroscopy by Hippocrates and Theophilus: prognosis

versus diagnosis. J Urol, 2007 Jan; 177(1):50-2.

124. Kouba E, Hubbard JS, Moore D, Wallen E, Pruthi RS. Prospective evaluation of short-

term impact and recovery of health-related quality of life in men undergoing radical

prostatectomy. BJU Int, 2007 Jan; 99(1):72-6.

125. Tornehl C, Derksen JE, Maygarden S, Connolly AM, Pruthi RS. Bladder leiomyoma

resection facilitated by abdominal development of the paravaginal space. Issues in Urology,

2007; p. 14-17.

126. Pruthi RS, Kouba E, Carson CC, Wallen E. Cyclooxygenase-2 inhibitors and other NSAIDs

in urology: current peril or future promise. Urology, 2006 Nov; 68(5):917-23. Review. No

abstract available.

127. Pruthi RS, Tornehl C, Gaston K, Lee K, Moore D, Carson C, Wallen E. Impact of race,

age, income and residence on prostate cancer knowledge, screening behavior and health

maintenance in siblings of patients with prostate cancer. Eur Urol, 2006 Jul; 50(1):64-9.

Epub 2005 Dec 12.

128. Pruthi RS, Kouba E, Hubbard JS, Funkhouser W, Wallen E. Large presacral

schwannoma after radical prostatectomy: Part 2. Eur Urol, June 2006; pp 968-971.

129. Pruthi RS, Hubbard JS, Kouba E, Funkhouser W, Wallen E. Short Survey: Large

presacral schwannoma after radical prostatectomy. Eur Urol, 2006 May;49(5): 914-7. Epub

2006 Feb 24.

130. Gaston KE, Pruthi RS. Racial differences in prostate cancer. NC Med J, 2006 Mar-Apr;

67(2):130-5.

131. Pruthi RS, Derksen JE, Moore D, Carson CC, Grigson G, Watkins C, Wallen E. Phase II

trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive

radiation therapy or radical prostatectomy. Clin Cancer Res, 2006 Apr 1; 12(7 Pt 1):2172-7.

132. Kouba E, Hubbard JS, Wallen E, Pruthi RS. Incisional hernia in a 12 mm non-bladed

trocar site following laparoscopic nephrectomy. TSW Urol, 2006 Mar 26; 6:2399-402 .

133. Thomas R, Albala DM, Castle EP, Pruthi RS. Symposium: Robotic surgery in urology:

Hype, hope, and reality. Contemporary Urology, 2006; p. 26-32.

16

134. Fielding JR, Borland D, Lee KH, Clarke JP, Wallen E, Pruthi R, Taylor RM. Virtual

pyeloscopy using volumetric depth peeling. Acad Radiol, 2006; 13(6):759-63.

135. Gaston KE, Kouba E, More DT, Pruthi RS. The use of erythropoeitin in patients

undergoing radical prostatectomy: effects on hemtocrit, transfusion rates, and quality of life.

Urol Int, 2006; 77(3):211-5.

136. Molitierno J, Evans A, Mohler JL, Moore D, Pruthi RS. Characterization of biochemical

recurrence after radical prostatectomy. Urol Int, 2006; 77(2):130-4.

137. Derksen JE, Pruthi RS. A case of urachal adenocarcinoma in a young female treated with

partial cystectomy. Issues in Urology, 2006; pp.14-17.

138. Smith JA, Cookson M, Hall MC, Keane TE, Pruthi RS. Confronting a rising PSA after

prostatectomy. Patient Care, 2005; pp 16-22.

139. Pruthi RS, Wallen E. Cyclooxygenase-2: a therapeutic target for prostate cancer. Clin

Genitourin Cancer, 2005; 4(3):203-11.

140. Hubbard JS, Pruthi RS, Wallen EM. A guide to understanding and minimizing the

complications of laparoscopic urologic surgery. Contemporary Urology, 2005; p 46-51.

141. Maygarden SJ, Pruthi RS. Gleason grading and volume estimation in prostate needle

biopsies: evolving issues. Am J Clin Pathol, 2005; 123 Suppl:S58-66.

142. Kouba E, Evans AJ, Gaston K, Wallen EW, Pruthi RS. Cystititis, carcinoma, and the use

of urinary cytology. Issues in Urology, 2005; pp.1-7.

143. Richman M, Pruthi RS. Laparoscopic excision of parapelvic renal cyst causing

obstructive uropathy. Issues in Urology, 2005; pp 1-4.

144. Stefaniak HM, Wallen E, Pruthi RS. The contribution of race to prostate cancer outcome

– tumor biology versus socioeconomic and behavioral factors. Contemporary Urology,

145. 2005; 66-70.

146. Richman M McLaughlin S, Maygarden S, Pruthi RS. Initial incision of the lateral pelvic

fascia and early ligation of the vascular pedicles during radical prostatectomy: potential to

reduce positive margin rates. BJU Int, 2005 Jan; 95(1):40-5.

147. Pruthi RS, Derksen JE, Gaston K, Wallen EW. Rationale for the use of COX-2 inhibitors

in prevention and treatment of bladder cancer. Urology, 2004 Oct; 64(4):637-42.

148. Kouba E, Tornehl C, Lavelle J, Wallen E, Pruthi RS. Partial nephrectomy with fibrin

glue repair: measurement of vascular and pelvicaliceal bond integrity in a live porcine and

isolated abbatoir animal model. J Urol, 2004 Jul; 172: 326-30.

149. Gaston K, Pruthi RS. Value of urinary cytology in the diagnosis and management of

urinary tract malignancies. Urology, 2004 Jun; 63(6):1009-16

150. Pruthi RS, Chun J, Richman M. The use of a fibrin tissue sealant during laparoscopic

partial nephrectomy. BJU Int, 2004 Apr; 93:813-7.

17

151. Richman M, Molitierno J, Pruthi RS. Retroperitoneal cyst of the lienorenal ligament.

Urology, 2004 Feb; 63(2): 379.

152. Pruthi RS, Derksen JE, Moore D. A pilot study of use of the cyclooxygenase-2 inhibitor

celecoxib in recurrent prostate cancer after definitive radiation therapy or radical

prostatectomy. BJU Int, 2004 Feb; 93(3):275-8.

153. Chun J, Pruthi RS. Is neoadjuvant hormonal therapy before radical prostatectomy

indicated? Urol Int, 2004; 72(4):275-80.

154. Smith JA, Cookson M, Hall MC, Keane TE, Pruthi RS. Confronting a rising PSA after

prostatectomy. Contemporary Urology, 2004; 16: 34-46.

155. Kang J, Mohler JL, Pruthi RS. Comparison of clinical and pathological features in

African American and Caucasian patients with localized prostate cancer. BJU Int, 2004; 93

:1207-10.

156. Derksen E, Pruthi RS. COX-2 inhibitors in PSA-recurrent prostate cancer: a pilot study.

BJU Int, 2004; 93: 275-8.

157. Gaston K, Moore DT, Pruthi RS. Hand-assisted laparoscopic nephrectomy: prospective

evaluation of the learning curve. J Urol, 2004 Jan; 171(1); 63-7.

158. Pruthi RS, Richman M, Derksen JE, Maygarden S. Stage T1 renal cell carcinoma

relapsing in the vagina 10 years after initial diagnosis. J Urol, 2003 Dec; 170(6 Pt 1): 2379-

80.

159. Pruthi RS, Chun J, Richman M. Reducing time to oral diet and hospital discharge in

patients undergoing radical cystectomy using a perioperative care plan. Urology, 2003 Oct;

62(4): 661-5; discussion 665-6.

160. Pruthi RS, Derksen JE, Gaston K. Cyclooxygenase-2 as a potential target in the

prevention and treatment of genitourinary tumors: a review. J Urol, 2003 June; 169(6):

2352-9.

161. Pruthi RS, Gaston K, Derksen JE. Regarding effect of nonsteroidal anti-inflammatory

agents and finasteride on prostate cancer risk. J Urol, 2003 Jun; 169(6):2304; author

162. reply 2304-5.

163. Pruthi RS, Chun J, Richman M. Hand-assisted laparoscopic nephrectomy: complications

related to the handport site. BJU Int, 2003 Apr; 91(6):584-5.

164. Pruthi RS, Issa MM, Fielding J. Evaluation and treatment of the incidental adrenal mass.

Contemporary Urology, 2003 Apr; 43-55.

165. Pruthi RS, Derksen JE. Use of the COX-2 inhibitor celecoxib in PSA-recurrent prostate

cancer after definitive radiation therapy or radical prostatectomy. Prostate Cancer and

Prostatic Diseases, 2003; 6 (Suppl 1): S30.

18

166. Gaston K, Lee K, Pruthi RS. Impact of race, income, and residence on prostate cancer

knowledge, screening behavior, and health maintenance in sibling of patients with prostate

cancer. J American College of Surgeons, 2003; 197 (3 Suppl): S92.

167. Pruthi RS. PSA doubling time may point to cancer aggressiveness. Urology Times,

2003; 31(3), 32.

168. Derksen JE, Fitzsimmons N, Ornstein D, Pruthi RS. Early urethral catheter removal after

radical retropubic prostatectomy. J American College of Surgeons, 2003; 197 (3 Suppl):

S92.

169. Small E, Halabi S, Dalgagni G, Pruthi R, Phillips G, Edelman M, Bajorin D. Overview of

bladder cancer trials in the cancer and leukemia group B. Cancer, 2003; 97(8 Suppl): 2090-

8.

170. Pruthi RS, Kang J, Vick R. Desmopressin-induced hyponatremia and seizures after

laparoscopic radical nephrectomy. J Urol, 2002 Jul; 168(1):187.

171. Chun J, Pruthi RS. The role of neoadjuvant hormonal therapy before radical

prostatectomy. The Prostate Journal, 2002; 4(4):86-90.

172. Pruthi RS, Richman M, Ornstein DK. A case of T1c, N3, M1 prostate cancer. Urol Int,

2002; 69(1):82-4.

173. Ornstein DK, Pruthi RS. Prostate-specific antigen. Expert Opin Pharmacother, 2000

Dec; 1(7):1399-1411.

174. Pruthi RS. Regarding prostate specific antigen bounce after radioactive seed implantation

followed by external beam radiation for prostate cancer. J Urol, 2000 Dec; 164(6):2031.

175. Pruthi RS, Petrus CD, BundrickWS Jr. New onset vesicovaginal fistula after transurethral

collagen injection in women who have undergone cystectomy and orthotopic neobladder

creation: presentation and definitive treatment. J Urol, 2000 Nov; 164(5):1638-9.

176. Pruthi RS. The dynamics of PSA in benign and malignant diseases of the prostate. BJU

Int, 2000 Oct; 86(6):652-8.

177. Pruthi RS, Petrus CD, Nidess R. Venable DD. Penile fracture of the proximal corporal

body. J Urol, 2000 Aug; 164(2):447-8.

178. Petrus CD, Pruthi RS. Crossed renal ectopia with an associated ureteral stone:

sonographic, CT, and pyelographic findings. Infections in Urology, 2000; 13(6):159-62.

179. Pruthi RS. PSA Kinetics: A review of PSA doubling times and half-lives in patients with

treated and untreated prostate cancer. The Prostate Journal, 2000; 2(4).

180. Pruthi RS. The value of urine cytology in the diagnosis and management of urinary tract

malignancies. Pathology Case Reviews, 2000; 5(2):102-5.

19

181. Pruthi RS, Angell SA, Brooks JD, Gill HG. Partial nephrectomy and caval thrombectomy

for renal cell carcinoma in a solitary kidney with an accessory renal vein. BJU Int, 1999

Jan; 83(1):142-3.

182. Angell SA, Pruthi RS, Shortliffe LD. The urodynamic relationship of renal pelvic and

bladder pressures, and urinary flow rate in rats with congenital vesicoureteral reflux. JUrol,

1998 Jul; 160(1):150-6.

183. Pruthi RS. Regarding recurrence patterns after radical retropubic prostatectomy: clinical

usefulness of prostate specific antigen doubling times and log slope prostate specific

antigen. J Urol, 1998 May; 159(5):1650.

184. Angell SA, Pruthi RS, Gill H. A testicular teratoma with a unique mode of spread. Urol

Int, 1998; 61(2):119-20.

185. Pruthi RS, Terris MK, Issa MI, Kabalin J.K. Renal masses presenting 25 and 50 years

following blunt renal trauma. Urol Int, 1998; 61(1):43-6.

186. Pruthi RS, Angell SA, Dubocq F, Merguerian PA, Shortliffe LD. The use of renal

parenchymal area in children with high grade vesicoureteral reflux. J Urol, 1997 Sep; 158(3

Pt 2):1232-5.

187. Pruthi RS, Johnstone I, Tu IP, Stamey TA. PSA doubling times in patients who fail

radical prostatectomy: correlation with histologic characteristics of the primary cancer.

Urology, 1997 May; 49(5):737-42.

188. Pruthi RS, Haese A, Huland E, Stamey TA. The use of serum concentration techniques to

enhance early detection of recurrent prostate cancer after radical prostatectomy. Urology,

1997 Mar; 49 (3):404-10.

189. Issa MM, Mc, Pruthi RS , Namara D. New technique of ureteral stent placement

impacted ureteral calculus: the guidewire loop technique. Urology, 1997 Apr; 49 (4):614-7.

190. Issa MM, Pruthi RS, Vial C, McNamara DE, Terris MK. An unusual complication

following uroflowmetry: hyponatremia and seizure. Urologia Internationalis, 1997;

59(2):129-30.

191. Pruthi RS, Angell SK, Gill H. Furuncular myiasis of the scrotum. Infections in Urology,

1997; 10 (4):102-4.

192. Angell SA, Pruthi RS, Merguerian PA. Pediatric genitourinary tumors. Curr Opin Oncol,

1996 May; 8(3):240-6.

193. Angell SA, Pruthi RS, Freiha FS. A primary thyroid-like carcinoma of the kidney.

Urology, 1996; 48 (4): 632-5.

194. Pruthi RS, Angell SA, Dubocq F, Merguerian PA, Shortliffe LD. Use of longitudinal

renal parenchymal area in children with high grade vesicoureteral reflux. Pediatrics, 1996;

98 (3):619.

20

195. Farouk M, Vigna SV, Haebig JA, Gettys TW, McVeyDC, Chari R, Pruthi RS, Meyers

WC. Secretin receptors in a new preparation of plasma membranes from intrahepatic biliary

epithelium. Journal of Surgical Research, 1993 Jan; 54:1-6.

196. Pruthi RS, Farouk M, Tsai WS, Michalopoulos G, Meyers WC. The effect of octreotide

on hepatic regeneration in rats. Surgery, 1993 Jan; 113(1):84-9.

197. Farouk M, Geoghegan JG, Pruthi RS, Pappas TN, Meyers WC. ICV neuropeptide Y

stimulates bile duct secretion via a vagal mechanism. Gut, 1992 Nov; 33(11):1562-5.

198. Pruthi RS, Farouk M, Meyers WC. Somatostatin analogue inhibits hepatic regeneration.

Surgical Forum, 1991; 42:144-7.

199. Farouk M, Pruthi RS, Meyers WC. The appearance and characterization of intrahepatic

secretin receptors following common bile duct ligation. Surgical Forum, 1991; 42:156-9.

200. Meyers WC, Farouk M, Pruthi RS, et al.(Southern Surgeon¹s Club). A prospective

analysis of 1518 laparoscopic cholecystectomies. New England J Med, 1991; 324:1073-8.

201. Prosser ES, Pruthi RS, Csernansky JG. Differences in the time course of dopaminergic

supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.

Psychopharmacology, 1989; 99:109-16.

202. Csernansky JG, Kerr S, Pruthi RS, Prosser ES. Mesolimbic dopamine receptor increases

two weeks after hippocampal kindling. Brain Research, 1988; 449:357-60.

Editorials

1. Smith A, Pruthi RS. The impact of comorbidity on survival of invasive bladder cancer

patients, 1996-2007: a Danish population-based cohort study. Editorial Comment on Article

(Invited), Urology, 2010 Feb; 75(2):398.

2. Nix J, Pruthi RS. Significance of distal ureteral margin at radical cystectomy for urothelial

carcinoma. Invited Editorial Comment. J Urol, 2010 Jan; 183(1):86; discussion 86. Epub. No

abstract available.

3. Nix J, Pruthi RS. Reply from Authors re: Oliver W. Hakenberg. Moving towards evidence-

based surgery. Eur Urol. In press. Doi:10.1016/j.eurouro.2009.11.003, Eur Urol, 2009

November 25. Epub ahead of print. No abstract available.

4. Pruthi RS. Editorial Comment in re: Lowrance WT, Rumohr JA, Chang SS, Clark PE,

Smith JA Jr, Cookson MS. Contemporary open radical cystectomy: analysis of perioperative

outcomes. J Urol, 2008; 179(4):1313-8.

5. Pruthi RS. Editorial Comment in re: Tokgoz H, Turkolmez K, Resorlu B, Kose K, Tulunay

O, Beduk Y. Pathological staging of muscle invasive bladder cancer. Is substaging of pT2

tumors really necessary? Int Braz J Urol, 2007; 33(6):777-84.

21

6. Pruthi RS. Editorial Comment in re: Stopping smoking might reduce tumor recurrence in

nonmuscle-invasive bladder cancer. BJU Int. 2007 April 5 (epub ahead of print).

7. Pruthi RS. Editorial Comment in re: Prostate cancers scored as Gleason 6 on prostate biopsy

are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome. J Urol, 2006;

176(3):979-84; discussion 984.

8. Pruthi RS. Editorial Comment in re: Expression of COX-2 in normal and pyelonephritic

kidney, renal intraepithelial neoplasia and renal cell carcinoma. Eur Urol, 2006; 50(1):92-7.

9. Pruthi RS. Editorial Comment in re: Long-term benefit of 5-Aminolevulinic acid-

fluorescence-assisted transurethral resection of superficial bladder cancer: five-year results of a

prospective randomized study. J Urol, 2005; 175: 2291-91.

Abstracts and Scientific Presentations (refereed)

1. Graves J, Lomboy J, Wood C, Tan H, Nielsen M, Smith A, North A, McKenna P, Pruthi RS.

“Impact of surgeon practice location and employment type on procedural practice pattersn:

potential implications of a declining non-metropolitan (NM) workforce.” Poster Session at

the American Urological Association Annual Meeting, San Francisco, CA, May 20, 2018.

2. McCormick B, Deal A, Borawski K, Raynor M, Viprakasit D, Wallen E, Woods M, Pruthi

RS. “Implementation of medical scribes in an academic urology practice: an analysis of

productivity, revenue, and satisfaction.” Poster Session at the American Urological

Association Annual Meeting, San Francisco, CA, May 20, 2018

3. Tan H, Chung A, Gotz D, Smith A, Wallen E, Pruthi RS , Nielsen, M. “Desperate Access to

Electronic Health Records and Quality Reporting Among Urologists” Poster Session at

the American Urological Association Annual Meeting, San Francisco, CA, May 18, 2018.

4. Garrren B, Mueller D, Filippou P, Narang G, Nielsen M, Pruthi R, Et al. “Importance of

patient-reported outcomes in improving perioperative care among cystectomy patients”

Podium Session at the American Urological Association Annual Meeting, San Francisco,

CA, May 18, 2018.

5. Filippou P, Mahajan S, Deal A, Wallen EM, Pruthi RS, H Tan, Smith AB. ‘Gender bias in

letters of recommendation for urology resident applicants.’ Podium presentation at the American College of Surgeons Clinical Congress, San Diego, CA, October 2017.

6. Filippou P, Deal A, Narang G, McCormick BJ, Nielsen ME, Pruthi RS, Wallen EM, Woods

ME, Smith AB. ‘Patient refusal of neo-aduvant chemotherapy for muscle invasive bladder

cancer.’ Podium presentation at the American Urological Association Annual Meeting,

Boston, MA, May 2017.

7. Casilla−Lennon M, Cho S, Deal A, Benson J, Narang G, Filippou P, McCormick B, Pruthi R,

Wallen E, Woods M, Nielsen ME, Smith A. “Financial Toxicity Prevalence and Delay in

22

Care Among Bladder Cancer Patients.” American Urologic Association Annual Meeting.

Boston, Massachusetts. May 2017. Poster Presentation.

8. Filippou P, Deal A, Narang G, McCormick BJ, Nielsen ME, Pruthi RS, Wallen EM, Woods

ME, Smith AB. ‘Patient refusal of neo-aduvant chemotherapy for muscle invasive bladder

cancer.’ Podium presentation at the Southeastern Section of American Urological Association

Annual Meeting, Austin, Texas March 24 2017.

9. Casilla−Lennon M, Cho S, Deal A, Benson J, Narang G, Filippou P, McCormick B, Pruthi R,

Wallen E, Woods M, Nielsen ME, Smith A. “Financial Toxicity Prevalence and Delay in

Care Among Bladder Cancer Patients.” Southeastern Section of American American

Urologic Association Annual Meeting. Boston, Massachusetts. March 24, 2017. Poster

Presentation.

10. Pauline Filippou, Allison Deal, Benjamin McCormick Raj Pruthi. State of the Art Lecture:

Robotic Radical Cystectomy: What we have learned over the past 10 years. Society of

Robotic Surgery Annual Meeting. February 25, 2017. Miami, Florida.

11. Raj Pruthi. Video: Intra-Corporeal Ileal Conduit formation: If When, and How? Society of

Robotic Surgery Annual Meeting. February 25, 2017. Miami, Florida.

12. Raj Pruthi. Association of travel distance to cystectomy on readmission and survival.

Presentation. Society of Pelvic Surgeons Annual Meeting. October 8, 2016. St. Louis,

Missouri.

13. Raj S. Pruthi Contemporary Management of Superficial Bladder Cancer and CIS.

Presentation. Indian AUA Annual Meeting, May 7, 2016, San Diego, California.

14. Maxim McKibben, E Will Kriby, Joshua Langston, Matthew Nielsen, Mathew Raynor, Eric

Wallen, Angela Smith, Michael Woods, Raj Pruthi. Projecting the Urology Workforce over

the Next 20 Years. Podium Session. AUA Annual Meeting, May 7, 2016, San Diego,

California.

15. Troy Sukhu, Jason Lomboy, Matthew Macey, Anne Marie Meyer, Ke Meng, Matthew

Nielsen, Raj Pruthi, et al. The Association of Travel distance to cystectomy on readmission

and survival. Podium Session. AUA Annual Meeting, May 7, 2016, San Diego, California.

16. Jason Lomboy, Matthew Macey, Troy Sukhu, Sarah Stanley, Allsion Deal, Dana Meuller,

Matthew Nielsen, Raj Pruthi, et.al. Feasibility of structured telephone calls for system

management following cystectomy. Poster Session. Southeastern Section of American

Urological Association, March 20, 2016. Nashville, Tennessee.

17. Troy Sukhu, Jason Lomboy, Matthew Macey, Allison Deal, Eric Wallen, Michael Woods,

Raj Pruthi, et al. The Association between preoperative leukocytosis and postoperative

outcomes following cystectomy for bladder cancer. Poster Session. Southeastern Section of

American Urological Association, March 20, 2016. Nashville, Tennessee.

18. Troy Sukhu, Jason Lomboy, Matthew Nielsen, Anne-Marie Meyer, Ke Meng, Matthew

Nielsen, Raj Pruthi, et.al. The effect of distance to a high-volume center on receipt of

treatment for invasive bladder cancer. Poser Session. Southeastern Section of American

Urological Association, March 20, 2016. Nashville, Tennessee.

23

19. Joshua Langston, Heather Schultz, Troy Sukhu, Jason Lomboy, Matthew Macey, Venitia

Orcutt, E. Will Kirby, Matthew Nielsen, Angela Smith, and Raj Pruthi. Advanced practice

providers in the U.S. Urology. Poster Session. Southeastern Section of American Urological

Association, March 20, 2016. Nashville, Tennessee.

20. Joshua Langston, Matthew Macey, Troy Sukhu, Jason Lomboy, Allison Deal, E.Will Kirby,

Davis Viprakasit, Matthew Nielsen, Raj Pruthi and Angela Smith. Surgical Equipment cost

awareness among urological surgeons. Poster Session. Southeastern Section of American

Urological Association, March 20, 2016. Nashville, Tennessee.

21. Matthew Macey, Troy Sukhu, Jason Lomboy, Sarah Stanley, Allison Deal, Dana Meuller,

Matthew Nielsen, Raj Pruthi, et. al. Understanding the trajectory of symptoms and

functioning in the 90-day cystectomy period. Podium Session. Southeastern Section of

American Urological Association, March 20, 2016. Nashville, Tennessee.

22. Troy Sukhu, Jason Lomboy, Matthew Macey, Allison Deal, Eric Wallen, Michael Woods,

Raj Pruthi, et. al. Evaluating the timing of surgical complications following cystectomy.

Poster Session. Southeastern Section of American Urological Association, March 19, 2016.

Nashville, Tennessee.

23. Jason Lomboy, Matthew Macey, Troy Sukhu, Allison Deal, Mathew Raynor, Eric Wallen,

Michael woods, Raj Pruthi, et al. The Association between preoperative leukocytosis and

postoperative outcomes following nephrectomy for kidney cancer. Poster Session.

Southeastern Section of American Urological Association, March 18, 2016. Nashville,

Tennessee.

24. Jason Lomboy, Matthew Macey, Troy Sukhu, Anne-Marie Meyer, Ke Meng, Matthew

Nielsen, Raj Pruthi, et. al. The Relationship between travel distance to cystectomy and

likelihood and remission. Podium Session. Southeastern Section of American Urological

Association, March 18, 2016. Nashville, Tennessee.

25. Maxim McKibben, Matthew Nielsen, Raj Pruthi, et al. Robot Assisted Nephrouretectomy for

treatment of upper tract urothelial cell carcinoma. Poster Session. Southeastern Section of

American Urological Association, March 18, 2016. Nashville, Tennessee.

26. Jason Lomboy, Matthew Macey, Troy Sukhu, Allison Deal, Eric Wallen, Michael Woods,

Raj Pruthi, et al. Evaluating the timing of surgical complications following prostatectomy.

Podium Session. Southeastern Section of American Urological Association, March 17, 2016.

Nashville, Tennessee.

27. Matthew Macey, Troy Sukhu, Jason Lomboy, Allison Deal, Eric Wallen, Michael Woods,

Raj Pruthi, et. al. The Association between preoperative leukocytosis and postoperative

outcomes following prostectomy for prostate cancer. Poster Session. Southeastern Section of

American Urological Association, March 17, 2016. Nashville, Tennessee.

28. Raj S. Pruthi. Compensation and Job Satisfaction in Urology and Urologic Oncology. Society

of Urologic Oncology Annual Conference. December 2, 2015. Washington, DC.

29. Jason Lomboy, MD; Matthew Macey, MD; Troy Sukhu, MD; Anne-Marie Meyer, PhD; Ke

Meng, PhD; Matthew Nielsen, MD, MS; Raj Pruthi, MD, et al. The Effect of Distance to

24

High-Volume Center on Receipt of Treatment for invasive Bladder Cancer. Podium

Session. Society of Urologic Oncology Annual Conference. December 4, 2015. Washington,

DC.

30. Troy Sukhu, MD; Jason Lomboy, MD; Matthew Macey, MD; Anne-Marie Meyer, PhD; Ke

Meng, PhD; Matthew Nielsen MD, MS; Raj Pruthi, et al. The Relationship Between Travel

Distance to Cystectomy and likelihood of Readmission. Poster Session. Society of Urologic

Oncology Annual Conference. December 2, 2015. Washington, DC.

31. Raj S. Pruthi. Compensation and Job Satisfaction in Urology. Mid-Atlantic and New England

Sections of the American Urological Association Joint Meeting. October 23, 2015. Paradise

Island, Bahamas.

32. David Johnson, Dana Mueller, Mary Dunn, Angela Smith, Michael Woods, Eric Wallen, Raj

Pruthi and Matthew Nielsen. Reducing decisional conflict in men making treatment decisions

about localized prostate cancer. Poster Session, American Urological Association, May 19,

2015. New Orleans, LA.

33. Peter Greene, E. Sophie Spencer, Matthew Lyons, Raj Pruthi, et al. Functional outcomes

following radical cystectomy in women with bladder cancer: a systematic review. Poster

Session, American Urological Association, May 18, 2015. New Orleans, LA.

34. The Significance of symptomatology: Analysis from the International renal cell carcinoma-

venous thrombus consortium (IRCC-VTC). Jamie S Pak*, Danny Lascano, Julia B

Finkelstein, James M McKiernan, G Joel DeCastro, New York, NY, Umberto Capitanio,

Milan, Italy, Joaquı´n A Carballido, Madrid, Spain, Venancio Chantada, Corun˜a, Spain,

Thomas Chromecki, Graz, Austria, Gaetano Ciancio, Miami, FL, Siamak Daneshmand, Los

Angeles, CA, Christopher P Evans, Sacramento, CA, Paolo Gontero, Turin, Italy, Javier

Gonza´lez, Madrid, Spain, Axel Haferkamp, Frankfurt, Germany, Markus Hohenfellner,

Heidelberg, Germany, William C Huang, New York, NY, Theresa M Koppie, Portland, OR,

Estefanı´a L Espino´s, Madrid, Spain, Adam Lorentz, Atlanta, GA, Juan I Martı´nez-

Salamanca, Madrid, Spain, Dario Martul, Corun˜a, Spain, Alon Y Mass, New York, NY,

Viraj A Master, Atlanta, GA, Carmen Mir, Miami, FL, Francesco Montorsi, Milan, Italy,

Giacomo Novara, Padua, Italy, Padraic O’Malley, New York, NY, Sascha Pahernik,

Heidelberg, Germany, Juan Palou, Barcelona, Spain, Jose´ LP Moreno, Valencia, Spain, Raj

S Pruthi, Chapel Hill, et al. Poster Session. American Urological Association, May 17, 2015.

New Orleans, LA.

35. Nicholas Pruthi, Sophie Spencer, Matthew Lyons, Peter Greene, Max McKibben, Matthew

Nielsen, Raj Pruthi, et.al. The Impact of fellowship and career focus in urology on

socioeconomic , workforce, and quality of life issues. Poster Session, American Urological

Association, May 16, 2015. New Orleans, LA.

36. Matthew Lyons, Tzy-Mey Kuo, Anne-Marie Meyer, E. Sophie Spencer, Peter Greene,

Angela Smith, Michael Woods, Eric Wallen, Raj Pruthi, et al. Poster Session, American

Urological Association, May 16, 2015. New Orleans, LA.

37. E. Sophie Spencer, Peter Greene, Matthew Lyons, Anne Marie Meyer, Ke Meng, Raj Pruthi,

et al. Understanding the Relationship between 30 and 90 day Emergency room visits and

readmissions following radical cystectomy. Poster Session, American Urological Association,

May 15, 2015. New Orleans, LA.

25

38. Nicholas Pruthi, Sophie Spencer, Matthew Lyons, Peter Greene, Max McKibben, Matthew

Nielsen, Raj Pruthi, et. al. Private practice, academics, or employed: does employment status

impact work , income, and job satisfaction? Poster Session. Southeastern Section of

American Urological Association, March 22, 2015. Savannah, Georgia.

39. Nicholas Pruthi, Sophie Spencer, Matthew Lyons, Peter Greene, Max McKibben, Matthew

Nielsen, Raj Pruthi, et, al. Job satisfaction in urology: The influence of demographic,

economic and workload factors. Poster Session. Southeastern Section of American

Urological Association, March 22, 2015. Savannah, Georgia.

40. Tracy Rose, Matthew Lyons, Allison Deal, E. Sophie Spencer, Peter Greene, Matthew

Nielsen, Raj Pruthi, et.al. Trends and predictors of palliative care services and mortality in the

treatment of advanced bladder cancer. Poster Session. Southeastern Section of American

Urological Association, March 20, 2015. Savannah, Georgia.

41. Nicholas Pruthi, Sophie Spencer, Matthew Lyons, Peter Greene, Max McKibben, Matthew

Nielsen, Raj Pruthi, et.al. The Impact of fellowship and career focus in urology on

socioeconomic , workforce, and quality of life issues. Poster Session. Southeastern Section

of American Urological Association, March 19, 2015. Savannah, Georgia.

42. Nicholas Pruthi, Sophie Spencer, Matthew Lyons, Peter Greene, Max McKibben, Matthew

Nielsen, Raj Pruthi, et, al. The feminization of the workforce in urology: economic,

workforce, and quality of life issues. Poster Session. Southeastern Section of American

Urological Association, March 19, 2015. Savannah, Georgia.

43. E. Sophie Spencer, Matthew Lyons, Peter Greene, Anne-Marie Meyer, Ke Meng, Raj Pruthi,

et.al. Understanding the relationship between 30- and 90- day emergency room visits and

readmissions following radical cystectomy. Poster Session. Southeastern Section of American

Urologial Association, March 19, 2015.Savannah Georgia.

44. Peter Greene, Matthew Lyons, E. Sophie Spencer, Anne Marie Meyer, Ke Meng, Raj Pruthi,

Eric Wallen, Michael Woods, Matthew Nielsen and Angela Smith. Investigating Patterns of

Care for Treatment of Muscle-Invasive Bladder Cancer in a Multi-Payer State Database.

Poster Session. Society of Urologic Oncology Annual Conference. December 2014. North

Bethesda, MD.

45. Matthew Lyons, Angela Smith, Karen Crowell, E. Sophie Spencer, Peter Greene, Michael

Woods, Eric Wallen, Raj Pruthi, Matthew Nielsen and Cheryl Lee. Functional Outcomes

Following Radical Cystectomy in Women with Bladder Cancer: A Systematic Review. Poster

Session. Society of Urologic Oncology Annual Conference. December 2014. North Bethesda,

MD.

46. E. Sophie Spencer, Matthew Lyons, Peter Greene, Anne Marie Meyer, Ke Meng, Raj Pruthi,

Eric Wallen, Michael Woods, Matthew Nielsen and Angela Smith. Understanding The

Relationship Between 30- And 90-Day Emergency Room Visits And Readmissions

Following Radical Cystectomy. Poster Session. Society of Urologic Oncology Annual

Conference. December 2014. North Bethesda, MD.

26

47. McBride JA, McKibben MJ, Vukina J, Matthews J, Pruthi R, Raynor M, Wallen E, Woods

M, Nielsen M, Smith A. Identifying Incidence and Risk Factors for VTE among Partial and

Radical Nephrectomy Patients. Podium Presentation. American College of Surgeons Clinical

Congress. October 2014. San Francisco, CA.

48. McKibben MJ, McBride JA, Vukina J, Matthews J, Pruthi R, Wallen E, Woods M, Nielsen

M, Smith A. Operative Times Predict Length of Stay Following Radical Cystectomy and

Nephrectomy. Podium Presentation. American College of Surgeons Clinical Congress.

October 2014. San Francisco, CA.

49. McKibben MJ, Vukina J, McBride JA, Matthews J, Pruthi R, Wallen E, Woods M, Nielsen

M, Smith A. Predictors of 30-day Readmissions following Radical Cystectomy for Bladder

Cancer. Podium Presentation. American College of Surgeons Clinical Congress. October

2014. San Francisco, CA.

50. Josip Vukina, Maxim McKibben, J. Abram McBride, Jonathan Matthews, Raj Pruthi, Eric

Wallen, Michael Woods, Matthew Nielsen, Angela Smith. . Identifying Incidence and Risk

Factors for VTE Among Radical Prostatectomy Patients for Prostate Cancer. Podium

Presentation. American College of Surgeons Clinical Congress. October 2014. San Francisco,

CA.

51. McBride JA, McKibben MJ, Vukina J, Matthews J, Pruthi R, Wallen E, Woods M, Nielsen

M, Smith A. Predictors of 30-Day Readmission following Partial and Radical Nephrectomy

for Kidney Cancer. Poster Session. American Urological Association Annual Meeting.

May16, 2014. Orlando, FL.

52. Vukina J, McBride JA, McKibben MJ, Matthews J, Pruthi R, Wallen E, Woods M, Nielsen

M, Smith A. Identifying Incidence and Risk Factors for VTE among Cystectomy Patients for

Bladder Cancer. Poster Session. American Urological Association Annual Meeting. May 16,

2014. Orlando, FL.

53. Abram McBride, Max McKibben, Josip Vukina, Jonathan Matthews, Raj Pruthi, Eric Wallen,

Michael Woods, Matthew Nielsen and Angela Smith. Longer operative times predict

increased length of stay following cystectomy. Podium Session. Southeastern Section of the

American Urological Association. March 23, 2014. Hollywood, Florida.

54. Josip Vukina, Abram McBride, Max McKibben, Jonathan Matthews, Raj Pruthi, Eric Wallen,

Michael Woods, Matthew Nielsen and Angela Smith. Identifying incidence and risk factors

for VTE among Cystectomy Patients for Bladder Cancer. Podium Session. Southeastern

Section of the American Urological Association. March 23, 2014. Hollywood, Florida.

55. Abram McBride, Max McKibben, Josip Vukina, Jonathan Matthews, Raj Pruthi, Mathew

Raynor, Eric Wallen, Michael Woods, Matthew Nielsen and Angela Smith. Identifying

incidence and risk factors for VTE among Partial and radical Nephrectomy Patients for

Kidney Cancer. Poster Session. Southeastern Section of the American Urological

Association. March 23, 2014. Hollywood, Florida.

56. Gordon Fifer, Mathew Raynor, Michael Woods, Eric Wallen and Raj Pruthi. Robotic

Ureteral Reconstruction Distal to the Ureteropelvic Junction: Clinical Series with short term

follow up. Podium Session. Southeastern Section of the American Urological Association.

March 22, 2014. Hollywood, Florida.

27

57. Max McKibben, Josip Vukina, Abram McBride, Jonathan Matthews, Raj Pruthi, Eric Wallen,

Matthew Raynor, Michael Woods, Matthew Nielsen and Angela Smith . Predictors of 30-Day

Readmission following Radical Cystectomy for Bladder Cancer. Poster Session. Southeastern

Section of the American Urological Association. March 21, 2014. Hollywood, Florida.

58. Abram McBride, Max McKibben, Josip Vukina, Jonathan Matthews, Raj Pruthi, Mathew

Raynor, Eric Wallen, Michael Woods, Matthew Nielsen and Angela Smith. Predictors of 30-

Day Readmission Following Partial and Radical Nephrectomy for Kidney Cancer. Podium

Session. Southeastern Section of the American Urological Association. March 21, 2014.

Hollywood, Florida.

59. Josip Vukina, Abram McBride, Max McKibben, Jonathan Matthews, Raj Pruthi, Eric Wallen,

Michael Woods, Matthew Nielsen and Angela Smith. Longer operative times predict

increased length of stay following prostatectomy for prostate cancer. Podium session.

Southeastern Section of the American Urological Association. March 20, 2014. Hollywood

Florida.

60. Max McKibben, Josip Vukina, Abram McBride, Jonathan Matthews, Raj Pruthi, Eric Wallen,

Michael Woods, Matthew Nielsen and Angela Smith. Identifying Incidence and Risk Factors

for VTE Amon Radical Prostatectomy Patients for Prostate Cancer. Poster Session.

Southeastern Section of the American Urological Association. March 20, 2014. Hollywood,

Florida.

61. Raj S. Pruthi, Intracorporeal ileal conduit. Video Session- Robotic-assisted Radial

Cystectomy, techniques and results. 2n Techno Urology Congress, Improving Minimally

Invasive Surgery, January 30, 2014. Orbassano-Toino, Italy.

62. Gordon Fifer, Mathew Raynor, Michael Woods, Eric Wallen, Raj Pruthi. Initial Operative

Experience with Robotic Ureteral Reconstruction Distal to the Ureteropelvic Junction.

Moderated Poster. World Congress of Endourology & SWL. October 25, 2013. New Orleans,

LA.

63. Will Kirby MD, David Johnson MD, MPH, Jed Ferguson MD, PhD; Jonathan Matthews

MPH, Angela Smith MD, Matthew Nielsen MD, MS; Michael Woods MD; Raj Pruthi MD,

Eric Wallen, MD. Differences in Complications & Associated Risk Factors in Open Versus

Laparoscopic Partial Nephrectomy. Surgical Forum Session, American College of Surgeons,

October 8, 2013. Washington, DC.

64. David Johnson, MD, MPH: Will Kirby MD; Jed Ferguson MD, PhD, Angela Smith MD;

Jonathan Matthews MPH; Michael Woods MD; Matthew Nielsen MD, MS; Mathew Raynor

MD; Raj Pruthi MD; Eric Wallen MD. Nutritional Predictors for Complications Following

Radical Cystectomy: an Analysis of the American College of Surgeons National Quality

Improvement Program (ACS-NSQIP) Surgical Forum Session, American College of

Surgeons. October 7, 2013. Washington, DC.

65. E. Will Kirby MD, Joshua P Langston MD, David C Johnson MD, MPH; Jed E Ferguson

MD, PhD; Raj S Pruthi MD. Economic Impact of Training and Career Choices in Urologic

Surgery. Surgical Forum Session, American College of Surgeons. October 7, 2013,

Washington, DC.

28

66. David Johnson; Nancy Wang; Will Kirby; Jed Ferguson; Jonathan Matthews; Matthew

Nielsen; Raj Pruthi; Angela Smith; Eric Wallen; Michael Woods. Morbidity and Mortality

Following Radical Cystectomy: An Analysis of The American College Of Surgeons National

Surgical Quality Improvement Program. American Urological Association. May 6, 2013. San

Diego, California.

67. David Johnson; Angela Smith; Josip Vukina; Jed Ferguson; Will Kirby; Mathew Raynor;

Michael Woods; Eric Wallen; Raj Pruthi; Matthew Nielsen. Estimating the Burden of

Preoperatively Misclassified, Surgically Removed Benign Renal Masses in the United States:

Implications for the Current Standard of Care. American Urological Association. May 6,

2013. San Diego, California.

68. Will Kirby; Jed Ferguson; David Johnson; Simon Neuwahl; Matthew Nielsen; Michael

Woods; Eric Wallen; Angela Smith; Mathew Raynor; Raj Pruthi; Erin Fraher. Future supply

of urologists: Projected to decrease dramatically between 2009-2025. Moderated Poster.

American Urological Association. May 5, 2013. San Diego, California.

69. David Johnson; Will Kirby; Jed Ferguson; Jonathan Matthews; Matthew Nielsen; Raj Pruthi;

Angela Smith; Eric Wallen; Michael Woods. Utilization Of Preoperative Chemotherapy And

Associated Outcomes After Radical Cystectomy: An Analysis Of The American College Of

Surgeons National Quality Improvement Program. Moderated Poster. American Urological

Association. May 5, 2013. San Diego, California.

70. Will Kirby; Jed Ferguson; David Johnson; Jonathan Matthews; Matthew Nielsen; Raj Pruthi;

Angela Smith; Eric Wallen; Michael Woods. Metabolic Syndrome as a useful Predictor Of

Complications Following GU Oncologic Surgery. Moderated Poster. American Urological

Association. May 4, 2013. San Diego, California.

71. Raj Pruthi, MD, FACS. Localized CAP-Individualizing Therapy. 23rd Annual Advances in

Urology, April 20, 2013. Key West, Florida.

72. Raj Pruthi, MD, FACS. Cystectomy. 23rd Annual Advances in Urology, April 20, 2013. Key

West, Florida.

73. James Ferguson, Will Kirby, David Johnson, Angela Smith, Matthew Nielsen, Raj Pruthi,

Eric Wallen, Michael Woods, and Mathew Raynor. Trends in Tumor Complexity and Warm

Ischemia time in Patients Undergoing Robot-Assisted Partial Nephrectomy. Poster Session.

Southeastern Section of the American Urological Association. March 17, 2013.

Williamsburg, VA.

74. Jed Ferguson, David Johnson, Will Kirby, Jonathan Matthews, Matthew Nielsen, Raj Pruthi, Eric Wallen, Michael Woods and Angela Smith. Diffusion of Laparoscopy and Differences

in Complications Compared to Open Radical Nephrectomy. Poster Session. Southeastern

Section of the American Urological Association. March 17, 2013. Williamsburg, VA.

75. Will Kirby, Jed Ferguson, David Johnson, Jonathan Matthews, Matthew Nielsen, Raj Pruthi,

Eric Wallen, Michael Woods and Angela Smith. Differences in Complications & Associated

Risk Factors in Open Versus Laparoscopic Partial Nephrectomy. Poster Session.

Southeastern Section of the American Urological Association. March 17, 2013.

Williamsburg, VA.

29

76. David Johnson, Will Kirby, Jed Ferguson, Jonathan Matthews, Matthew Nielsen, Raj Pruthi,

Angela Smith, Eric Wallen and Michael Woods. Utilization of Preoperative Chemotherapy

and Associated Outcomes after Radical Cystectomy: An Analysis of the American College of

Surgeons National Quality Improvement Program (ACS-NSQIP). Podium Session.

Southeastern Section of the American Urological Association. March 16, 2013.

Williamsburg, VA.

77. David Johnson, Will Kirby, Jed Ferguson, Ankur Manvar, Michael Woods, Eric Wallen,

Mathew Raynor, Matthew Nielsen, Raj Pruthi and Angela Smith. What is the Impact of

Prostate Biopsy on LUTS? Podium Session. Southeastern Section of the American Urological

Association. March 16, 2013. Williamsburg, VA.

78. David Johnson, Will Kirby, Jed Ferguson, Angela Smith, Michael Woods, Mathew Raynor,

Eric Wallen, Luke Fifer, Raj Pruthi and Matthew Nielsen. Estimating the Burden of

Preoperatively Misclassified, Surgically Removed Benign Renal Masses in the United States:

Implications for the current standard of Care. Podium Session. Southeastern Section of the

American Urological Association. March 15, 2013. Williamsburg, VA.

79. David Johnson, James Ferguson, Will Kirby, Benjamin Calvo, Michael Meyers, Karen

Stitzenberg, Hon Kim, Angela Smith, Michael Woods, Matthew Nielsen, Eric Wallen, Raj

Pruthi and Mathew Raynor. Urologic Involvement in Surgical Resection of Recurrent

Colorectal Cancer. Poster Session. Southeastern Section of the American Urological

Association. March 15, 2013. Williamsburg, VA.

80. Jed Ferguson, David Johnson, Will Kirby, Jonathan Matthews, Matthew Nielsen, Raj Pruthi,

Angela Smith, Eric Wallen and Michael Woods. Nutritional Predictors for complications

following Radical Cystectomy: An Analysis of the American College of Surgeons National

Quality Improvement Program (ACS-NSQIP). Poster Session. Southeastern Section of the

American Urological Association. March 15, 2013. Williamsburg, VA.

81. David Johnson, Will Kirby, Jed Ferguson, Jonathan Matthews, Matthew Nielsen, Raj Pruthi,

Angela Smith, Eric Wallen and Michael Woods. Morbidity and Mortality following Radical

Cystectomy: An Analysis of the American College of Surgeons National Surgical Quality

Improvement Program (NSQIP). Poster Session. Southeastern Section of the American

Urological Association. March 15, 2013. Williamsburg, VA.

82. David Johnson, Will Kirby, Jed Ferguson, Ankur Manvar, Michael Woods, Eric Wallen,

Mathew Raynor, Matthew Nielsen, Raj Pruthi and Angela Smith. Podium Session. The Short-

Term Impact of Prostate Biopsy (PBX) on patients’ Erectile Function (EF). Podium Session.

Southeastern Section of the American Urological Association. March 14, 2013.

Williamsburg, VA.

83. Jed Ferguson, Will Kirby, David Johnson, Angela Smith, Michael Woods, Eric Wallen,

Matthew Nielsen, Raj Pruthi, et al: Who makes the decision regarding treatment for localized

prostate cancer, patient or physician? Results from a population-based study. Podium

Session. Southeastern Section of the American Urological Association. March 14, 2013.

Williamsburg, VA.

84. Will Kirby, Jed Ferguson, David Johnson, Jonathan Matthews, Matthew Nielsen, Raj Pruthi,

Eric Wallen, Michael Woods and Angela Smith. Resident Experience as a Predictive Factor

30

for Peri-Operative outcomes Following Radical Prostatectomy. Poster Session. Southeastern

Section of the American Urological Association. March 14, 2013. Williamsburg, VA.

85. Jed Ferguson, Will Kirby, David Johnson, Jonathan Matthews, Matthew Nielsen, Raj Pruthi,

Eric Wallen, Michael Woods and Angela Smith. Complication Differences between Open

versus Laparoscopic Prostatectomy. Poster Session. Southeastern Section of the American

Urological Association. March 14, 2013. Williamsburg, VA.

86. Jed Ferguson, David Johnson, Will Kirby, Angela Smith, Michael Woods, Eric Wallen,

Mathew Raynor, Matthew Nielsen and Raj Pruthi. Practice Type and Employment of

Urologists in the United States: An Analysis of Changes over the Past Decade. Poster

Session. Southeastern Section of the American Urological Association. March 14, 2013.

Williamsburg, VA.

87. Will Kirby, Jed Ferguson, David Johnson, Jonathan Matthews, Mathew Nielsen, Raj Pruthi,

et al: Metabolic Syndrome as a useful predictor of complications following GU Oncologic

Surgery. Poster Session. Southeastern Section of the American Urological Association.

March 14, 2013. Williamsburg, VA.

88. Jed Ferguson, David Johnson, Will Kirby, Ankur Manvar, Angela Smith, Michael Woods,

Eric Wallen, Mathew Raynor, Raj Pruthi and Matthew Nielsen. Use and Perceptions of

information obtained from the internet: Analysis of Urological Oncology Patients. Poster

Session. Southeastern Section of the American Urological Association. March 14, 2013.

Williamsburg, VA.

89. Joshua Langston, Will Kirby, Jed Ferguson, David Johnson, Angela Smith, Davis Viprakasit,

Mathew Raynor, Michael Woods, Eric Wallen, Matthew Nielsen and Raj Pruthi. Economic

Impact of Training and Career choices in Urologic Surgery. Poster Session. Southeastern

Section of the American Urological Association. March 14, 2013. Williamsburg, VA.

90. Will Kirby, Jed Ferguson, David Johnson, Angela Smith, Michael Woods, Eric Wallen,

Mathew Raynor, Matthew Nielsen and Raj Pruthi. Trends in the Geographic Structure of the

Urology Workforce in The United States. Poster Session. Southeastern Section of the

American Urological Association. March 14, 2013, Williamsburg, VA.

91. Will Kirby, Jed Ferguson, David Johnson, Angela Smith, Michael Woods, Eric Wallen,

Mathew Raynor, Matthew Nielsen and Raj Pruthi. Trends in the Age and Gender of the

Urology Workforce in The United States. Poster Session. The Southeastern Section of the

American Urological Association. March 14, 2013. Williamsburg, VA.

92. David Johnson, Will Kirby, James Ferguson, Benjamin Calvo, Michael Meyers, Karen

Stitzenberg, Hong Kim, Angela Smith, Michael Woods, Matthew Nielsen, Eric Wallen, Raj

Pruthi and Mathew Raynor. Nephrostomy Placement after Surgical Resection of Locally

Recurrent Colorectal Cancer: An Assessment of Risk Factors. Poster Session. Southeastern

Section of the American Urological Association. March 14, 2013. Williamsburg, VA.

93. Jed Ferguson, David Johnson, Will Kirby, Angela Smith, Michael Woods, Eric Wallen,

Mathew Raynor, Matthew Nielsen, and Raj Pruthi. An Analysis of the Supply of Urologic

Surgeons in the United Sates. Poster Session. Southeastern Section of the American

Urological Association. March 14, 2013. Williamsburg, VA.

31

94. David Johnson, Will Kirby, Jed Ferguson, Angela Smith, Michael Woods, Eric Wallen,

Mathew Raynor, Matthew Nielsen, and Raj Pruthi. Projection Models Evaluating the Future

Supply of Urologists in the United States. Poster Session. Southeastern Section of the

American Urological Association. March 14, 2013. Williamsburg, VA.

95. Raj Pruthi, MD: Post-op Complications. American Urological Association Advanced Robotic

Urologic Oncology; Curing Cancer through technology and skill. January 26, 2013.Tampa,

FL.

96. Jed Ferguson, David Johnson, Will Kirby, Jonathan Matthews, Matthew Nielsen, Raj Pruthi,

et, al: Nutritional Predictors for Complications Following Radical Cystectomy: An Analysis

of the American College of Surgeons National Quality Improvement Program (ACS-NSQIP).

13th Annual Meeting of the Society of Urological Oncology, November 29, 2012. Rockville,

Maryland.

97. Will Kirby, Jed Ferguson, David Johnson, Jonathan Matthews, Matthew Nielsen, Raj Pruthi,

et, al: Resident Experience as a Predictive Factor for Peri-Operative Outcomes Following

Radical Prostatectomy. 13th Annual Meeting of the Society of Urological Oncology,

November 29, 2012.Rockville, Maryland.

98. David Johnson, Will Kirby, Jed Ferguson, Jonathan Matthews, Matthew Nielsen, Raj Pruthi,

et.al: Which is the Most Suitable Treatment Approach for Upper Tract Urothelial Carcinoma

(UTUC): Neoadjuvant vs. Adjuvant Chemotherapy? 13th Annual Meeting of the Society of

Urological Oncology, November 30, 2012. Rockville, Maryland.

99. David Johnson, Jed Ferguson, will Kirby, Angela Smith, Michael Woods, Kim Rathmell,

Mathew Raynor, Eric Wallen, Raj Pruthi and Matthew Nielsen. Estimating the Burden of

Preoperatively Misclassified, Surgically Removed Benign Renal Masses in the United States:

Implications for the Current Standard of Care. 13th Annual Meeting of the Society of

Urological Oncology, November 30, 2012. Rockville, Maryland.

100. Jed Ferguson, Will Kirby, David Johnson, Jonathan Matthews, Matthew Nielsen, Raj

Pruthi, et. al: Differences in Complications between Open versus Laparoscopic

Prostatectomy. 13th Annual Meeting of the Society of Urological Oncology, November 30,

2012. Rockville, Maryland.

101. Raj S. Pruthi, MD. Robotic vs. Open Cystectomy: What is the Evidence in 2012? Kaiser

Permanante Urology Symposium. Las Vegas, NV. November 2, 2012.

102. Raj S. Pruthi, MD. Robotic Radical Cystectomy Protocols. Kaiser Permanante Urology Symposium. Las Vegas, NV. November 2, 2012.

103. Mathew Raynor , MD; Ian Udell, MD; Raj Kurpad, MD; Matthew E. Nielsen, MD;

Michael E. Woods, MD; Eric M. Wallen, MD; Raj S. Pruthi, MD. Video: Robot-Assisted

Retroperitoneal Partial Nephrectomy. American College of Surgeons Clinical Congress,

October, 2, 2012. Chicago, Illinois.

104. Ian Udell, MD; Raj Kurpad, MD; Angela B. Smith, MD; Michael E. Woods, MD; Eric

Wallen, MD; Matthew Nielsen, MD: Raj Pruthi, MD, FACS. Cost Analysis of Robotic-

32

Assisted Radical Cystectomy Versos Open Radical Cystectomy Utilizing A Prospective,

Randomized Cohort. American College of Surgeons Clinical Congress, October 2, 2012.

Chicago, Illinois.

105. Ian Udell, MD; Raj Kurpad, MD, Angela B. Smith, MD; Michael E. Woods, MD; Eric

Wallen, MD; Matthew Nielsen, MD; Raj Pruthi, MD, FACS. Prospective Randomized

Controlled Trial of Robotic Versus Open Radical Cystectomy for Bladder Cancer: Median 3-

Year Follow-Up Results. American College of Surgeons Clinical Congress, October 2, 2012.

Chicago, Illinois.

106. Ian Udell MD; Raj Kurpad, MD, Angela B. Smith, MD; Michael E. Woods, MD; Eric M

Wallen, MD; Raj Pruthi, MD; FACS; Matthew Nielsen, MD. The Cost Impact of Routine

Addition of Urovysion Fish to Non-Muscle-Invasive Bladder Cancer Surveillance. American

College of Surgeons Clinical Congress, October 2, 2012. Chicago, Illinois.

107. Ian Udell MD; Raj Kurpad, MD; Angela B. Smith, MD; Michael E. Woods, MD; Eric

Wallen, MD; Raj Pruthi, MD, FACS; Matthew Nielsen, MD. Surveillance Guidelines for

Low Grade Non-Invasive Bladder Cancer: A Cost Comparison. American College of

Surgeons Clinical Congress, October 2, 2012. Chicago, Illinois.

108. Raj Kurpad MD; Erin Fraher, PhD; Simon Neuwahl, BA; Ian Udell, MD; Eric Wallen,

MD; Angela Smith, MD; Matthew Nielsen, MD; Michael Woods, MD; Raj Pruthi, MD,

FACS. The Evolving Role and Age Structure of International Medical Graduates (IMGs) on

the Urology Workforce in the United States1981-2009. American College of Surgeons

Clinical Congress, October 2, 2012. Chicago, Illinois

109. Raj Kurpad MD; Erin Fraher, PhD; Simon Neuwahl, BA; Ian Udell, MD; Eric Wallen,

MD; Angela Smith, MD; Matthew Nielsen, MD; Michael Woods, MD; Raj Pruthi, MD,

FACS. Trends in the Age and Gender of the Urology Workforce in the United States: 1981-

2009. American College of Surgeons Clinical Congress, October 2, 2012. Chicago, Illinois.

110. Raj S. Pruthi, MD. Introduction: Prostate Cancer, American College of Surgeons Clinical

Congress, October 2, 2012. Chicago, Illinois.

111. Mathew C Raynor, MD; Ian Udell, MD; Raj Kurpad, MD; Matthew E. Nielsen, MD;

Michael E. Woods, MD; Eric M. Wallen, MD; Raj S. Pruthi, MD. Robot-Assisted

Retroperitoneal Partial Nephrectomy. American College of Surgeons Clinical Congress,

October 2, 2012. Chicago, Illinois.

112. Ian Udell MD; Raj Kurpad, MD; Angela B. Smith, MD: Michael E. Woods, MD; Eric

Wallen, MD; Matthew Nielsen, MD Raj Pruthi, MD, FACS. Cost Analysis of Robot-Assisted

Radical Cystectomy Versus Open Radical Cystectomy Utilizing A Prospective, Randomized

Cohort. American College of Surgeons Clinical Congress, October 2, 2012. Chicago, Illinois.

113. Ian Udell MD; Raj Kurpad, MD; Angela B. Smith, MD: Michael E. Woods, MD; Eric

Wallen, MD; Matthew Nielsen, MD Raj Pruthi, MD, FACS. Prospective Randomized

Controlled Trial of Robotic Versus Open Radical Cystectomy for Bladder Cancer: Median 3-

Year Follow-Up Results. American College of Surgeons Clinical Congress, October 2, 2012.

Chicago, Illinois.

33

114. Ian Udell MD; Raj Kurpad, MD; Angela B. Smith, MD: Michael E. Woods, MD; Eric

Wallen, MD; Raj Pruthi, MD, FACS; Matthew Nielsen, MD. The Cost Impact of Routine

Addition of Urovysion Fish to Non-Muscle-Invasive Bladder Cancer Surveillance. American

College of Surgeons Clinical Congress, October 2, 2012. Chicago, Illinois.

115. Ian Udell MD; Raj Kurpad, MD; Angela B. Smith, MD: Michael E. Woods, MD; Eric

Wallen, MD; Raj Pruthi, MD, FACS; Matthew Nielsen, MD. Surveillance Guidelines for

Low Grade Non-Invasive Bladder Cancer: A Cost Comparison. American College of

Surgeons Clinical Congress, October 2, 2012. Chicago, Illinois.

116. Raj Kurpad, MD; Erin Fraher; Simon Neuwahl; Ian Udell; Eric Wallen; Angela Smith;

Matthew Nielsen; Michael Woods; Raj Pruthi. The Evolving Role and Age Structure of

International Medical Graduates (IMGs) on the Urology Workforce in the United States:

1981-2009. American College of Surgeons Clinical Congress, October 2, 2012, Chicago.

Illinois.

117. Raj Kurpad MD; Erin Fraher, MD; Simon Neuwahl, BA; Ian Udell, MD; Eric Wallen,

MD; Angela Smith, MD; Matthew Nielsen, MD; Michael Woods, MD; Raj Pruthi, MD,

FACS. Trends in the Age and Gender of the Urology Workforce in the United States: 1981-

2009. American College of Surgeons Clinical Congress, October 2, 2012, Chicago. Illinois.

118. Raj S. Pruthi. Introduction: Prostate Cancer. American College of Surgeons Clinical

Congress, October 1, 2012, Chicago. Illinois.

119. Ian Udell, Raj Kurpad, Angela Smith, Michael Woods, Eric Wallen, Raj Pruthi, Matthew

Nielsen. Surveillance Guidelines for Low Grade Non-Invasive Bladder Cancer: A Cost

Comparison. American Urological Association May 22, 2012. Atlanta, GA.

120. Ian Udell, Raj Kurpad, Angela Smith, Jeff Nix, Matthew Nielsen, Eric Wallen, Michael

Woods, Raj Pruthi. Prospective Randomized Controlled Trial of Robotic Versus Open

Radical Cystectomy for Bladder Cancer: Median 3-Year Follow-Up Results. American

Urological Association, May 22, 2012. Atlanta, GA.

121. Ian Udell, Raj Kurpad, Jed Ferguson, Angela Smith, Matthew Nielsen, Eric Wallen,

Michael Woods, Raj Pruthi. An evaluation of Neoadjuvant chemotherapy eligibility rates

among patients undergoing radical Cystectomy for bladder cancer. American Urological

Association, May 22, 2012. Atlanta, GA.

122. Ian Udell, Raj Kurpad, Angela Smith, Matthew Nielsen, Eric Wallen, Michael Woods,

Raj Pruthi. Long-Term Follow-Up of Patients Initially Managed with Active Surveillance for

Solid Renal Masses. American Urological Association, May 22, 2012. Atlanta, GA.

123. Matthew H Hayn, Ahmed El-Nahas, Andrew P Stegemann, Piyush K Agarwal, Ketan K

Badani, M Derya Balbay, Erik P Castle, Prokar Dasgupta, Reza Ghavamian, Ashok K

Hemal, Brent K Hollenbeck, David Josephson, A Karim Kader, Shamim Kahn, Adam S

Kibel, Mani Menon, Alex Mottrie, Kenneth Nepple, John G Pattaras, James O Peabody,

Vassilis Poulakis, Raj S Pruthi, et.al. Is Robot-Assisted Cystectomy Effective for T3 Bladder

Cancer? Results from the International Robotic Cystectomy Consortium. American

Urological Association, May 22, 2012. Atlanta, GA.

34

124. Ian Udell, Raj Kurpad, Jed Ferguson, Angela Smith, Matthew Nielsen, Eric Wallen,

Michael Woods, Raj Pruthi. “Cost Analysis of Robotic-Assisted Radical Cystectomy versus

open Radical Cystectomy Utilizing a Prospective, Randomized cohort. American Urological

Association, May 21, 2012. Atlanta, GA.

125. Kamran Ahmed, Matthew H Hayn, Andrew P Stegemann, Piyush K Agarwal, Ketan K

Badani, M Derya Balbay, Erik P Castle, Prokar Dasgupta, Reza Ghavamian, Khurshid A

Guru, Ashok K Hemal, Brent K Hollenbeck, David Josephson, A Karim Kadar, Adam S

Kibel, Mani Menon, Alex Mottrie, Kenneth Nepple, John G Pattaras, James O Peabody,

Vasssilis Poulkis, Raj S Pruthi, et.al. Comparison of Outcomes Between Intra-Corporeal and

Extra-Corporeal Urinary Diversion After Robot-Assisted Radical Cystectomy-The IRCC

Results. American Urological Association, May 21, 2012. Atlanta, GA.

126. Ian Udell, Raj Kurpad, Angela Smith, Matthew Nielsen, Raj Pruthi, Eric Wallen, Michael

Woods, William Kim. Defining the Molecular Determinants of Sensitivity to EGFR

Inhibition in Urothelial Carcinoma. American Urological Association, May 21, 2012.

Atlanta, GA.

127. Simon Neuwahl, Raj Kurpad, Erin Fraher, Thomas Ricketts, George Sheldon, Howard

Snyder, Matthew Nielsen, Raj Pruthi. An Analysis of the Supply of Urologic Surgeons in the

United States. American Urological Association, May 20, 2012. Atlanta, GA.

128. Lixin Song, Raj Kurpad, Ian Udell, Jeanette Bensen, Angela Smith, Matthew Nielsen,

Eric Wallen, Michael Woods, Raj Pruthi, James Mohler. “Who Makes The Decision

Regarding Treatment for Localized Prostate Cancer, Patient or Physician? Results from A

Population-Based Study”. American Urological Association May 20, 2012. Atlanta, GA.

129. Scott Haake, A. Rose Brannon, Raj Kurpad, Ian Udell, Angela Smith, Matthew Nielsen,

Raj Pruthi, Eric Wallen, Michael Woods, W. Kim Rathmell. Clear cell renal cell carcinoma

displays differential gene expression based on gender. American Urological Association,

May 20, 2012. Atlanta, GA.

130. Rose Brennan, Scott Haake, Raj Kurpad, Ian Udell, Angela Smith, Matthew Nielsen, Raj

Pruthi, Eric Wallen, Michael Woods, W. Kim Rathmell. Meta-Analysis of Clear Cell Renal

Cell Carcinoma Gene Expression Delineates Subgroups. American Urological Association,

May 20, 2012. Atlanta, GA.

131. Simon Neuwahl, Ian Udell, Erin Fraher, Thomas Ricketts, George Sheldon, Howard

Snyder, Matthew Nielsen, Raj Pruthi. Practice Type and Employment of Urologists in the

United States: An Analysis of Changes Over the Decade. American Urological Association,

May 19, 2012. Atlanta, GA.

132. Ian Udell, Raj Kurpad, Ankur Manvar, Matthew Nielsen, Mathew Raynor, Angela Smith,

Eric Wallen, Michael Woods and Raj Pruthi. The Affect on the Long-Term Emotional and

Physical Well-being of Patients Undergoing Radical Cystectomy. Southeastern Section of the

American Urological Association, March 25, 2012. Amelia Island, Florida.

133. Raj Kurpad, Ian Udell, Matthew Nielsen, Michael Woods, Raj Pruthi, Eric Wallen and

Mathew Raynor. Robot-Assisted Retroperitoneal Partial Nephrectomy: Initial Clinical

Experience and Outcomes. Southeastern Section of the American Urological Association,

March 25, 2012. Amelia Island, Florida.

35

134. Ian Udell, Raj Kurpad, Ankur Manvar, Matthew Nielsen, Angela Smith, Eric Wallen,

Michael Woods and Raj Pruthi. The Quality of Prostate Cryotherapy Information on the

Internet. Southeastern Section of the American Urological Association, March 25, 2012.

Amelia Island, Florida.

135. Raj Pruthi, Learning Curve and Cost. UC San Diego Urology Postgraduate Course

Masters Robotics for Urologic Oncology and Pelvic Reconstruction, March 24, 2012. La

Jolla, CA.

136. Raj Pruthi, Urinary Diversion during Robotic Cystectomy. UC San Diego Urology

Postgraduate Course Masters Robotics for Urologic Oncology and Pelvic Reconstruction,

March 24, 2012. La Jolla, CA.

137. Raj Pruthi, Optimizing Outcomes with a Clinical Care Pathway, UC San Diego Urology

Postgraduate Course Masters Robotics for Urologic Oncology and Pelvic Reconstruction,

March 24, 2012. La Jolla, CA.

138. Raj Pruthi, Special Cases-Prostate Sparing/Female, UC San Diego Urology Postgraduate

Course Masters Robotics for Urologic Oncology and Pelvic Reconstruction, March 24, 2012.

La Jolla, CA.

139. Raj Kurpad, Ian Udell, Matthew Nielsen, Mathew Raynor, Angela Smith, Eric Wallen,

Michael Woods, Raj Pruthi and Kim Rathmell. Recurrence and Survival Following

Preoperative Sorafenib for Advanced Renal Cell Carcinoma. Southeastern Section of the

American Urological Association, March 23, 2012. Amelia Island, Florida.

140. Raj Kurpad, Ian Udell, Sophia Delphe, Matthew Nielsen, Mathew Raynor, Eric Wallen,

Michael Woods, Raj Pruthi and Angela Smith. Single Institution Evaluation of Patterns of

Care for Renal Cell Carcinoma: A 5-Year Analysis. Southeastern Section of the American

Urological Association, March 23, 2012. Amelia Island, Florida.

141. Raj Kurpad, Ian Udell, Rose Brannon, Scott Haake, Matthew Nielsen, Mathew Raynor,

Eric Wallen, Michael Woods, Raj Pruthi and Kim Rathmell. Meta-Analysis of Clear Cell

Renal Cell Carcinoma Gene Expression Delineates Subgroups. Southeastern Section of the

American Urological Association, March 23, 2012. Amelia Island, Florida.

142. Ian Udell, Raj Kurpad, Raj Pruthi, Mathew Raynor, Angela Smith, Eric Wallen, Michael

Woods and Matthew Nielsen. Surveillance Protocols for Localized Kidney Cancer: A Cost

Comparison. Southeastern Section of the American Urological Association, March 23, 2012.

Amelia Island, Florida.

143. Ian Udell, Raj Kurpad, Matthew Nielsen, Mathew Raynor, Angela Smith, Eric Wallen,

Michael Woods and Raj Pruthi. Robotic-Assisted Laparoscopic Intracorporeal Urinary

Diversion: Combined Initial Experience. Southeastern Section of the American Urological

Association, March 23, 2012. Amelia Island, Florida.

144. Ian Udell, Raj Kurpad, Matthew Nielsen, Michael Woods, Raj Pruthi, Eric Wallen and

Mathew Raynor. Robot-Assisted Ureteral Reconstruction: Initial Clinical Experience and

Outcomes. Southeastern Section of the American Urological Association, March 23, 2012.

Amelia Island, Florida.

36

145. Ian Udell, Raj Kurpad, Andrew Blackburne, Matthew Nielsen, Mathew Raynor, Angela

Smith, Eric Wallen, Michael Woods and Raj Pruthi. Robotic Partial Nephrectomy and the

Internet: Is the Information Evidenced –Based? Southeastern Section of the American

Urological Association, March 23, 2012. Amelia Island, Florida.

146. Ian Udell, Raj Kurpad, Raj Pruthi, Mathew Raynor, Angela Smith, Eric Wallen, Michael

Woods and Matthew Nielsen. Surveillance Guidelines for Low Grade Non-Invasive Bladder

Cancer: A Cost Comparison. Southeastern Section of the American Urological Association,

March 22, 2012. Amelia Island, Florida.

147. Raj Kurpad, Ian Udell, Matthew Nielsen, Mathew Raynor, Angela Smith, Eric Wallen,

Michael Woods and Raj Pruthi. The Impact of Radical Cystectomy on Renal Function: An

Analysis of Variance Based on Age, Gender, Race and Diversion Technique. Southeastern

Section of the American Urological Association, March 22, 2012. Amelia Island, Florida.

148. Ian Udell, Raj Kurpad, Mathew Raynor, Angela Smith, Eric Wallen, Michael Woods, Raj

Pruthi and Matthew Nielsen. Reported Patterns of Utilization of Intravesical Therapy in Non-

Muscle –Invasive Bladder Cancer: Results From the BCAN/SUO/AUA/LUGPA Electronic

Survey. Southeastern Section of the American Urological Association, March 22, 2012.

Amelia Island, Florida.

149. Raj Kurpad, Ian Udell, Jeff Nix, Matthew Nielsen, Eric Wallen, Michael Woods, Raj

Pruthi and Angela Smith. Prospective Randomized Controlled Trial of Robotic Versus Open

Radical Cystectomy for Bladder Cancer: Median 3-Year Follow-Up Results. Southeastern

Section of the American Urological Association, March 22, 2012. Amelia Island, Florida.

150. Raj Kurpad, Ian Udell, Jed Ferguson, Angela Smith, Matthew Nielsen, Eric Wallen,

Michael Woods and Raj Pruthi. An Evaluation of Neoadjuvant Chemotherapy Eligibility

Rates among Patients Undergoing Radical Cystectomy for Bladder Cancer. Southeastern

Section of the American Urological Association, March 22, 2012. Amelia Island, Florida.

151. Raj Kurpad, Ian Udell, Matthew Nielsen, Mathew Raynor, Angela Smith, Eric Wallen,

Michael Woods and Raj Pruthi. Use and Outcomes of Adjuvant Chemotherapy in PT3-4 Or

Node Positive Bladder Cancer: Analysis of Modern Surgical Cohort. Southeastern Section of

the American Urological Association, March 22, 2012. Amelia Island, Florida.

152. Raj Kurpad, Ian Udell, Ankur Manvar, Matthew Nielsen, Mathew Raynor, Angela Smith,

Eric Wallen, Michael Woods and Raj Pruthi. Outcomes with Intravesical Therapy in Patients

with Initial T1 Bladder Cancer. Southeastern Section of the American Urological

Association, March 22, 2012. Amelia Island, Florida.

153. Raj Kurpad, Ian Udell, Jed Ferguson, Matthew Nielsen, Mathew Raynor, Angela Smith,

Eric Wallen, Michael Woods and Raj Pruthi. An Evaluation of Adjuvant Chemotherapy

Eligibility Rates among Patients Undergoing Radical Cystectomy. Southeastern Section of

the American Urological Association, March 22, 2012. Amelia Island, Florida.

154. Ian Udell, Raj Kurpad, Raj Pruthi, Mathew Raynor, Angela Smith, Eric Wallen, Michael

Woods, and Matthew Nielsen. The Cost Impact of Addition of NMP22 Bladderchek to Non-

Invasive Bladder Cancer Surveillance. Southeastern Section of the American Urological

Association, March 22, 2012. Amelia Island, Florida.

37

155. Raj Kurpad, Ian Udell, William Kim, Matthew Nielsen, Mathew Raynor, Angela Smith,

Eric Wallen, Michael Woods and Raj Pruthi. Defining the Molecular Determinants of

Sensitivity to EGFR Inhibition in Urothelial Carcinoma. Southeastern Section of the

American Urological Association, March 22, 2012. Amelia Island, Florida.

156. Ian Udell, Raj Kurpad, Jed Ferguson, Matthew Nielsen, Mathew Raynor, Angela Smith,

Eric Wallen, Michael Woods and Raj Pruthi. Cost Analysis of Robotic-Assisted Radical

Cystectomy versus Open Radical Cystectomy Utilizing a Prospective, Randomized Cohort.

Southeastern Section of the American Urological Association, March 22, 2012. Amelia

Island, Florida.

157. Ian Udell, Raj Kurpad, Raj Pruthi, Mathew Raynor, Angela Smith, Eric Wallen, Michael

Woods and Matthew Nielsen. The Cost Impact of Addition of Urovysion Fish to Non-Muscle-Invasive Bladder Cancer Surveillance. Southeastern Section of the American

Urological Association, March 22, 2012. Amelia Island, Florida.

158. Busby, JE, Pruthi, RS. Moderator Session 10: Bladder & Prostate Cancer Poster Session.

Southeastern Section of the American Urological Association, March 22, 2012. Amelia

Island, FL.

159. Raj S. Pruthi. Robotic Neobladder: Video. Miami Robotics Symposium, February 17,

2012. Miami, Fl.

160. Raj S. Pruthi. State-Of-the Art Lecture: Robotic Cystectomy. Robotics Symposium,

February 17, 2012. Miami, Fl.

161. Raj S. Pruthi. Introduction: Why Bladder Cancer? American College of Surgeons

Clinical Congress, October 26, 2011, San Francisco, CA.

162. Raj S. Pruthi. Future Directions: Where do we go from here? American College of

Surgeons Clinical Congress, October 26, 2011, San Francisco, CA.

163. Raj S. Pruthi. Trends in Regionalization of Adrenalectomy to Higher Volume Surgical

Centers. Discussant, Surgical Forum Session. American College of Surgeons Clinical

Congress, October 24, 2011, San Francisco, CA.

164. John P. Selph, Joshua Langston, Gilad Amiel, Tom Guzzo, Yair Lotan, Neal Shore,

Angela Smith, Eric Wallen, Raj Pruthi, Matthew Nielsen. Patterns of Utilization of Urine-

Based Markers in Non-Muscle-Invasive Bladder Cancer: Results from the BCAN / SUO /

AUA / LUGPA Electronic Survey. Surgical Forum Session American College of Surgeons

Clinical Congress, October 24, 2011, San Francisco, CA.

165. Shayn M, Stegeman A, Agarwal P, Badani K, Balbay M, Castle E, Dasgupta P,

Hellenthal N, Hemal A, Josephson D, Kader A, Kibel A, Mottrie A, Nepple K, Pattaras J,

Peabody J, Poulakis V, Pruthi R, Redorta J, Rha K, Richstone L, Saar M, Scherr D, Siemer S,

Stoeckle M, Wallen E, Wiklund P, Wilson T, Woods M, Uyh B, Guru K. Pathologic and

early oncologic outcomes after robotic-assisted radical cystectomy: Results from the

International Robotic-Cystectomy Consortium. American Urological Association, May 17,

2011. Washington, DC.

38

166. Marshall S, Hayn M, Stegemann A, Agarwal P, Badani K, Balbay M, Castle E, Dasgupta

P, Hemal A, Josephson D, Kader A, Kibel A, Mottrie A, Nepple K, Pattara J, Peabody J,

Poulakis V, Pruthi R, Redorta J, Rha K, Richstone L, Saar M, Scherr D, Siemer S, Stoeckle

M, Wallen E, Wiklund P, Wilson T, Woods M, Yuh B, Guru K. Lymph node yield and

predictors of extended lymphadenectomy at the time of robot-assisted radical cystectomy:

Results from the International Robotic Cystectomy Consortium. American Urological

Association, May 17, 2011. Washington, DC.

167. Selph JP, Raynor M, Langston J, Smith A, Nielsen M, Wallen E, Pruthi R. The stepwise

approach to robotic-assisted laparoscopic intracorporeal urinary diversion. American

Urological Association, May 17, 2011. Washington, DC.

168. Selph JP, Raynor M, Langston J, Smith A, Nielsen M, Wallen E, Pruthi R. Initial

experience with robotic-assisted approaches to partial cystectomy. American Urological

Association, May 17, 2011. Washington, DC.

169. Chinedu M, Nunez R, Pruthi R, Nielsen M, Wallen E, Smith A, Hunphreys M, Castle E.

Robotic Radial Cystectomy: Medium-Term Oncologic Follow-Up. American Urological

Association, May 17, 2011. Washington, DC.

170. Langston J, Selph JP, Manvar A, Ferguson J, Smith A, Raynor M, Nielsen M, Wallen E,

Pruthi R. The evaluation of the learning curve associated with robotic radical cystectomy:

Initial 100 cases. American Urological Association, May 16, 2011. Washington, DC.

171. Langston J, Raynor M, Selph P, Mmeji C, Nielsen M, Wallen E, Castle E, Pruthi R.

Robotic-assisted laparoscopic intracorporeal urinary diversion: Combined initial experience.

American Urological Association, May 16, 2011. Washington, DC.

172. Langston J, Ferguson, Selph JP, Smith A, Raynor M, Nielsen M, Wallen E, Pruthi R.

Cost analysis of robotic-assisted radical cystectomy versus open radical cystectomy utilizing

a prospective, randomized cohort. American Urological Association, May 14, 2011.

Washington, DC.

173. Pruthi RS, Castle E, Davis JW. Robot assisted radical cystectomy and extended

lymphadenectomy. American Urological Association, May 14, 2011. Washington, DC.

174. Pruthi RS. Radical cystectomy and urinary diversion in bladder cancer. Urology

Nursing Society “Urology Nursing 2011”, March 24, 2011. Chapel Hill, North Carolina.

175. Langston J, Selph JP, Ferguson J, Manvar A, Sawh S, Raynor M, Nielsen M, Wallen E, Pruthi R. Cost analysis of robotic-assisted versus laparoscopic versus open partial

nephrectomy. Southeastern Section of the American Urological Association, March 19,

2011. New Orleans, Louisiana.

176. Selph JP, Langston J, Manvar A, Ferguson J, Smith A, Nielsen M, Wallen E, Pruthi R.

Re-secting T1 bladder tumors: Single-institution analysis in a modern cohort of patients.

Southeastern Section of the American Urological Associations, March 19, 2011. New

Orleans, Louisiana.

39

177. Selph JP, Langston J, Martin A, Smith A, Sawh S, Raynor M, Nielsen M, Wallen E,

Castle E, Pruthi R. Oncologic outcomes for node-positive patients undergoing robotic radical

cystectomy. Southeastern Section of the American Urological Association, March 19, 2011.

New Orleans, Louisiana.

178. Langston J, Selph JP, Ferguson J, Manvar A, Smith A, Raynor M, Nielsen M, Wallen E,

Pruthi R. The evaluation of the learning curve associated with robotic radical cystectomy:

Initial 100 cases. Southeastern Section of the American Urological Association, March 19,

2011. New Orleans, Louisiana.

179. Langston J, Selph JP, Ferguson J, Manvar A, Smith A, Raynor M, Nielsen M, Wallen E,

Pruthi R. Robotic-assisted laparoscopic radical prostatectomy: Evaluation o f the functional

and oncologic learning curve. Southeastern Section of the American Urological Association,

March 19, 2011. New Orleans, Louisiana.

180. Selph JP, Langston J, Martin A, Smith A, Sawh S, Raynor M, Nielsen M, Wallen E,

Castle E, Pruthi R. Robotic radical cystectomy: Medium-term oncologic follow-up.

Southeastern Section of the American Urological Association, March 19, 2011. New

Orleans, Louisiana.

181. Selph JP, Langston J, Ferguson J, Manvar A, Smith A, Vyas S, Raynor M, Nielsen M,

Wallen E, Pruthi R. Does robotic radical cystectomy for bladder cancer affect long-term

health-related quality of life? Southeastern Section of the American Urological Association,

March 19, 2011. New Orleans, Louisiana.

182. Langston J, Selph JP, Sawh S, Kim W, Godley P, Whang Y, Rathmell WK, Nielsen M,

Wallen E, Pruthi R. Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or

external beam radiotherapy in high risk localized prostate cancer: A phase II trial.

Southeastern Section of the American Urological Association, March 18, 2011. New

Orleans, Louisiana.

183. Selph JP, Langston J, Sawh S, Ferguson J, Manvar A, Smith A, Wallen E, Pruthi R,

Lotan Y, Nielsen M. Risk-specific intensity of surveillance practices in non-muscle-invasive

bladder cancer: Results from the BCAN/SUO/AUA/LUGPA Electronic Survey.

Southeastern Section of the American Urological Association, March 18, 2011. New

Orleans, Louisiana.

184. Selph JP, Langston J, Sawh S, Ferguson J, Manvar A, Smith A, Wallen E, Pruthi R,

Lotan Y, Nielsen M. Patterns of utilization of urine-based markers in non-muscle-invasive

bladder cancer: Results from BCAN/SUO/AUA/LUGPA Electronic Survey. Southeastern

Section of the American Urological Association, March 18, 2011. New Orleans, Louisiana.

185. Langston J, Selph JP, Manvar A, Ferguson J, Sawh S, Smith A, Raynor M, Nielsen M,

Carson C, Pruthi R. Clinical and pathologic differences between patients undergoing

TURBT for newly-diagnosed versus recurrent bladder lesions detected by cystoscopy.

Southeastern Section of the American Urological Association, March 18, 2011. New

Orleans, Louisiana.

186. Selph JP, Langston J, Ferguson J, Manvar A, Smith A, Nielsen M, Wallen E, Pruthi R.

The fate of men with incidental prostate cancer diagnosed at the time of radical cystectomy.

40

Southeastern Section of the American Urological Association, March 17, 2011. New

Orleans, Louisiana.

187. Langston J, Selph JP, Manvar A, Ferguson J, Smith A, Raynor M, Nielsen M, Wallen E,

Pruthi R. HIFU and the internet: A quality control study of online information.

Southeastern Section of the American Urological Association, March 17, 2011. New

Orleans, Louisiana.

188. Pruthi R. Outcomes of robotic radical cystectomy and urinary diversion. American

Urological Association Advanced Robotic Urologic Oncology, January 28, 2011.

Celebration, Florida.

189. Pruthi R. Video: Robotic cystectomy and neobladder. American Urological Association

Advanced Robotic Urologic Oncology, January 28, 2011. Celebration, Florida.

190. Pruthi R. Complications of robotic cystectomy and diversion. American Urological

Association Advanced Robotic Urologic Oncology, January 28, 2011. Celebration, Florida.

191. Pruthi R. Learning robotic cystectomy: Recommendations for beginners. American

Urological Association Advanced Robotic Urologic Oncology, January 28, 2011.

Celebration, Florida.

192. Pruthi R. Video: Robotic anterior pelvic exenteration. American Urological Association

Advanced Robotic Urologic Oncology, January 28, 2011. Celebration, Florida.

193. Pruthi R. Video: Robotic Intracorporeal urinary diversion. American Urological

Association Advanced Robotic Urologic Oncology, January 28, 2011. Celebration, Florida.

194. Pruthi RS. Robotic Intracorporeal urinary diversion. IRUS National Meeting, January

14, 2011. Las Vegas, Nevada.

195. Rosenman JG, Chen RC, Hoffman LG, Chiu WK, Pruthi RS, Wallen EM, Kim WY,

Rathmell WK, Godley PA, Whang YE. Phase 1 study of concurrent weekly docetaxel,

androgen deprivation, and high-dose external beam radiation therapy (RT) for high-risk

prostate cancer. American Society for Radiation Oncology, November 3, 2010. San Diego,

California.

196. Pruthi RS. Robotic radical cystectomy for bladder cancer. Society of Pelvic Surgeons,

September 17, 2010. Durham, North Carolina.

197. Pruthi RS. Robot assisted radical cystectomy: Oncologic outcomes and perspectives.

Society of Urological Robotic Surgery presentation at the 28th World Congress, September 2,

2010. Chicago, Illinois.

198. Pruthi RS. Estrogen deficiency as an unintended side effect of androgen deprivation

therapy. Indian AUA Annual Meeting, May 29, 2010, San Francisco, California.

199. McKim S, Simopoulos E, Raynor M, Smith A, Nielsen M, Wallen W, Pruthi R. Robotic

cystectomy and the internet: Fact or fiction? American Urological Association, May 29 –

June 3, 2010. San Francisco, California.

41

200. McKim S, Simopoulos E, Raynor M, Smith A, Nielsen M, Wallen W, Pruthi R.

Preliminary experience with prostate-sparing cystectomy for urothelial carcinoma of the

bladder. American Urological Association, May 29 – June 3, 2010. San Francisco,

California.

201. Raynor M, McKim S, Simopoulos E, Smith A, Nielsen M, Wallen W, Pruthi R. Does

obesity impact outcomes in patients undergoing robotic cystectomy for bladder cancer: a

multi-institutional analysis. American Urological Association, May 29 – June 3, 2010. San

Francisco, California.

202. Simopoulos E, McKim S, Raynor M, Smith A, Nielsen M, Wallen E, Pruthi R. The

impact of race and gender in patients undergoing radical cystectomy for bladder cancer.

American Urological Association, May 29 – June 3, 2010. San Francisco, California.

203. McKim S, Simopoulos E, Raynor M, Smith A, Nielsen M, Wallen E, Pruthi R. The

impact of radical cystectomy on renal function: An analysis of variance based on age,

gender, race, and diversion technique. American Urological Association, May 29 – June 3,

2010. San Francisco, California.

204. Raynor M, McKim S, Simopoulos E, Smith A, Nielsen M, Wallen E, Pruthi R. Multi-

institutional analysis of robotic radical cystectomy for bladder cancer: Peri-operative

outcomes in 227 patients. American Urological Association, May 29 – June 3, 2010. San

Francisco, California.

205. Simopoulos E, McKim S, Raynor M, Smith A, Nielsen M, Wallen E, Pruthi R. Long-

term follow-up of patients initially managed with active surveillance for solid renal masses.

American Urological Association, May 29 – June 3, 2010. San Francisco, California.

206. Raynor M, McKim S, Simopoulos E, Smith A, Nielsen M, Wallen E, Pruthi R.

Feasibility and outcomes of robotic-assisted laparoscopic radical cystectomy for bladder

cancer in the elderly. American Urological Association, May 29 – June 3, 2010. San

Francisco, California.

207. McKim S, Simopoulos E, Raynor M, Smith A, Nielsen M, Wallen E, Pruthi R. Robotic-

assisted laparoscopic intracorporeal urinary diversion. American Urological Association,

May 29 – June 3, 2010. San Francisco, California.

208. Pruthi RS. Estrogen deficiency as an unintended consequence of ADT. Indian American

Urological Association, May 29, 2010. San Francisco, California.

209. Pruthi RS. Surgery and urinary reconstruction for muscle-invasive bladder cancer.

Understanding Bladder Cancer – a Bladder Cancer Advocacy Network Patient Forum, Friday

Center, May 15, 2010. Chapel Hill, North Carolina.

210. McKim S, Simopoulos E, Smith A, Nix J, Raynor M, Nielsen M, Wallen E, Pruthi R.

Prospective, randomized trial of robotic versus open radical cystectomy for bladder cancer:

peri-operative and pathological results. Southeastern Section of the American Urological

Association, March 12, 2010. Miami Beach, Florida.

211. Raynor M, Smith A, Amling C, Busby JE, Castle E, Davis R, Thomas R, Nielsen M,

Wallen E, Pruthi R. Complications associated with robotic radical cystectomy for bladder

42

cancer: A multi-institutional analysis. Southeastern Section of the American Urological

Association, March 12, 2010. Miami Beach, Florida.

212. McKim S, Simopoulos E, Smith A, Raynor M, Nielsen M, Wallen E, Pruthi R. Robotic-

assisted laparoscopic intracorporeal urinary diversion. Southeastern Section of the American

Urological Association, March 12, 2010. Miami Beach, Florida.

213. McKim S, Simopoulos E, Smith A, Raynor M, Nielsen M, Wallen E, Pruthi R.

Feasibility and outcomes of robotic-assisted laparoscopic radical cysectomy for bladder

cancer in the elderly. Southeastern Section of the American Urological Association, March

12, 2010. Miami Beach, Florida.

214. McKim S, Simopoulos E, Nielsen M, Wallen E, Pruthi R. Fast track program in patients

undergoing radical cystectomy: Experience in 362 consecutive cases. Southeastern Section

of the American Urological Association, March 12, 2010. Miami Beach, Florida.

215. Raynor M, Smith A, Amling C, Busby JE, Castle E, Davis R, Thomas R, Nielsen M,

Wallen E, Pruthi R. Multi-institutional analysis of robotic radical cystectomy for bladder

cancer: Peri-operative outcomes in 227 patients. Southeastern Section of the American

Urological Association, March 12, 2010. Miami Beach, Florida.

216. Simopoulos E, McKim S, Dray E, Smith A, Nielsen M, Wallen E, Pruthi R. Does age

affect presentation and outcomes in patients undergoing radical cystectomy for bladder

cancer? Southeastern Section of the American Urological Association, March 12, 2010.

Miami Beach, Florida.

217. Simopoulos E, McKim S, Rathmell K, William K, Godley P, Whang Y, Nielsen M,

Wallen E, Pruthi R. A neoadjuvant clinical trial with sorafenib for patients with Stage II or

greater renal cell carcinoma. Southeastern Section of the American Urological Association,

March 11, 2010. Miami Beach, Florida.

218. Simopoulos E, McKim S, Waldorf B, Smith A, Nielsen M, Wallen E, Pruthi R. Long-

term follow-up of patients initially managed with active surveillance for solid renal masses.

Southeastern Section of the American Urological Association, March 11, 2010. Miami

Beach, Florida.

219. Raynor M, Nielsen M, Wallen E, Pruthi R. Robotic-assisted laparoscopic intracorporeal

urinary diversion. Video. Southeastern Section of the American Urological Association,

March 11, 2010. Miami Beach, Florida.

220. Raynor M, Nielsen M, Wallen E, Pruthi R. Robotic-assisted approaches to partial

cystectomy for benign and malignant disease of the bladder. Video. Southeastern Section of

the American Urological Association, March 11, 2010. Miami Beach, Florida.

221. Pruthi RS. Expansion of Robotics in Urologic Oncology: Video of technique and

summary of outcomes. 5th International Congress, Minimally Invasive Robotics Association,

January 27, 2010. San Diego, California.

222. Pruthi RS. Extracorporeal and intracorporeal urinary diversion after robotic cystectomy.

International Robotic Urology Symposium, January 16, 2010. Las Vegas, Nevada.

43

223. McKim S, Simopoulos E, Kim W, Godley P, Whang Y, Rathmell WK, Nielsen M,

Wallen E, Pruthi RS. Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or

external beam radiotherapy in high risk localized prostate cancer: a Phase II trial. Society of

Urologic Oncology Annual Meeting, December 2 - 4, 2009. Bethesda, Maryland.

224. Simopoulos E, McKim S, Rathmell WK, Kim W, Godley P, Whang Y, Nielsen M,

Wallen E, Pruthi RS. A neoadjuvant clinical trial with sorafenib for patients with Stage II or

greater renal cell carcinoma. Society of Urologic Oncology Annual Meeting, December 2 -

4, 2009. Bethesda, Maryland.

225. Simopoulos E, McKim S, Waldorf B, Smith A, Nielsen M, Wallen E, Pruthi RS. Long-

term follow up of patients initially managed with active surveillance for solid renal masses.

Society of Urologic Oncology Annual Meeting, December 2 – 4, 2009. Bethesda, Maryland.

226. Simopoulos E, McKim S, Lavien G, Smith A, Nielsen M, Wallen E, Pruthi RS.

Elimination of bowel preparation in patients undergoing cystectomy and urinary diversion.

Society of Urologic Oncology Annual Meeting, December 2 – 4, 2009. Bethesda, Maryland.

227. Raynor M, Smith A, Amling C, Busby JE, Castle E, Davis R, Thomas R, Nielsen M,

Wallen E, Pruthi RS. Multi-institutional analysis of robotic radical cystectomy for bladder

cancer: perioperative outcomes in 227 patients. Society of Urologic Oncology Annual

Meeting, December 2 – 4, 2009. Bethesda, Maryland.

228. McKim S, Simopoulos E, Nielsen M, Wallen E, Pruthi RS. Fast track program in patients

undergoing radical cystectomy: experience in 362 consecutive cases. Society of Urologic

Oncology Annual Meeting, December 2 – 4, 2009. Bethesda, Maryland.

229. McKim S, Simopoulos E, Dray E, Smith A, Nielsen M, Kim W, Wallen E, Pruthi RS.

Use and outcomes of adjuvant chemotherapy in PT3-4 or node positive bladder cancer:

analysis of a modern surgical cohort. Society of Urologic Oncology Annual Meeting,

December 2 – 4, 2009. Bethesda, Maryland.

230. Hayn M, Hellenthal N, Hussain A, Andrews P, Carpentier P, Castle E, Dasgupta P, Davis

R, Khan S, Kibel A, Kim H, Manoharan M, Menon M, Mottrie A, Ornstein D, Peabody J,

Pruthi R, Redorta J, Richstone L, Schanne F, Stricker H, Wiklund P, Wilding G, Guru K.

Does prior robot-assisted prostatectomy experience affect outcomes at robot-assisted radical

cystectomy? Results from the International Robotic Cystectomy Consortium. Society of

Urologic Oncology Annual Meeting, December 4, 2009. Bethesda, Maryland.

231. Hellenthal N, Hussain A, Andrews P, Carpentier P, Castle E, Dasgupta P, David R, Khan

S, Kibel A, Kim H, Manoharan M, Menon M, Mottrie A, Ornstein D, Peabody J, Pruthi R,

Redorta J, Richstone L, Schanne F, Stricker H, Wiklund P, Wilding G, Guru K.

Lymphadenectomy at the time of robotic-assisted radical cystectomy: results from the

International Robotic Cystectomy Consortium. Society of Urologic Oncology Annual

Meeting, December 4, 2009. Bethesda, Maryland.

232. Hellenthal N, Hussain A, Andrews P, Carpentier P, Castle E, Dasgupta P, Davis R, Khan

S, Kibel A, Kim H, Manoharan M, Menon M, Mottrie A, Ornstein D, Peabody J, Pruthi R,

Redorta J, Richstone L, Schanne F, Stricker H, Wiklund P, Wilding G, Guru K. Status of

surgical margins after robot-assisted radical cystectomy: results from the International

Robotic Cystectomy Consortium. Society of Urologic Oncology Annual Meeting, December

4, 2009. Bethesda, Maryland.

44

233. Pruthi RS. Management of recurrent superficial bladder cancer. Emory University,

Advances in Urology 2009, December 4, 2009. Atlanta, Georgia.

234. Pruthi RS. Robotic-assisted cystectomy. Emory University, Advances in Urology 2009,

December 4, 2009. Atlanta, Georgia.

235. Pruthi RS, Smith A, Wallen E. Robotic-assisted laparoscopic radical cystectomy:

evaluation of the learning curve. American College of Surgeons, October 13, 2009. Chicago,

Illinois.

236. Nielsen M, Kurpad R, Wallen E, Pruthi R. Robotic-assisted laparoscopic pelvic

lymphadenectomy. American College of Surgeons, October 13, 2009. Chicago, Illinois.

237. Pruthi RS, Lentz AC, Sand M, Kouba E, Wallen EM. Impact of marital status in patients

undergoing radical cystectomy for bladder cancer. American College of Surgeons, October

12, 2009. Chicago, Illinois.

238. Kurpad R, Kim W, Rathmell WK, Godley P, Whang Y, Fielding J, Smith L, Pettiford A,

Schultz H, Nielsen M, Wallen E, Pruthi R. The impact of a multidisciplinary approach in the

management of urologic malignancies: does it influence diagnostic and treatment decisions?

American College of Surgeons, October 12, 2009. Chicago, Illinois.

239. Smith A, Coward M, Lal A, Kurpad R, Nielsen M, Wallen E, Pruthi RS. Cost analysis of

robotic-assisted laparoscopic radical cystectomy for bladder cancer. American College of

Surgeons, October 12, 2009. Chicago, Illinois.

240. Smith A, Coward M, Kim W, Grigson G, Kurpad R, Nielsen M, Wallen E, Pruthi RS. A

Phase II study of neoadjuvant erlotinib (Tarceva) in patients with muscle-invasive bladder

cancer undergoing radical cystectomy: preliminary results. American College of Surgeons,

October 12, 2009. Chicago, Illinois.

241. Coward M, Simham J, Carson C, Pruthi RS. Racial differences in prostate-specific

antigen in hypogonadal men treated with testosterone replacement therapy. American

College of Surgeons, October 12, 2009. Chicago, Illinois.

242. Pruthi RS. Modern approaches to the treatment of muscle-invasive bladder cancer.

American College of Surgeons, October 12, 2009. Chicago, Illinois.

243. Pruthi RS. The impact of estrogen deficiency in the male secondary to hormonal therapy

for prostate cancer. New England Section of the American Urological Association,

September 25, 2009. Washington, DC.

244. Smith A, Coward M, Kelly D, Kurpad R, Nielsen M, Wallen E, Pruthi RS. An analysis

of the impact of race on bladder cancer treatment and mortality. American Urological

Association, April 2009. Chicago, Illinois.

245. Johnson D, Kelly D, Smith A, Coward M, Pruthi RS, Wallen E. Impact of hospital type

on surgical treatment for kidney cancer: recent trends. American Urological Association,

April 2009. Chicago, Illinois

45

246. Wallen E, Brannon AR, Pruthi RS, Reddy A, Seiler M, Ganeson S, Bhanot G, Rathmell

WK. Distinct molecular subtypes of clear cell renal cell carcinoma identified by simplified

mRNA profiling predicts clinical outcome. American Urological Association, April 2009.

Chicago, Illinois.

247. Coward M, Smith A, Belsante J, Kurpad R, Schultz H, Nix J, Wallen E, Pruthi RS.

Clinical outcomes of a stapled ileal neobladder after radical cystectomy for bladder cancer.

American Urological Association, April 2009. Chicago, Illinois.

248. Nix J, Coward M, Smith A, Kurpad R, Nielsen M, Wallen E, Pruthi RS. Feasibility and

outcomes of robotic-assisted laparoscopic radical cystectomy for bladder cancer in the

elderly. American Urological Association, April 2009. Chicago, Illinois.

249. Coward M, Smith A, Kurpad, Nix J, Schultz H, Nielsen M, Wallen E, Pruthi RS.

Robotic-assisted laparoscopic radical cystectomy for bladder cancer: perioperative outcomes

in 85 patients and comparison an open cohort. American Urological Association, April 2009.

Chicago, Illinois.

250. Nix J, Coward M, Smith A, Kurpad R, Schultz H, Nielsen M, Wallen E, Pruthi RS.

Prospective randomized trial of open versus robotic-assisted laparoscopic radical cystectomy

for bladder cancer: interim results. American Urological Association, April 2009. Chicago,

Illinois.

251. Smith A, Coward M, Lal A, Kurpad R, Nix J, Nielsen M, Wallen E, Pruthi RS.

Analgesic use in open versus robotic-assisted laparoscopic radical prostatectomy. American

Urological Association, April 2009. Chicago, Illinois.

252. Smith A, Coward M, Lal A, Kurpad R, Nix J, Nielsen M, Wallen E, Pruthi RS.

Analgesic use in men undergoing robotic-assisted laparoscopic radical prostatectomy: a

detailed analysis of demographic, clinical and operative influences. American Urological

Association, April 2009. Chicago, Illinois.

253. Smith A, Coward M, Doak H, Kurpad R, Nix J, Nielsen M, Wallen E, Pruthi RS.

Outcomes and implications of follow-up biopsies of men on active surveillance for low-risk

prostate cancer. American Urological Association, April 2009. Chicago, Illinois.

254. Coward M, Smith A, Kurpad R, Nielsen M, Wallen E, Pruthi RS. Poster: Achieving

complete success after robotic radical prostatectomy: is the trifecta in reach? Southeastern

Section of the American Urological Association, March 29, 2009. Mobile, Alabama.

255. Coward M, Smith A, Kurpad R, Shingleton WB, Nielsen M, Wallen E, Pruthi RS.

Poster: Robotic-assisted laparoscopic radical cystectomy: evaluation of the learning curve.

Southeastern Section of the American Urological Association, March 29, 2009. Mobile

Alabama.

256. Coward M, Smith A, Kurpad R, Nielsen M, Wallen E, Pruthi RS. Poster: Impact of

obesity and adiposity on outcomes of patients undergoing radical cystectomy for bladder

cancer. Southeastern Section of the American Urological Association, March 29, 2009.

Mobile, Alabama.

46

257. Smith A, Coward M, Kurpad R, Nielsen M, Wallen E. Pruthi RS. Poster: The impact of

a multidisciplinary approach to the management of bladder cancer. Southeastern Section of

the American Urological Association, March 29, 2009.

258. Coward M, Smith A, Kurpad R, Nielsen M, Wallen E, and Pruthi RS. Impact of obesity

on operative, pathologic and functional outcomes after robotic-assisted laparoscopic radical

prostatectomy. Southeastern Section of the American Urological Association, March 27,

2009. Mobile, Alabama.

259. Johnson D, Kelly D, Smith A, Coward M, Pruthi RS, Wallen E. Impact of hospital type

on surgical treatment for kidney cancer: recent trends. Southeastern Section of the American

Urological Association, March 27, 2009. Mobile, Alabama.

260. Coward M, Smith A, Kurpad R, Nielsen M, Wallen E, Pruthi RS. Robotic-assisted

laparoscopic radical cystectomy for bladder cancer: experience in 85 patients and

comparison to an open cohort. Southeastern Section of the American Urological Association,

March 27, 2009. Mobile, Alabama.

261. Smith A, Coward M, Lal A, Kurpad R, Nielsen M, Wallen E, Pruthi RS. Cost analysis of

robotic-assisted laparoscopic radical cystectomy for bladder cancer. Southeastern Section of

the American Urological Association, March 27, 2009. Mobile, Alabama.

262. Smith A, Coward M, Kim W, Grigson G, Kurpad R, Wallen E, Nielsen M, Pruthi RS. A

Phase II study of neoadjuvant erlotinib (Tarceva) in patients with muscle-invasive bladder

cancer undergoing radical cystectomy: preliminary results. Southeastern Section of the

American Urological Association, March 27, 2009. Mobile, Alabama.

263. Kelly D, Smith A, Coward M, Kurpad R, Nielsen M, Wallen E, Pruthi RS. An analysis

of the impact of race on bladder cancer treatment and mortality. Southeastern Section of the

American Urological Association, March 27, 2009. Mobile, Alabama.

264. Belsante J, Coward M, Smith A, Kurpad R, Wallen E, Pruthi RS. Preliminary experience

with prostate-sparing cystectomy for urothelial carcinoma of the bladder. Southeastern

Section of the American Urological Association, March 27, 2009. Mobile, Alabama.

265. Smith A, Coward M, Nielsen, Wallen E, Pruthi RS. Video: Robotic-assisted

laparoscopic anterior pelvic exenteration for bladder cancer in the female. Southeastern

Section of the American Urological Association, March 27, 2009. Mobile, Alabam

266. Doak H, Smith A, Coward M, Kurpad R, Nielsen M, Wallen E, Pruthi RS. Outcomes

and implications of follow-up biopsies of men on active surveillance for low-risk prostate cancer. Southeastern Section of the American Urological Association, March 26, 2009.

Mobile, Alabama.

267. Coward M, Smith, A, Nielsen M, Wallen E, Pruthi RS. Video: Robotic-assisted

laparoscopic pelvic lymphadenectomy. Southeastern Section of the American Urological

Association, March 26, 2009. Mobile, Alabama.

268. Pruthi R, Kim W, Rathmell K, Whang Y, Godley P, Wallen E, Kurpad R, Smith A. The

impact of a multidisciplinary approach in the management of urologic malignancies: does it

47

influence diagnostic and treatment decisions? American Society of Clinical Oncology 2009

Genitourinary Cancers Symposium, February 26 – 28, 2009. Orlando, Florida.

269. Pruthi R, Kim W, Kurpad R, Smith A, Heathcote S, Rathmell K, Whang Y, Godley P,

Wallen E. A Phase II study of neoadjuvant erlotinib in patients with muscle-invasive bladder

cancer undergoing radical cystectomy: preliminary clinical results. American Society of

Clinical Oncology 2009 Genitourinary Cancers Symposium, February 26 – 28, 2009.

Orlando, Florida.

270. Pruthi R, Kim W, Rathmell K, Whang Y, Godley P, Wallen E, Kurpad R, Smith A. The

impact of a multidisciplinary approach to the management of bladder cancer. American

Society of Clinical Oncology 2009 Genitourinary Cancers Symposium, February 26 – 28,

2009. Orlando, Florida.

271. Doak H, Smith A, Coward M, Kurpad R, Nielsen M, Wallen E, Pruthi R. Outcomes and

implications of follow up biopsies of men on active surveillance for low risk prostate cancer.

Society of Urologic Oncology, December 4 – 5, 2008. Bethesda, Maryland.

272. Smith A, Coward M, Kelly D, Nielsen M, Wallen E, Pruthi R. Evaluation of the

incidence of a second urologic malignancy (bladder cancer and kidney cancer) in men with a

diagnosis of prostate cancer. Society of Urologic Oncology, December 4 – 5, 2008.

Bethesda, Maryland.

273. Smith A, Coward M, Kurpad R, Nielsen M, Wallen E, Pruthi R. The impact of a

multidisciplinary approach in the management of urologic malignancies: does it influence

diagnostic and treatment decisions? Society of Urologic Oncology, December 4 – 5, 2008.

Bethesda, Maryland.

274. Smith A, Coward, Kelly D, Kurpad R, Nielsen M, Wallen E, Pruthi R. An analysis of the

impact of race on bladder cancer treatment and mortality. Society of Urologic Oncology,

December 4 – 5, 2008. Bethesda, Maryland.

275. Coward M, Smith A, Kurpad R, Nielsen M, Wallen E, Pruthi R. Robotic-assisted

laparoscopic radical cystectomy: medium-term clinical and oncologic follow up. Society of

Urologic Oncology, December 4 – 5, 2008. Bethesda, Maryland.

276. Coward M, Smith A, Kurpad R, Nielsen M, Wallen E, Pruthi R. Robotic-assisted

laparoscopic anterior pelvic exenteration for bladder cancer in the female. Society of

Urologic Oncology, December 4 – 5, 2008. Bethesda, Maryland.

277. Coward M, Smith A, Kurpad R, Nielsen M, Wallen E, Pruthi R. Impact of obesity and

adiposity on outcomes of patients undergoing radical cystectomy for bladder cancer. Society

of Urologic Oncology, December 4 – 5, 2008. Bethesda, Maryland.

278. Coward M, Smith A, Pearson M, Kurpad R, Kim W, Nielsen M, Wallen E, Pruthi R. A

Phase II study of neoadjuvant erlotinib (tarceva) in patients with muscle-invasive bladder

cancer undergoing radical cystectomy: prelimary results. Society of Urologic Oncology,

December 4 – 5, 2008. Bethesda, Maryland.

279. Smith A, Coward M, Kurpad R, Wallen E, Pruthi R. Robotic-assisted laparoscopic

radical cystectomy: evaluation of the learning curve. World Congress of Endourology,

December 2, 2008. Shanghai, China.

48

280. Smith A, Coward M, Kurpad R, Wallen E, Pruthi R. Robotic-assisted laparoscopic

radical cystectomy for bladder cancer: experience in 71 patients and comparison to an open

cohort. World Congress of Endourology, December 2, 2008. Shanghai, China.

281. Smith A, Coward M, Kurpad R, Wallen E, Pruthi R. Robotic-assisted laparoscopic

radical cystectomy: short-term clinical follow up. World Congress of Endourology,

December 2, 2008. Shanghai, China.

282. Smith A, Coward M, Kurpad R, Wallen E, Pruthi R. Cost analysis of robotic-assisted

laparoscopic radical cystectomy for bladder cancer. World Congress of Endourology,

December 2, 2008. Shanghai, China.

283. Smith A, Coward M, Kurpad R, Wallen E, Pruthi R. The impact of bladder neck sparing

modification on surgical and functional outcomes after robotic-assisted laparoscopic radical

prostatectomy. World Congress of Endourology, December 2, 2008. Shanghai, China.

284. Smith A, Coward M, Kurpad R, Wallen E, Pruthi R. Robotic-assisted laparoscopic

pelvic lymphadenectomy. World Congress of Endourology, December 1, 2008. Shanghai,

China.

285. Smith A, Coward M, Kurpad R, Wallen E, Pruthi R. Robotic-assisted laparoscopic

anterior pelvic exenteration for bladder cancer in the female. World Congress of

Endourology, December 1, 2008. Shanghai, China.

286. Smith A, Coward M, Kurpad R, Wallen E, Pruthi R. Impact of race on operative,

pathologic and functional outcomes after robotic-assisted laparoscopic radical prostatectomy.

World Congress of Endourology, December 1, 2008. Shanghai, China.

287. Smith A, Coward M, Kurpad R, Wallen E, Pruthi R. Impact of obesity on operative,

pathologic and functional outcomes after robotic-assisted laparoscopic radical prostatectomy.

World Congress of Endourology, November 30, 2008. Shanghai, China.

288. Smith A, Coward M, Kurpad R, Wallen E, Pruthi R. Does an enlarged intravesical

median lobe impact surgical and functional outcomes after robotic-assisted laparoscopic

radical prostatectomy? World Congress of Endourology, November 30, 2008. Shanghai,

China.

289. Smith A, Coward M, Kurpad R, Wallen E, Pruthi R. Does prior laparoscopic hernia

repair impact surgical and functional outcomes after robotic-assisted laparoscopic radical

prostatectomy? World Congress of Endourology, November 30, 2008. Shanghai, China.

290. Kouba E and Pruthi RS. Thomas Edison and the X-ray: Collaboration between industry

and academia and effects on the evolution of urology. 4th International Congress on the

History of Urology, November 8, 2008. Linthicum, Maryland.

291. Pruthi R.S. and Wallen E. The Impact of Bladder Neck-Sparing Modification on

Outcomes after Robotic-Assisted Laparoscopic Radical Prostatectomy. American College of

Surgeons, October 13, 2008. San Francisco, California.

49

292. Pruthi R.S. and Wallen E. Robotic-Assisted Laparoscopic Anterior Pelvic Exenteration

for Bladder Cancer in the Female: Technique and Outcomes. American College of Surgeons,

October 13, 2008. San Francisco, California.

293. Nix J., Pearson M., Kouba E., Wallen E., Pruthi R.S. Robotic-assisted laparoscopic

radical cystectomy. American College of Surgeons, October 13, 2008. San Francisco,

California.

294. Pearson M., Nix J., Kouba E., Wallen E., Pruthi R.S. Relationship of obesity and

incidental prostate cancer detection in men undergoing radical cystoprostatectomy for bladder

cancer. American College of Surgeons, October 13, 2008. San Francisco, California.

295. Pearson M., Nix J., Kim W., Grigson G., Wallen E., Pruthi R.S. A Phase II Study of

neoadjuvant erlotinib (Tarceva) in patients with muscle-invasive bladder cancer undergoing radical cystectomy. American Society of Clinical Oncology. June 6, 2008. Chicago, Illinois.

296. Pearson, M., Nix J., McKim S., Wallen E., Pruthi R.S. Partial cystectomy for bladder

cancer: analysis of recent trends in its use and misuse. American Urological Association.

May 20, 2008. Orlando, Florida.

297. Pearson M., Nix J., Wallen E., Pruthi R.S. Robotic-assisted laparoscopic radical

cystectomy: evaluation of the learning curve. American Urological Association. May 19,

2008. Orlando, Florida.

298. Pearson M., Nix J., Wallen E., Pruthi R.S. Robotic-assisted laparoscopic versus open radical

cystectomy: comparisons of a simultaneous experience. American Urological Association.

May 19, 2008. Orlando, Florida.

299. Pearson M., Nix J., Kouba E., Smith A., Wallen E., Pruthi R.S. Characterization of pT3A

renal carcinoma in tumors less than 4.0 cm in size. American Urological Association. May

19, 2008. Orlando, Florida.

300. Khurshid G., Pruthi R.S., Zubair B., Wallen E, Muhltaler F., Mohler J., Strickler H., Kim H.,

Wiklund P., Peabody J., Menon M. International Robot-assisted Cystectomy Consortium

(IRCC): Immediate oncologic results after one hundred and sixty two cases. American

Urological Association. May 19, 2008. Orlando, Florida.

301. Pearson M., Nix J., Amin C., Rathmell K., Whang Y., Godley P., Pruthi R.S., Wallen E.

Effect of neoadjuvant tyrosine kinase inhibitors on patients undergoing radical nephrectomy.

American Urological Association. May 18, 2008. Orlando, Florida.

302. Pearson M., Nix J., McKim S., Wallen E., Pruthi R.S. Trends of length of stay in patients

undergoing radical cystectomy. American Urological Association. May 18, 2008. Orlando,

Florida.

303. Pearson M., Nix J., Kim W., Grigson G., Wallen E., Pruthi R.S. A Phase II Study of

neoadjuvant erlotinib (Tarceva) in patients with muscle-invasive bladder cancer undergoing

radical cystectomy: preliminary results. American Urological Association. May 18, 2008.

Orlando, Florida.

50

304. Pearson M., Nix J., McKim S., Wallen E., Pruthi R.S. Trends of cystectomy use in

octogenarians with bladder cancer. American Urological Association. May 17, 2008,

Orlando, Florida.

305. Pruthi R.S. Professional Pathways Career Choices. Young Urologists Forum. Southeast

Section of the American Urological Association. March 8, 2008. San Diego, California.

306. Pruthi R.S. Moderator, Bladder Cancer Podium Session. Southeast Section of the American

Urological Association. March 8, 2008. San Francisco, California.

307. Nix J., Pearson M., Kouba E., Wallen E., Pruthi R.S. Clinical usefulness of serum CA 125

levels in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.

Southeast Section of the American Urological Association. March 8, 2008. San Diego,

California.

308. Nix J., Pearson M., Wallen E., Pruthi R.S. The impact of bladder neck sparing modification

on surgical and functional outcomes after robotic-assisted laparoscopic radical

prostatectomy? Southeast Section of the American Urological Association. March 8, 2008.

San Diego, California.

309. Pearson M., Nix J., Amin C., Rathmell K., Whang Y., Wallen E., Pruthi R.S. Effect of

neoadjuvant tyrosine kinase inhibitors on patients undergoing radical nephrectomy.

Southeast Section of the American Urological Association. March 7, 2008. San Diego,

California.

310. Wallen E., Pruthi R.S. Video: Bladder neck preservation during robotic-assisted

laparoscopic prostatectomy. Southeast Section of the American Urological Association.

March 7, 2008. San Diego, California.

311. Nix J., Pearson M., Wallen E., Pruthi R.S. Impact of obesity on operative, pathologic, and

functional outcomes after robotic-assisted laparoscopic radical prostatectomy. Southeast

Section of the American Urological Association. March 7, 2008. San Diego, California.

312. Pearson M., Nix J., McKim S., Wallen E., Pruthi R.S. Partial cystectomy for bladder

cancer: analysis of recent trends in its use and misuse. Southeast Section of the American

Urological Association. March 6, 2008. San Diego, California.

313. Pruthi R.S. Phase II trial of Lapatinib in hormone refractory prostate cancer. American

Society of Clinical Onocology (ASCO) - 2008 Genitourinary Cancers Symposium - A

Multidisciplinary Approach. February 15, 2008. San Francisco, California.

314. Pearson M., Nix J., Amin C., Rathmell K., Whang Y., Godley P., Pruthi R.S. Effect of

neoadjuvant tyrosine kinase inhibitors on patients undergoing radical nephrectomy.

American Society of Clinical Oncology (ASCO) - 2008 Genitourinary Cancers Symposium -

A Multidisciplinary Approach. February 14, 2008. San Francisco, California.

315. Nix J., Pearson M., Wallen EM, Pruthi R.S. Trends in cystectomy use in octogenarians with

bladder cancer. Society of Urologic Oncology. December 1, 2007. Bethesda, Maryland.

51

316. Pearson M., Nix J., Wallen EM, Pruthi R.S. The impact of bladder neck sparing

modification on surgical and functional outcomes after robotic-assisted laparoscopic radical

prostatectomy. Society of Urologic Oncology. December 1, 2007. Bethesda, Maryland.

317. Pearson M., Nix J., Kim W., Grigson G., Wallen EM, Pruthi R.S. A Phase II Study of

neoadjuvant erlotinib (Tarceva) in patients with muscle-invasive bladder cancer undergoing

radical cystectomy: preliminary results. Society of Urologic Oncology. December 1, 2007.

Bethesda, Maryland.

318. Rathmell, Amin C., Cowey C., Pruthi R.S., Wallen E., Khandani A. Neoadjuvant therapy

with sorfenib for locally advanced renal cell carcinoma (RCC). AACR Molecular Targets

Meeting. October 2007. San Francisco, California.

319. Rathmell K., Amin C., Pruthi R.S., Wallen E. Neoadjuvant clinical trials: a new twist on an old study. AACR Molecular Targets Meeting. October 2007. San Francisco, California.

320. Lentz A, Sands M, Kouba E, Wallen E, Pruthi R.S. Clinical Usefulness Of Serum Ca 125

Levels In Patients Undergoing Radical Cystectomy For Transitional Cell Carcinoma Of The

Bladder. American College of Surgeons, October 9, 2007. New Orleans, Louisiana.

321. Miller J., Swords K., Carson CC, Lavelle J., Wallen E., Pruthi R.S. Diagnostic Rates And

Other Outcomes Based On Initial Versus Repeat Biopsy In A Cohort Of Men Undergoing An

Modern Biopsy (10-12 Core) Scheme. American College of Surgeons, October 9, 2007. New

Orleans, Louisiana.

322. Miller J, Bhalani V, Baldwin N, Kouba E, Wallen E, Pruthi R.S. Expectant management of

patients with low-risk superficial bladder cancer. American Urological Association, May 22,

2007, Anaheim, California.

323. Miller J, Smith A, Gunn K, Kouba E, Wallen E, Pruthi R.S. Impact of surgical treatment of

renal carcinoma on renal function and blood pressure: A race- and age-dependent

association. American Urological Association, May 22, 2007, Anaheim, California.

324. Miller J, Smith A, Kouba E, Wallen E, Pruthi R.S. Gender-dependent associations between

body composition in patients with renal cell carcinoma (RCC). American Urological

Association, May 21, 2007, Anaheim, California.

325. Miller J, Smith A, Kouba E, Wallen E, Pruthi R.S. Prospective evaluation of short-term

impact and recovery of health-related quality of life (HRQOL) in men undergoing robotic-

assisted laparoscopic radical prostatectomy vs open radical prostatectomy (ORP). American

Urological Association, May 20, 2007, Anaheim, California.

326. Lentz A, Sands M, Kouba E, Wallen E, Pruthi R.S. A comparison of the Bricker versus

Wallace ureteroileal anastamosis in patients undergoing urinary diversion for bladder cancer.

American Urological Association, May 20, 2007, Anaheim, California.

327. Lentz A, Sands M, Kouba E, Wallen E, Pruthi R.S. Stomal complications in patients

undergoing radical cystectomy and ileal conduit urinary diversion for bladder cancer.

American Urological Association, May 20, 2007, Anaheim, California.

52

328. Lentz A, Sands M, Kouba E, Wallen E, Pruthi R.S. Impact of marital status in patients

undergoing radical cystectomy for bladder cancer. American Urological Association, May

20, 2007, Anaheim, California.

329. Pruthi R.S., Wallen E., Robotic-assisted laparoscopic radical cystectomy (video). American

Urological Association, Southeastern Section. March 10, 2007. Orlando, Florida.

330. Kouba E., Miller J., Wallen E., Pruthi R.S. Characterization of Acute Phase Inflammation in

Men Undergoing Robotic-Assisted Laparoscopic Radical prostatectomy (RALRP). American

Urological Association, Southeastern Section. March 10, 2007. Orlando, Florida.

331. Miller J., Anderson A., Fielding J., Kouba E., Wallen E., Pruthi R.S. Accuracy of MR and

CT cross sectional imaging in the staging of invasive bladder cancer: a prospective study

blinded to clinical outcome. American Urological Association, Southeastern Section. March

10, 2007. Orlando, Florida.

332. Miller J, Swords K, Carson CC, Lavelle J, Wallen E, Pruthi RS. Diagnostic rates and other

outcomes based on initial versus repeat biopsy in a modern cohort of men undergoing an

extended biopsy (10-12 core) scheme. American Urological Association, Southeastern

Section. March 10, 2007. Orlando, Florida.

333. Miller J., Kouba E., Smith A., Wallen E., Pruthi R.S Prospective evaluation of short-term

impact and recovery of health-related quality of life (HRQOL) in men undergoing Robotic-

assisted laparoscopic radical prostatectomy (RALRP) VS. open radical prostatectomy (ORP).

American Urological Association, Southeastern Section. March 10, 2007. Orlando, Florida.

334. Lentz A, Smith A, Kouba E, Wallen E, Pruthi RS. Impact of surgical treatment of renal

carcinoma on renal function and blood pressure: a race- and age-dependent association.

American Urological Association, Southeastern Section, March 10, 2007. Orlando, Florida.

335. Lentz A, Smith A, Kouba E, Wallen E, Pruthi RS. Gender dependent associations between

body composition in patients with renal cell carcinoma (RCC). American Urological

Association, Southeastern Section, March 10, 2007. Orlando, Florida.

336. Miller J., Bhalani V., Wallen E., Pruthi R.S Expectant management of patients with low-risk

superficial bladder cancer. American Urological Association, Southeastern Section. March

10, 2007. Orlando, Florida.

337. Lentz A., Sands M., Kouba E., Wallen E., Pruthi R.S Stomal complications in patients

undergoing radical cystectomy and ileal conduit urinary diversion for bladder cancer.

American Urological Association, Southeastern Section. March 10, 2007. Orlando, Florida.

338. Lentz A., Wallen E., Pruthi R.S Robotic-assisted laparoscopic radical cystectomy: initial

experience and operative outcomes. American Urological Association, Southeastern Section.

March 10, 2007. Orlando, Florida.

339. Carson CC 3rd, Coward M., Simhan J., Pruthi R.S. Prostate cancer in hypogonadal men on

testosterone replacement therapy. American Urological Association, Southeastern Section.

March 8, 2007. Orlando, Florida.

53

340. Miller J., Kouba E., Smith A., Wallen E., Pruthi R.S Prospective evaluation of short-term

impact and recovery of health-related quality of life (HRQOL) in men undergoing Robotic-

assisted laparoscopic radical prostatectomy (RALRP) VS. open radical prostatectomy (ORP).

Society of Urologic Oncology. December 2, 2006. Bethesda, Maryland.

341. Lentz A., Wallen E., Pruthi R.S Robotic-assisted laparoscopic radical cystectomy: initial

experience and operative outcomes. Society of Urologic Oncology. December 2, 2006.

Bethesda, Maryland.

342. Hickerson A., Kouba E., Wallen E., Pruthi R.S. The Impact of Race and Gender in Patients

Undergoing Radical Cystectomy for Bladder Cancer. American College of Surgeons, October

10, 2006. Chicago, Illinois.

343. McRackan D, Kouba E., Smith A., Wallen E., Pruthi R.S Expectant management of small

renal masses: Does a delay in therapy pose a clinical or pathological risk to the patient?

American College of Surgeons, October 10, 2006. Chicago, Illinois.

344. Wallen E, Pruthi RS. The burden of kidney cancer in America: the urologic diseases of

America project. American Urological Association. May 22, 2006, Atlanta, Georgia.

345. Hubbard JS, Stefaniak H, Molitierno J, Wallen E, Pruthi RS. Incidental finding of prostate

cancer at cystoprostatectomy: changes in incidence in the PSA era. American Urological

Association. May 21, 2006. Atlanta, Georgia.

346. McRackan D, Kouba E, Smith A, Wallen E, Pruthi RS. Expectant management of small

renal masses: does a delay in therapy pose a clinical or pathological risk to the patient?

American Urological Association. May 21, 2006. Atlanta, Georgia.

347. Hickerson A., Pruthi R.S., Wallen E.: Laparoscopic retroperitoneal lymph node dissection

for low-stage testicular cancer: challenges and benefits. American Urological Association,

Southeastern Section. March 2, 2006. San Juan, Puerto Rico.

348. McRackan D, Kouba E., Wallen E., Pruthi R.S Recent experience of surgical management

of renal masses: the evolution of laparoscopic approaches in clinical practice. American

Urological Association, Southeastern Section. March 2, 2006. San Juan, Puerto Rico.

349. Hickerson A., Kouba E., Wallen E., Pruthi R.S.: Evaluation of the routine use of

metocloperamide in patients undergoing radical cystectomy and urinary diversion. American

Urological Association, Southeastern Section. March 2, 2006. San Juan, Puerto Rico.

350. Thomasch J., Kouba E., Hickerson A., Wallen E., Pruthi R.S Impact of Race on time to

androgen independence and subsequent biochemical progression in men with advanced

prostate cancer. American Urological Association, Southeastern Section. March 2, 2006. San

Juan, Puerto Rico.

351. McRackan D, Evans A., Carson C., Wallen E., Michell P., Pruthi R.S An evaluation of

prostate cancer knowledge in patients with prostate cancer in patients with prostate cancer

and their partners. American Urological Association, Southeastern Section. March 2, 2006.

San Juan, Puerto Rico.

54

352. McRackan D, Evans A., Carson C., Wallen E., Michell P., Pruthi R.S An evaluation of

prostate cancer knowledge in patients with prostate cancer: impact of demographic and

socioeconomic variables. American Urological Association, Southeastern Section. March 2,

2006. San Juan, Puerto Rico.

353. Hickerson A., Leese P., Moore D.,Wallen E., Mohler J., Pruthi R.S.: Impact of race on

treatment selection and disease progression in men who choose observation for clinically-

localized prostate cancer. American Urological Association, Southeastern Section. March 2,

2006. San Juan, Puerto Rico.

354. Hickerson A, Leese P, Moore D, Wallen E, Mohler J, Pruthi RS. Watchful waiting for

patients with locally-advanced and node-positive prostate cancer: biochemical and clinical

outcomes. American Urological Association, Southeastern Section. March 2, 2006. San

Juan, Puerto Rico.

355. Stefaniak H, Carson CC, Pruthi RS, Wallen E. Tadalafil therapy beginning on postoperative

day one preserves potency in men undergoing radical prostatectomy - preliminary one-year

results. American Urological Association, Southeastern Section. March 2, 2006, San Juan,

Puerto Rico.

356. Wallen E, Pruthi RS. The burden of kidney cancer in America: the urologic disease of

America project. American Urological Association, Southeastern Section. March 2, 2006,

San Juan, Puerto Rico.

357. McRackan D, Kouba E., Smith A., Wallen E., Pruthi R.S Expectant management of small

renal masses: Does a delay in therapy pose a clinical or pathological risk to the patient?

American Urological Association, Southeastern Section. March 2, 2006. San Juan, Puerto

Rico.

358. Thomasch J., Kouba E., Hickerson A., Wallen E., Pruthi R.S Impact of Race on time to

androgen independence and subsequent biochemical progression in men with advanced

prostate cancer. Society of Urologic Oncology. December 2, 2005. Bethesda, Maryland.

359. Pruthi R.S., Carson C.C. COX-2 inhibitors in PSA recurrent prostate cancer after definitive

radiation therapy or radical prostatectomy. Urologic Research Society, November 10, 2005.

Boston Massachusetts.

360. Hubbard J.S., Derksen J.E., Molitierno J., Wallen E., Pruthi R.S. Hand Assisted

Laparoscopic Nephrectomy for Large Renal Masses. American College of Surgeons, October

16, 2005. San Francisco, California.

361. Stefaniak H., Carson C.C., Pruthi R.S., Wallen E., Tadalafil therapy beginning on post-

operative day one preserves potency in men undergoing radical prostatectomy. American

College of Surgeons, October 16, 2005. San Francisco, California.

362. Hubbard J.S., Wallen E., Pruthi R.S. Prospective evaluation of short-term impact and

recovery of health-related quality of life (HRQOL) in men undergoing radical prostatectomy

(RP). American Urological Association,. May 25, 2005. San Antonio, Texas.

55

363. Santa-Cruz R.S., Derksen J.E., Molitierno J., Wallen E., Pruthi R.S Efficacy and Safety of

En Bloc Ligation of the Renal Hilum at the time of Laparoscopic Nephrectomy: Review of

62 consecutive cases. American Urological Association,. May 22, 2005. San Antonio, Texas.

364. Derksen JE., Grigson G., Wallen E., Pruthi R.S., Phase II trial of celecoxib in PSA recurrent

prostate cancer after definitive radiation therapy or radical prostatectomy. American

Urological Association. May 22, 2005. San Antonio, Texas.

365. Stefaniak H., Wallen E., Pruthi R.S. Neoadjuvant Docetaxel and Estramustine Followed by

Radical Prostatectomy or Radiation Therapy for Patients with High-Risk Prostate Cancer.

American Urological Association. May 21, 2005. San Antonio, Texas.

366. Stefaniak H., Carson C.C., Pruthi R.S., Wallen E., Tadalafil therapy beginning on post-

operative day one preserves potency in men undergoing radical prostatectomy. American

Urological Association, Southeastern Section. March 3, 2005. Charleston, South Carolina.

367. Santa-Cruz R.S., Derksen J.E., Molitierno J., Wallen E., Pruthi R.S Efficacy and Safety of

En Bloc Ligation of the Renal Hilum at the time of Laparoscopic Nephrectomy: Review of

62 consecutive cases. American Urological Association, Southeastern Section. March 5,

2005. Charleston, South Carolina.

368. Santa-Cruz R.S., Derksen J.E., Molitierno J., Wallen E., Pruthi R.S Hand Assisted

Laparoscopic Nephrectomy for Large Renal Masses. American Urological Association,

Southeastern Section. March 5, 2005. Charleston, South Carolina.

369. Santa-Cruz R.S., Derksen J.E., Molitierno J., Wallen E., Pruthi R.S. Safe and effective

application of laparoscopic partial nephrectomy for small renal masses: duplication of open

principles and practices. American Urological Association, Southeastern Section. March 5,

2005. Charleston, South Carolina.

370. Derksen JE., Grigson G., Wallen E., Pruthi R.S. Phase II trial of celecoxib in PSA recurrent

prostate cancer after definitive radiation therapy or radical prostatectomy. American

Urological Association, Southeastern Section. March 5, 2005. Charleston, South Carolina.

371. Evans A., Derksen J.E., Molitierno J., Wallen E., Pruthi R.S. Complications and reasons for

prolonged stay in patients undergoing radical cystectomy utilizing a perioperative pathway.

American Urological Association, Southeastern Section. March 4, 2005. Charleston, South

Carolina.

372. Evans A., Derksen J.E., Molitierno J., Wallen E., Pruthi R.S. Costs and surgical outcomes

associated with radical cystectomy: changes over the past decade. American Urological

Association, Southeastern Section. March 3, 2005. Charleston, South Carolina.

373. Stefaniak H., Wallen E., Pruthi R.S. The use of the COX-2 inhibitor celecoxib to reduce

perioperative pain associated with radical retropubic prostatectomy (RRP). American

Urological Association, Southeastern Section. March 3, 2005. Charleston, South Carolina.

374. Hubbard J.S., Wallen E., Pruthi R.S. Prospective evaluation of short-term impact and

recovery of health-related quality of life (HRQOL) in men undergoing radical prostatectomy

(RP). American Urological Association, Southeastern Section. March 3, 2005. Charleston,

South Carolina.

56

375. Stefaniak H., Wallen E., Pruthi R.S. Neoadjuvant Docetaxel and Estramustine Followed by

Radical Prostatectomy or Radiation Therapy for Patients with High-Risk Prostate Cancer.

American Urological Association, Southeastern Section. March 3, 2005. Charleston, South

Carolina.

376. Hubbard J.S., Stefaniak H., Molitierno J., Wallen E., Pruthi R.S. Incidental Finding of

prostate cancer at cystoprostatectomy: changes in incidence in the PSA era. American

Urological Association, Southeastern Section. March 3, 2005. Charleston, South Carolina.

377. Hubbard J.S., Stefaniak H., Molitierno J., Wallen E., Pruthi R.S., Incidental Finding of

prostate cancer at cystoprostatectomy: changes in incidence in the PSA era. Society of

Urologic Oncology. December 3, 2004. Bethesda, Maryland.

378. Stefaniak H., Wallen E., Pruthi R.S. Neoadjuvant Docetaxel and Estramustine Followed by

Radical Prostatectomy or Radiation Therapy for Patients with High-Risk Prostate Cancer.

Society of Urologic Oncology. December 3, 2004. Bethesda, Maryland.

379. Santa-Cruz R.S., Derksen J.E., Molitierno J., Wallen E., Pruthi R.S. Safe and effective

application of laparoscopic partial nephrectomy for small renal masses: duplication of open

principles and practices. Society of Urologic Oncology. December 3, 2004. Bethesda,

Maryland.

380. Derksen JE., Pruthi R.S., Phase II trial of celecoxib in PSA recurrent prostate cancer after

definitive radiation therapy or radical prostatectomy. American College of Surgeons. October

11, 2004. New Orleans, Louisiana.

381. McLaughlin S., Chun J., Richman M., Pruthi R.S. Potential role of initial incision of the

lateral pelvic fascia, development of a perirectal pocket, and early ligation of the vascular

pedicles in reducing positive margins during radical prostatectomy. American College of

Surgeons. October 11, 2004. New Orleans, Louisiana.

382. Tornehl C., Kouba E., Wallen E., Pruthi R.S. Initial experience with fibrin tissue sealants

during laparoscopic partial nephrectomy. American College of Surgeons. October 11, 2004.

New Orleans, Louisiana.

383. Baggstrom MQ, Rosenman J, Pruthi R.S., Whang Y., Goyal L, Grigson G, Godley P. A

phase II trial of neo-adjuvant docetaxel (D) and estramustine (E) in patients with high

risk/locally advanced prostate cancer. American Society of Clinical Oncology. June 6, 2004.

New Orleans, Louisiana.

384. Pruthi R.S., Derksen JE. A phase II trial of celecoxib in PSA recurrent prostate cancer after

definitive radiation therapy or radical prostatectomy. American Society of Clinical Oncology.

June 6, 2004. New Orleans, Louisiana.

385. Kang, J., Pruthi, R.S. Comparison of grade and stage in African American and Caucasian

patients with prostate cancer: evaluation of clinical, biopsy, and surgical pathology.

American Urological Association, Chief Resident Meeting. May 13, 2004. San Francisco,

California.

57

386. Tornehl C., Gaston K.E., Carson C.C, Wallen E., Pruthi R.S. Impact of Race, Age, Income,

and Residence on Prostate Cancer (CaP) Knowledge, Screening Behavior, and Health

Maintenance in Siblings of Patients with CaPAmerican Urological Association. May 12,

2004. San Francisco, California.

387. Tornehl C., Kouba E., Wallen E., Pruthi R.S. Partial nephrectomy with fibrin glue repair:

measurement of vascular and pelvicaliceal bond integrity in a live porcine animal model.

American Urological Association. May 10, 2004. San Francisco, California.

388. McLaughlin S., Funkhouser W.K., Wallen E.M., Pruthi R.S. Expression of Cyclooxygenase-

2 in human renal cell carcinoma. American Urological Association. May 10, 2004. San

Francisco, California.

389. McLaughlin S., Shephard J., Wallen E.M., Pruthi R.S. Comparison of clinical and

pathological staging in patients undergoing primary versus delayed radical cystectomy for

bladder cancer. American Urological Association. May 9, 2004. San Francisco, California.

390. Tornehl C., Kouba E., Wallen E., Pruthi R.S. Initial experience with fibrin tissue sealants

during laparoscopic partial nephrectomy. American Urological Association, Southeastern

Section. March 25, 2004. Aruba.

391. Tornehl C., Kouba E., Wallen E., Pruthi R.S. Partial nephrectomy with fibrin glue repair:

measurement of vascular and pelvicaliceal bond integrity in a live porcine animal model.

American Urological Association, Southeastern Section. March 26, 2004. Aruba.

392. McLaughlin S., Chun J., Richman M., Pruthi R.S. Potential role of initial incision of the

lateral pelvic fascia, development of a perirectal pocket, and early ligation of the vascular

pedicles in reducing positive margins during radical prostatectomy. American Urological

Association, Southeastern Section. March 28, 2004. Aruba.

393. McLaughlin S., Chun J., Richman M., Pruthi R.S. Reducing time to oral diet and hospital

discharge in patients undergoing radical cystectomy. American Urological Association,

Southeastern Section. March 26, 2004. Aruba.

394. McLaughlin S., Shephard J., Wallen E.M., Pruthi R.S. Comparison of clinical and

pathological staging in patients undergoing primary versus delayed radical cystectomy for

bladder cancer. American Urological Association, Southeastern Section. March 26, 2004.

Aruba.

395. Hawke NA, Pruthi R.S., Funkhouser WK, Baldwin AS. Phosphorylated serine 536 as an

indicator of NF(B activity in prostate cancer. Keystone Symposia. January 11, 2004.

Colorado.

396. Gaston K., Lee K., Pruthi R.S. Impact of Race, Age, Income, and Residence on Prostate

Cancer (CaP) Knowledge, Screening Behavior, and Health Maintenance in Siblings of

Patients with CaP. Society of Urologic Oncology, December 5, 2003. Bethesda, Maryland.

397. Gaston K., Lee K., Pruthi R.S. Impact of a Sibling’s Diagnosis of Prostate Cancer (CaP) on

Prostate Cancer Knowledge, Screening Behavior, and other Health-related Activities. Society

of Urologic Oncology, December 5, 2003. Bethesda, Maryland.

58

398. McLaughlin S., Wallen E.M., Pruthi R.S. Expression of cyclooxygenase-2 (COX-2) in

human renal cell carcinoma (RCCa). Society of Urologic Oncology, December 5, 2003.

Bethesda, Maryland.

399. McLaughlin S., Shephard J., Wallen E.M., Pruthi R.S. Comparison of clinical and

pathological staging in patients undergoing primary versus delayed radical cystectomy for

bladder cancer. Society of Urologic Oncology, December 5, 2003. Bethesda, Maryland.

400. Derksen J.E., Pruthi R.S. The use of the COX-2 inhibitor celecoxib in PSA-recurrent

prostate cancer (CaP) after radiation therapy or radical prostatectomy: 12 month follow-up.

Society of Urologic Oncology, December 5, 2003. Bethesda, Maryland.

401. Gaston K., Lee K., Pruthi R.S. Impact of race, income, and residence on prostate cancer

knowledge, screening behavior, and health maintenance in sibling of patients with prostate

cancer. American College of Surgeons Clinical Congress, October 20, 2003. Chicago,

Illinois.

402. Derksen J.E., Fitzsimmons N., Ornstein D., Pruthi R.S. Early urethral catheter removal after

radical retropubic prostatectomy. American College of Surgeons Clinical Congress, October

20, 2003. Chicago, Illinois.

403. Pruthi R.S. COX-2 inhibitors in PSA-recurrent prostate cancer: a pilot study. Innovators in

Urology International Meeting. Amsterdam, The Netherlands. June 6, 2003.

404. Molitierno J., Tenkhenekov S., Ornstein D., Pruthi R.S. Incidental Finding of Prostate

Cancer at Cystoprostatectomy. American Urological Association. April 30, 2003. Chicago,

Illinois.

405. Ornstein DK, Fusaro V., Ross S., Hitt BA, Grigson G, Bell HA, Pruthi R.S., Liotta LA,

Petricoin EF. Analysis of serum proteomic profiles with Seldi-TOF and artificial intelligence

pattern-based recognition can help determine the need for prostate biopsy. April 29, 2003.

Chicago, Illinois.

406. Derksen J.E., Fitzsimmons N., Ornstein D., Pruthi R.S. Factors affecting length of stay after

radical retropubic prostatectomy. American Urological Association, Southeastern Section.

March 30, 2003. Savannah, Georgia.

407. Gaston K., Lee K., Pruthi R.S. The impact of a siblings diagnosis of prostate cancer on

prostate cancer knowledge, screening behavior, and other health-related activities. American

Urological Association, Southeastern Section. March 30, 2003. Savannah, Georgia.

408. Chun J., Pruthi R.S. The use of fibrin tissue sealants during laparoscopic partial

nephrectomy. American Urological Association, Southeastern Section. March 28, 2003.

Savannah, Georgia.

409. Molitierno J., Tenkhenekov S., Ornstein D., Pruthi R.S. Comparison of clinical and

pathological staging of bladder cancer. American Urological Association, Southeastern

Section. March 28, 2003. Savannah, Georgia.

59

410. Derksen J.E., Fitzsimmons N., Ornstein D., Pruthi R.S. Early urethral catheter removal after

radical retropubic prostatectomy. American Urological Association, Southeastern Section.

March 27, 2003. Savannah, Georgia.

411. Molitierno J, Evans A, Ornstein DK, Mohler JL, Pruthi R.S. Characterization of PSA

doubling times in patients who have failed radical prostatectomy. American College of

Surgeons Clinical Congress, October 8, 2002. San Francisco, California.

412. Gaston K, Pruthi, R.S. The use of erythropoietin in patients undergoing prostatectomy:

effects on hematocrit, transfusion rates, and quality of life. American College of Surgeons

Clinical Congress, October 8, 2002. San Francisco, California.

413. Derksen E., Pruthi, R.S. COX-2 inhibitors in PSA-recurrent prostate cancer: a pilot study.

American Urological Association, May 25, 2002. Orlando, California.

414. Gaston K, Pruthi, R.S. Hand-assisted laparoscopic nephrectomy: prospective evaluation of

the learning curve. American Urological Association, Southeastern Section. March 3, 2002.

Naples, Florida.

415. Derksen E., Pruthi, R.S. COX-2 inhibitors in PSA-recurrent prostate cancer: a pilot study.

American Urological Association, Southeastern Section. March 3, 2002. Naples, Florida.

416. Kang, J., Mohler, J.L., Maygarden S.J., Pruthi, R.S. Impact of positive biopsy location on

final tumor extent and unfavorable pathological outcomes in prostate cancer . American

Urological Association. June 6, 2001. Anaheim, California.

417. Kang, J., Mohler, J.L., Pruthi, R.S. Comparison of grade and stage in African American and

Caucasian patients with prostate cancer: evaluation of clinical, biopsy, and surgical

pathology. American Urological Association, Southeastern Section. April 1, 2001. New

Orleans, Louisiana.

418. Kang, J., Mohler, J.L., Pruthi, R.S. Impact of positive apical biopsies on unfavorable

pathological outcomes in prostate cancer . American Urological Association, Southeastern

Section. April 1, 2001. New Orleans, Louisiana.

419. Kang, J., Mohler, J.L., Pruthi, R.S. Unilaterally-positive sextent biopsies useful for

predicting final pathology . American Urological Association, Southeastern Section. April 1,

2001. New Orleans, Louisiana.

420. Pruthi, R.S., and Stamey, T.A. PSA doubling times and times to PSA recurrence in patients

who fail radical prostatectomy. 24nd Annual Northern California Residents Conference. May

3, 1997. San Francisco, California. (Winner, First Prize)

421. Pruthi, R.S., Tu, I-P, Johnstone, I., Stamey, T.A. PSA doubling times in patients who fail

radical prostatectomy: correlation with histology of the primary cancer. American Urological

Association. April 16, 1997. New Orleans, Louisiana.

422. Pruthi, R.S., Angell, S.A., Dubocq, F., Merguerian, P.A., Shortliffe, L.D. The use of renal

parenchymal area in children with vesicoureteral reflux. American Academy of Pediatrics --

Section on Urology. October 27, 1996. Boston, Massachusetts.

60

423. Pruthi, R.S., and Stamey, T.A. The use of serum concentration techniques to enhance early

detection of recurrent prostate cancer after radical prostatectomy. 23nd Annual Northern

California Residents Conference. April 27, 1996. Sacramento, California. (Winner, Second

Prize)

424. Pruthi, R.S., Angell S.A., Freiha, F.S. Papillary thyroid carcinoma found in the kidney. 22nd

Annual Northern California Residents Conference. March 4, 1995. Stanford, California.

(Winner, First Prize)

425. Pruthi, R.S., Farouk, M., Meyers, W.C. Somatostatin analogue inhibits hepatic regeneration.

Clinical Congress of the American College of Surgeons. October 21, 1991. Chicago, Illinois.

426. Pruthi, R.S., Farouk, M., Meyers, W.C. The effect of octreotide on liver regeneration in the

rat. 22nd Annual AOA Original Studies Symposium. March 28, 1991. Durham, North

Carolina.

Videos

Pruthi RS, Stefaniak H, Wallen EM. Robot-assisted laparoscopic anterior pelvic exenteration for

bladder cancer in women. J of Endourology, Part B, Videourology, 2007;

DOI:10.1089/vid.209.056.

Pruthi RS, Wallen EM. Robotic-assisted laparoscopic radical cystoprostatectomy. Surgery-in-

Motion. European Urology. February, 2008.

Pruthi RS, Wallen EM. Robotic-assisted laparoscopic radical cystoprostatectomy. Intuitive

Corporation. January, 2008.

Chun J, Pruthi RS. Laparoscopic Partial Nephrectomy. Baxter Incorporated. April, 2003.

1>

Guidelines

‘Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis):

2007 update’ Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, Wolf JS Jr,

Schellhammer PF. American Urological Association. December, 2007, pp 1 -97.

Accepted

Cowey CL, Amin C, Pruthi RS, Wallen E, Nielsen M, Grigson G, Watkins C, Nance K, Crane J,

Jalkut M, Kim W, Godley P, Whang Y, Field J, Rathmell WK. A neoadjuvant clinical trial with

sorafenib for patients with Stage II or greater renal cell carcinoma. J of Clinical Oncology,

(accepted)

Teaching Record

Course Director

UNC

61

Course Director, Third Annual Landes Symposium on the Treatment of Genitourinary Cancers.

Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. June

17-18, 2005. Chapel Hill, North Carolina.

Course Co-director, Complex Laparoscopic Surgery in Urology. University of North Carolina,

Chapel Hill, North Carolina. February 13-14, 2005.

Course Director, Advances in the Treatment of Genitourinary Cancers. Lineberger

Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. February 13-14,

2004.

Course Director, Symposium on the Multidisciplinary Advances in the Treatment of Prostate

Cancer. Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel

Hill. February 1-2, 2003.

Course Co-Director Laparoscopic Renal Surgery. University of North Carolina, Chapel Hill,

North Carolina. September 14-15, 2001.

Course Co-director, Laparoscopic Renal Surgery. University of North Carolina, Chapel Hill,

North Carolina. June 13-14, 2001.

Local Course Director. Laparoscopic Renal Cryoablation: Live surgery telecast. University of

North Carolina, Chapel Hill, North Carolina. November 28, 2000.

Outside UNC

Co-Moderator: Poster Session titled MP54: Bladder Cancer: Invasive IV: American Urological

Association Annual Meeting, May 14, 2017. Boston, Massachusetts.

Co-Moderator: Urology-Bladder Society of Robotic Surgery Annual Meeting. February 25, 2017.

Miami, Florida.

Technical Expert Panel Member for AHRQ: Comparative Effectiveness Program for Review

#153: Emerging Approaches to the Diagnosis and Treatment of Non-muscle-invasive Bladder

Cancer October 2015

Co-Moderator: Bladder Cancer: Invasive IV: American Urological Association, May8, 2016. San

Diego, California.

Moderator: Resident Quiz Bowl. Southeastern Section of American Urological Association,

March 19, 2016. Nashville, Tennessee.

Moderator: Work/Life Balance –Making the Right Career Choices that Will Work for you and

Your Family. Mid-Atlantic and New England Sections of the American Urological Association

Joint Meeting. October 23, 2015. Paradise Island, Bahamas.

Moderator: Bladder Cancer/ Upper Tract TCC Podium Session

Southeastern Section of American Urological Association, March 22, 2015. Savannah, Georgia

62

Co-Moderator. Live Surgery Session II. 2nd Techno Urology Congress: Improving Minimally

Invasive Surgery, January 30, 2014. Orbassano, Torino, Italy.

Course Director. Robotic Radical Cystectomy: Getting Started and Tips and Tricks from the

Experts American Urological Association National Meeting, May 6, 2013. San Diego,

California.

Co-Moderator. Bladder Cancer: Invasive (III): American Urological Association National

Meeting, May 7, 2013. San Diego, California.

Co-Moderator. Prostate Cancer: Modern Concepts on Screening, Active Surveillance , and

Surgical Treatment. American College of Surgeons Clinical Congress, October 1, 2012. Chicago,

Illinois.

Moderator. Bladder Cancer: Metastatic Disease/Staging. American Urological Association

National Meeting, May 23, 2012. Atlanta, Georgia.

Moderator. Bladder Cancer: Therapeutic Advances. American College of Surgeons Clinical

Congress, October 26, 2011, San Francisco, CA.

Course Director. Robotic Radical Cystectomy: Getting Started and Tips and Tricks from the

Experts. American Urological Association National Meeting, May 15, 2011. Washington, DC.

Course Faculty. Live Surgery. Robot Assisted Radical Cystectomy and Extended

Lymphadenectomy. American Urological Association National Meeting, May 14, 2011.

Washington, DC.

Moderator: Session 1, American Urological Association National Meeting, May 14, 2011,

Washington, DC.

Moderator: Urooncology Poster Session, Southeastern Section of the American Urological

Association, March 19, 2011. New Orleans, Louisiana.

Moderator: Video: Robotic cystectomy and ileal conduit. American Urological Association

Advanced Robotic Urologic Oncology, January 28, 2011. Celebration, Florida.

Moderator. Robotic Radical Cystectomy. IRUS National Meeting, January 13, 2011. Las

Vegas, NV.

Moderator. Live Surgeries. Robotic Radical Prostatectomy. Robotic Adrenalectomy. Robotic

Partial Nephrectomy. IRUS National Meeting, January 13, 2011. Las Vegas, NV.

Course Director: “Robotic Cystectomy Presentation”. 28th World Congress, September 4, 2010.

Chicago, Illinois.

Chair: Robotic/Bladder Poster Session. 28th World Congress, September 1, 2010, Chicago,

Illinois.

Moderator: AUA Live Surgery Course “Robotic Radical Prostatectomy”. American Urological

Association Annual Meeting, May 29, 2010, San Francisco, California.

63

Moderator, Kidney Cancer. Indian American Urological Association, May 29, 2010. San

Francisco, California.

Moderator, Prostate/Testis Cancer Poster Session. Southeastern Section of the American

Urological Association, March 13, 2010. Miami Beach, Florida.

Co-Moderator. Urology. American College of Surgeons Annual Meeting, October 13, 2009.

Chicago, Illinois.

Panelist. Urological Surgery. American College of Surgeons Annual Meeting, October 13, 2009.

Chicago, Illinois.

Moderator. Urology and Reproductive Surgery II. American College of Surgeons Annual

Meeting, October 13, 2009. Chicago, Illinois.

Course Director. Carcinoma of the Bladder: Advances in Management. American College of

Surgeons Annual Meeting. October 12, 2009. Chicago, Illinois.

Moderator, Bladder Cancer Podium. Southeastern Section of the American Urological

Association, March 27, 2009. Mobile, Alabama.

Director, 8th Annual North Carolina Residents Seminar. November 1, 2008. Greensboro, North

Carolina.

Moderator/Course Director. ACS Course: Carcinoma of the Bladder: Advances in

Management. American College of Surgeons Annual Meeting. October 12, 2008, Chicago,

Illinois.

Moderator Bladder Cancer Podium Session. American Urological Association, Southeastern

Section. March 9, 2008. San Diego, California.

Director, 7th Annual North Carolina Residents Seminar. September 18, 2007. Greensboro, North

Carolina.

Moderator Bladder Cancer Podium Session. American Urological Association, Southeastern

Section. March 9, 2007. Lake Buena Vista, Florida.

Director, 6th Annual North Carolina Residents Seminar. October 5, 2006. Greensboro, North

Carolina.

Moderator Prostate Cancer Poster Session. American Urological Association, Southeastern

Section. March 2, 2006. San Juan, Puerto Rico.

Director, 5th Annual North Carolina Residents Seminar. September 11, 2005. Greensboro, North

Carolina.

Moderator Prostate Cancer Poster Session. American Urological Association, Southeastern

Section. March 6, 2005. Charleston, South Carolina.

Director, 4th Annual North Carolina Residents Seminar. November 1, 2004. Greensboro, North

Carolina.

64

Moderator – Laparoscopy Poster Session. American Urological Association, Southeastern

Section. March 26, 2004. Aruba.

Director, 3rd Annual North Carolina Residents Seminar. October 3, 2003. Greensboro, North

Carolina.

Director, 2nd Annual North Carolina Residents Seminar. September 15, 2002. Greensboro, North

Carolina.

Course Director, Hand-Assisted and Laparoscopic Urology Course. Dartmouth-Hitchcock

Medical Center, Hanover, New Hampshire, June 10-11, 2002.

Director, 1st Annual North Carolina Residents Seminar. October 12, 2001. Greensboro, North

Carolina.

Visiting Professorships

“ Improving Outcomes for Patients Undergoing Radical Cystectomy” SESAUA Visiting

Professor, Kentucky Urological Association Annual Meeting, November 5, 2016. Louisville,

Kentucky.

“The net present value of a career in urology. How much are we worth?” Visiting Professor,

Lahey Hospital and Medical Center Institute of Urology, June 16, 2016. Burlington, MA.

“Factors affecting job satisfaction and income in urology” Visiting Professor, Lahey Hospital and

Medical Center Institute of Urology, June 16, 2016. Burlington, MA.

“Improving outcomes in radical cystectomy: evaluating the potential of clinical pathways and

intracorporeal diversion.” Visiting Professor, Lahey Hospital and Medical Center Institute of

Urology, June 17, 2016. Burlington, MA.

“Robotic Intracorporeal Diversion and Net Present Value of a Career in Urology: How much are

we worth?” Visiting Professor Maxted Lecturer: MedStar Georgetown University Hospital,

Department of Urology. April 28, 2015. Washington, DC.

“Robotic Intracorporeal Diversion and Net Present Value of a Career in Urology: How much are

we worth?” Visiting Professor, Dartmouth-Hitch Medical Center, Section or Urology. February

11, 2015. Hanover, NH.

“Treatment of Non-muscle invasive bladder cancer” Division of Urology Grand Rounds, Oregon

Health and Science University, May 16, 2013, Portland, Oregon.

"The economics of urology: Are they enough of us and how much are we worth?" Division of

Urology, Oregon Health and Science University, May 18, 2013, Portland, Oregon.

“Live Surgery – Robotic Cystectomy.” 6th Jiangsu Province Endourology Symposium, The 1st

Affiliated Hospital of Nanjing Medical University, December 4, 2010, Nanjing, China.

“Robotic cystectomy.” Grand Rounds, 6th Jiangsu Province Endourology Symposium, The 1st

Affiliated Hospital of Nanjing Medical University, December 3, 2010, Nanjing, China.

65

“Robotic radical cystectomy and bladder cancer.” University of Mississippi, March 3, 2010.

University, Mississippi.

“Estrogen deficiency as a consequence of androgen deprivation therapy in men with prostate

cancer.” University of Mississippi, March 3, 2010. University, Mississippi.

“Contemporary management of non-muscle-invasive bladder cancer” Advances in Urology

2009. Emory University, December 2, 2009. Atlanta, Georgia

“Robotic Radical Cystectomy” Advances in Urology 2009. Emory University, December 2, 2009.

Atlanta, Georgia.

Robotic radical cystectomy for bladder cancer.” Harvard Programs in Urology, Harvard

University, November 30, 2009, Boston, Massachusetts.

“Robotic radical cystectomy for bladder cancer.” Tulane University, November 15, 2009, New

Orleans, Louisiana.

“Evaluation and Treatment Guidelines for Non-muscle invasive Bladder Cancer" Department of

Urology Grand Rounds. Roswell Park Cancer Institute. September 4, 2008. Buffalo, New York.

“Current Concepts in the Treatment of Invasive bladder Cancer" Department of Urology Grand

Rounds. Roswell Park Cancer Institute. September 4, 2008. Buffalo, New York.

“Robotic-assisted laparoscopic radical cystectomy: clinical and pathologic outcomes.”

Vanderbilt University, Nashville, Tennessee. December 17, 2007.

“The role of COX-2 inhibitors in urologic oncology.” Visiting Professor, Department of Urology

Grand Rounds. Stanford University. February 20, 2004. Stanford, California.

“The role of COX-2 inhibitors in oncology.” Department of Anesthesia, Pain Service Grand

Rounds. Stanford University. February 20, 2004. Stanford, California.

Lectures

3rd Year Medical Students

September 28, 2009, Urologic Cancer

October 6, 2008, Urologic Cancer

August 11, 2008, Urologic Cancer

June 9, 2008, Urologic Cancer

July 23, 2007, Urologic Cancer

May 7, 2007, Urologic Cancer

February 5, 2007, Urologic Cancer

April 10, 2006, Genitourinary Complaints

September 27, 2005, Urologic Cancer

August 1, 2005, Urologic Cancer

February 14, 2005, Urologic Cancer

December 6, 2004, Urologic Cancer

September 27, 2004, Urologic Cancer

August 6, 2004, Urologic Cancer

66

June 2, 2004, Urologic Cancer

April 16, 2004, Urologic Cancer

February 10, 2004, Urologic Cancer

December 2, 2003, Urologic Cancer

October 7, 2003, Urologic Cancer

August 5, 2003, Urologic Cancer

May 30, 2003, Urologic Cancer

April 15, 2003, Urologic Cancer

December 2, 2002, Urologic Cancer

May 21, 2002, Urologic Cancer

April 12, 2002, Urologic Cancer

September 28, 2001, Urologic Cancer

2nd Year Medical Students

December 11, 2009, Urinary Course, Urologic Malignancies

December 11, 2008, Urinary Course, Urologic Malignancies

December 2007, Urinary Course, Urologic Malignancies

December 2006, Urinary Course, Urologic Malignancies

December 2005, Urinary Course, Genitourinary Tumors: Kidney, Bladder, Testis, External Male

Genitourinary

December 10, 2004, Urinary Course, Genitourinary Tumors: Kidney, Bladder, Testis, External

Male Genitourinary

Grand Rounds UNC

“Non Muscle-Invasive Bladder Cancer: Guidelines-based Approach” Department of Urology

Grand Rounds, University of North Carolina, June 8, 2016.

“Management of non-muscle invasive bladder cancer.” Department of Urology Grand Rounds,

University of North Carolina, May 28, 2014.

“Robotic Surgery for Bladder Cancer: Innovation, Investigation, and Widespread Application”

Department of Surgery Grand Rounds, University of North Carolina, April 7, 2010.

“Evaluating the Impact of Race in Prostate Cancer”, Department of Surgery Grand Rounds,

University of North Carolina, July 30, 2008.

"Current Concepts in the Treatment of Invasive Bladder Cancer" Department of Surgery Grand

Rounds, University of North Carolina. January 24, 2008.

“ Modern Concepts in the Treatment of Prostate Cancer.” Department of Surgery Grand Rounds,

University of North Carolina. January 14, 2005.

“The role of COX-2 inhibitors in urologic oncology.” Department of Surgery Grand Rounds,

University of North Carolina. January 14, 2004. Chapel Hill, North Carolina.

“Management of Invasive Bladder Cancer” Department of Surgery Grand Rounds, University of

North Carolina. August 6, 2002. Chapel Hill, North Carolina.

“PSA and Prostate Cancer”: Department of Medicine Grand Rounds, University of North

Carolina. May 6, 2002. Chapel Hill, North Carolina.

67

“PSA and Prostate Cancer”: Department of Family Medicine Grand Rounds, University of North

Carolina. September 6, 2001. Chapel Hill, North Carolina

“Prostate Disease and Prostate Cancer” Westcare (UNC AHEC) Teleconference/Grandrounds.

August 21, 2001. Chapel Hill North Carolina (teleconference).

“Surgical Treatment of Prostate Cancer: Indications, Techniques, and Outcomes”: Department of

Surgery Grand Rounds, University of North Carolina. June 23, 2000, Chapel Hill, North

Carolina.

Continuing Education Lecture

UNC

“Optimal Care for Bladder Cancer Patients: Current Obstacles and Opportunities for Cystectomy

Patients”. UNC Cancer Network 2019 Medical and Oncology Lecture Series. Chapel Hill, NC,

April 24, 2019.

“ Guidelines for Non-Muscle Invasive Bladder Cancer” 14th Annual Floyd A. Fried Advances in

Urology Symposium. UNC Department of Urology, Chapel Hill, NC June 25, 2016

“An Assessment of Job Satisfaction and Income in Urology” 13th Annual Floyd A. Fried

Advances in Urology Symposium. UNC Department of Urology, Chapel Hill, NC June 19, 2015.

“ Workload, Compensation, and Job Satisfaction of the American Urologist” 12th Annual Floyd

A. Fried Advances in Urology Symposium. UNC Department of Urology, Chapel Hill, NC June

21, 2014.

“Net Present Value of a Career in Urology: a.k.a How much are you worth?” 11th Annual Landes

Symposium: Advances in Urology. UNC Urologic Surgery, Chapel Hill, North Carolina, June 21,

2013.

“Urologic Workforce: Past, Present & Future” 10th Annual Landes Symposium: Advances in

Urology. UNC Urologic Surgery, Chapel Hill, North Carolina, June 22, 2012.

“Robotic radical cystectomy for treatment of bladder cancer” 8th Annual Landes Symposium:

Advances in Urology. UNC Urologic Surgery, Chapel Hill, North Carolina, June 25, 2010.

“Radical cystectomy and urinary diversion.” Bladder Cancer Advocacy Network, North Carolina

Patient Forum, Chapel Hill, North Carolina, May 15, 2010.

“The current role of prostate sparing cystectomy for bladder cancer” 7th Annual Landes

Symposium: Advances in Urology. UNC Urologic Surgery, Chapel Hill, North Carolina, June

19, 2009.

“Evaluating the impact of race in prostate cancer” Medical Alumni Association Alumni

Weekend. October 24, 2008. Chapel Hill, North Carolina.

“Modern Concepts in the Treatment of Prostate Cancer” Medical Alumni Association Alumni

Weekend. October 24, 2008. Chapel Hill, North Carolina.

“Robotic Surgery on the Bladder” 2nd Annual International Gynecologic Oncology Symposium,

October 17, 2008. Chapel Hill, North Carolina.

“Establishing a Robotic Surgical Program: Roundtable Discussion” 2nd Annual International

Gynecologic Oncology Symposium, October 17, 2008. Chapel Hill, North Carolina.

68

“Guidelines in the treatment of non-invasive bladder cancer.” Sixth Annual Landes Symposium

on the Treatment of Genitourinary Cancers. Lineberger Comprehensive Cancer Center. The

University of North Carolina at Chapel Hill. June 22, 2008. Chapel Hill, North Carolina.

“The robotic cystectomy program at UNC.” Sixth Annual Landes Symposium on the Treatment

of Genitourinary Cancers. Lineberger Comprehensive Cancer Center. The University of North

Carolina at Chapel Hill. June 22, 2008. Chapel Hill, North Carolina.

“The multidisciplinary approach to urologic oncology.” Fifth Annual Landes Symposium on the

Treatment of Genitourinary Cancers. Lineberger Comprehensive Cancer Center. The University

of North Carolina at Chapel Hill. June 15, 2007. Chapel Hill, North Carolina.

“The robotic cystectomy program at UNC.” Fifth Annual Landes Symposium on the Treatment of

Genitourinary Cancers. Lineberger Comprehensive Cancer Center. The University of North

Carolina at Chapel Hill. June 15, 2007. Chapel Hill, North Carolina.

“Bone complications and their treatment in the prostate cancer patient” Fifth Annual Landes

Symposium on the Treatment of Genitourinary Cancers. Lineberger Comprehensive Cancer

Center. The University of North Carolina at Chapel Hill. June 15, 2007. Chapel Hill, North

Carolina.

“Understanding bone complications and their treatment in the prostate cancer patient.” Fourth

Annual Landes Symposium on the Treatment of Genitourinary Cancers. Lineberger

Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. June 23, 2006.

Chapel Hill, North Carolina.

“Modern Approaches to the Treatment of Bladder Cancer.” Fourth Annual Landes Symposium

on the Treatment of Genitourinary Cancers. Lineberger Comprehensive Cancer Center. The

University of North Carolina at Chapel Hill. June 23, 2006. Chapel Hill, North Carolina.

“Complex laparoscopic renal surgery.” Fourth Annual Landes Symposium on the Treatment of

Genitourinary Cancers. Lineberger Comprehensive Cancer Center. The University of North

Carolina at Chapel Hill. June 23, 2006. Chapel Hill, North Carolina.

“Complex laparoscopic renal surgery.”. Lineberger Comprehensive Cancer Center. The

University of North Carolina at Chapel Hill. June 18, 2005. Chapel Hill, North Carolina.

“Understanding bone complications and their treatment in the prostate cancer patient.” Third

Annual Landes Symposium on the Treatment of Genitourinary Cancers. Lineberger

Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. June 17, 2005.

Chapel Hill, North Carolina.

“COX-2 inhibitors in urology: current peril or future promise?” Third Annual Landes Symposium

on the Treatment of Genitourinary Cancers. Lineberger Comprehensive Cancer Center. The

University of North Carolina at Chapel Hill. June 17, 2005. Chapel Hill, North Carolina.

“The multidisciplinary approach to urologic oncology.” Symposium on the Multidisciplinary

Advances in the Treatment of Genitourinary Cancers. Lineberger Comprehensive Cancer

Center. The University of North Carolina at Chapel Hill. February 13, 2004. Chapel Hill, North

Carolina.

“The role of COX-2 inhibitors in urologic oncology.” Symposium on the Multidisciplinary

Advances in the Treatment of Genitourinary Cancers. Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. February 13, 2004. Chapel Hill, North

Carolina.

69

“Concepts and Controversies in the Management of Invasive Bladder Cancer” Symposium on the

Multidisciplinary Advances in the Treatment of Genitourinary Cancers. Lineberger

Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. February 13,

2004. Chapel Hill, North Carolina.

“Laparoscopic Renal Surgery” Symposium on the Multidisciplinary Advances in the Treatment

of Genitourinary Cancers. Lineberger Comprehensive Cancer Center. The University of North

Carolina at Chapel Hill. February 13, 2004. Chapel Hill, North Carolina.

“The multidisciplinary approach to urologic oncology.” Advances in Oncology Nursing

Symposium. Lineberger Comprehensive Cancer Center. The University of North Carolina at

Chapel Hill. November 12, 2003. Chapel Hill, North Carolina.

“Management of Rising PSA after definitive therapy for prostate cancer.” Symposium on the

Multidisciplinary Advances in the Treatment of Prostate Cancer. Lineberger Comprehensive

Cancer Center. The University of North Carolina at Chapel Hill. February 1, 2003. Chapel Hill,

North Carolina.

Outside UNC

Raj S. Pruthi, MD, “Doctors in Distress: Burnout in Urology: Georgia Urology Seminar,

November 18, 2017. Atlanta, GA.

Raj S. Pruthi, MD, “Doctors in Distress: Burnout in Urology: South Carolina Urological

Association Meeting, September 23, 2017. Charleston, SC.

Raj S. Pruthi, MD, “Robotic Radical Cystectomy for Bladder Cystectomy” Emirates Urological

Society Meeting, December 15-18, 2016. Dubai, United Arab Emirates.

Raj S. Pruthi, MD “Improving Outcomes for Patients Undergoing Radical Cystectomy”

Kentucky Urological Association Annual Meeting, November 5, 2016. Louisville, Kentucky.

Raj S. Pruthi, MD “Urology Pearls” September 7, 2016. Piedmont Health Services, Carrboro, NC

Raj S. Pruthi. MD. "Strategies to enhance recovery after cystectomy and urinary diversion" and

"Intracorporeal urinary diversion - if, when, and how." 2nd Annual Advances in Robotic

Intracorporeal Reconstruction Course, Methodist Hospital, March 7, 2015. Houston, TX.

Raj S. Pruthi, MD, FACS. Net Present Value of Career Earnings in Urology: How much is your

career worth? 7th Annual Excellence in Urology Seminar. February 21, 2015. Park City, Utah.

Raj S. Pruthi, MD, FACS. Job Satisfaction and Compensation in Urology. 7th Annual Excellence

in Urology Seminar. February 20, 2015. Park City, Utah.

Raj S. Pruthi, MD, FACS. Recent Trends in the Urology Workforce in the United States. 7th

Annual Excellence in Urology Seminar. February 19, 2015. Park City, Utah.

Panelist: Taking a patient with noninvasive bladder cancer that becomes increasingly refractory to

treatment and ultimately undergoing cystectomy. Korean Urological Association Annual

Meeting, November 14, 2014. Seoul, Korea.

70

Raj Pruthi, MD. Intracorporeal Urinary Diversion after Radical Cystectomy. Korean Urological

Association Annual Meeting. November 15, 2014.Seoul, Korea

Raj Pruthi, MD. Plenary Talk: The Future of Robotic bladder cancer surgery: Robotic

Intracorporeal diversion. Korean Urological Association Annual Meeting. November 15, 2014.

Seoul, Korea.

Raj Pruthi, MD. Optimizing outcomes in patients undergoing radical cystectomy. Korean

Urological Association Annual Meeting. November 14, 2014.Seoul, Korea.

Raj Pruthi, MD. Robotic radical cystectomy for bladder cancer. Korean Urological Association

Annual Meeting. November 14, 2014.Seoul, Korea.

Pruthi RS. “Evolution of Robotic Cystectomy” Urologic Oncology & Robotic Surgery on the

Beach, May 23, 2014. Miami Beach, Florida.

Panel Discussion: Challenging Cases in Urologic Oncology III, Bladder Cancer. Urologic

Oncology & Robotic Surgery on the Beach ,May 23, 2014. Miami Beach, Florida.

Panel Discussion: The Dilemma of Diversion in Robotic Cystectomy, Plenary Session, American

Urological Association, May 20, 2014, Orlando, Florida.

Raj S. Pruthi, MD, FACS “The role of nutrition in Surgery & Chemotherapy Bladder Cancer

Treatment.” May 14, 2014. BCAN Webinar

Panelist: Robotic Cystectomy, Bladder Cancer Panel: The Future of Invasive Bladder Cancer

Southeastern Section of the American Urological Association, March 23, 2014. Hollywood,

Florida.

Discussion Panel, Bladder Cancer Session II, 2013 Society of Urologic Oncology Annual

Meeting. December 6, 2013. Bethesda, Maryland.

Discussion Panel, Prostate Session III, 2013 Society of Urologic Oncology Annual Meeting

December 6, 2013. Bethesda, Maryland.

Panelist: Raj S. Pruthi. Panel: Robotic Surgery. Kaiser Permanante Urology Symposium. Las

Vegas, NV. November 2, 2012.

Coordinator and Presiding Officer, Raj S Pruthi, MD, FACS, Video Based Educations Session:

Urology. American College of Surgeons, October 8, 2013. New Orleans, LA

Raj S. Pruthi, MD, FACS “ The Challenge of Bacillus Calmette-Guerin (BCG) Refractory

Disease” February 9, 2013. Park City, Utah.

Raj S. Pruthi, MD, FACS “AUA Guidelines for Non-Muscle Invasive Bladder Cancer” 5th

Annual Excellence in Urology Symposium, February 8, 2013. Park City, Utah.

71

Raj S. Pruthi, MD, FACS “Non Muscle-Invasive Bladder Cancer: Diagnostic Strategies and Risk

Strategies and Risk Stratification” 5th Annual Excellence in Urology Symposium, February 7,

2013. Par City, Utah.

Pruthi RS. Bladder/Kidney Cancer. Plenary Session, American Urological Association, May 23,

2012. Atlanta Georgia.

Round Table Panel: Establishing an Urology Oncology Program. 2011 Society of Urologic

Oncology Winter Meeting. November 30, 2011. Bethesda, Maryland.

Discussion Panel, Dr. Douglas Sutherland: Proposal for a Surgical Technique RCT. 2011 Society

of Urologic Oncology Winter Meeting. November 30, 2011. Bethesda, Maryland.

Pruthi RS. Take home messages for bladder cancer. Plenary Session, American Urological

Association, June 3, 2010, San Francisco, California.

Pruthi RS. Bladder cancer take home points. Plenary Session, American Urological Association,

June 2, 2010. San Francisco, California.

Pruthi RS. The role of robotic radical cystectomy for the management of invasive bladder cancer.

Society of Urologic Oncology at the AUA, May 29, 2010, San Francisco, California.

Expansion of Robotics in Urologic Oncology: Video of technique and summary of outcomes. 5th

International Congress, Minimally Invasive Robotics Association, January 27, 2010. San Diego,

California.

Extracorporeal and intracorporeal urinary diversion after robotic cystectomy. International

Robotic Urology Symposium, January 16, 2010. Las Vegas, Nevada.

Androgen Deprivation Therapy Induced Estrogen Deficiency Side Effects. Birmingham Urology

Society, Birmingham, Alabama. December 9, 2009.

Androgen Deprivation Therapy Induced Estrogen Deficiency Side Effects. Tulane University,

New Orleans, Louisiana. December 8, 2009

Management of recurrent superficial bladder cancer. Emory University, Advances in Urology

2009, December 4, 2009. Atlanta, Georgia.

Robotic-assisted cystectomy. Emory University, Advances in Urology 2009, December 4, 2009.

Atlanta, Georgia.

Androgen Deprivation Therapy Induced Estrogen Deficiency Side Effects, Beth Israel/Brigham

and Women’s Program. December 2, 2009.

Current Concepts in the Management of Non-Invasive Bladder Cancer, Wilmington Urology

Association, Wilmington, North Carolina. December 1, 2009.

Current Concepts in the Management of Non-Invasive Bladder Cancer, Eastern North Carolina

Urology Association. November 3, 2009.

72

Androgen Deprivation Therapy Induced Estrogen Deficiency Side Effects, New England Section

of the AUA, Washington, DC. September 25, 2009.

“Novel Treatments for Localized Prostate Cancer – Cryo and HIFU” IAUA meeting at the AUA.

April 25, 2009, Chicago, Illinois.

“Clinical Care Pathways in Urologic Surgery” Surgical Techniques in Urologic Oncology. AUA

Course. March 21, 2009, Las Vegas, Nevada.

“Principles and Technical Considerations for Partial Nephrectomy” Surgical Techniques in

Urologic Oncology. AUA Course. March 21, 2009, Las Vegas, Nevada.

“Robotic Pelvic Lymphadenectomy for Prostate and Bladder Cancer” Surgical Techniques in

Urologic Oncology. AUA Course. March 21, 2009, Las Vegas, Nevada.

“Prostate-sparing Radical Cystectomy” Surgical Techniques in Urologic Oncology. AUA

Course. March 21, 2009, Las Vegas, Nevada.

Technical Aspects for Transrectal Ultrasound-guided Prostate Biopsy” Surgical Techniques in

Urologic Oncology. AUA Course. March 20, 2009, Las Vegas, Nevada.

“Robotic cystectomy” Roundtable discussion. Society of Urologic Oncology. December 4, 2008.

Bethesda, Maryland.

“Robotic cystectomy and pelvic lymphadenectomy” Plenary session. World Congress of

Endourology. December 2, 2008. Shanghai, China.

“New surgical technology in the treatment of prostate cancer: robotics, cryotherapy, and HIFU”

Management of Localized Prostate Cancer Course, American College of Surgeons, October 14,

2008. San Francisco, California.

“Modern Concepts in the Treatment of Invasive Bladder Cancer” ACS Course: Carcinoma of the

Bladder: Advances in Management. American College of Surgeons Annual Meeting, October

12, 2008, Chicago, Illinois.

“Evaluating the impact of race in prostate cancer” Department of Surgery Grand Rounds,

University of North Carolina. July 24, 2008.

“Robotic-assisted laparoscopic radical cystectomy: technique and early experience.” Intuitive

Corporation Seminar at AUA. Orlando, Florida, May 19, 2008.

“Professional Pathways Career Choices” Young Urologists Forum. Southeast Section of the

American Urological Association. March 8, 2008. San Diego, California.

Treatment of high-risk cancer.” Jacksonville, Florida, November 4, 2007.

“Robotic-assisted laparoscopic radical cystectomy: clinical and pathologic outcomes.” Urologic

Research Society, California, October 26, 2007.

“Debate on the management of small renal masses: Observation” Northeastern Section of the American Urological Association. September 9, 2007. Rochester, New York.

73

“Management of Invasive Bladder Cancer” Centennial Congress of the Societe Internationale

d’Urologie (SIU). September 4, 2007. Paris, France.

“Health disparities in prostate cancer” Texas Health Disparities Conference. May 31, 2007. Fort

Worth, Texas.

“Bone complications and their treatment in the prostate cancer patient.” Alamance Regional

Cancer Center. April 30, 2007. Burlington, North Carolina.

“Emerging Concepts in the Multidisciplinary treatment of high risk prostate cancer.” Kugelman

Cancer Center Urology-Oncology Rounds. April 30, 2007. Pensacola, Florida.

“Managing skeletal complications in the prostate cancer patient.” Rowan County Oncology

Rounds. April 17, 2007. Salisbury, North Carolina.

“Bone complications and their treatment in the prostate cancer patient.” Rex Cancer Center

Rounds. April 11, 2007. Raleigh, North Carolina.

“Emerging Concepts in the Treatment of Invasive Bladder Cancer.” First Annual Urology

Congress. April 6, 2007. San Francisco, California.

“Management of High-risk Patients with Prostate Cancer”. Duke-UNC Urologic Oncology

Forum. March 29, 2007. Durham, North Carolina.

“Emerging Concepts in the Treatment of Bladder Cancer including the Potential of Robotic

Cystectomy” Department of Urology Grand Rounds. Wake Medical Center. February 21, 2007.

Raleigh, North Carolina.

“Bone complications and their treatment in the prostate cancer patient.” Western Carolina

Oncology Society. December 1, 2006. Asheville, North Carolina.

“Modern Concepts in the Treatment of Bladder Cancer including the Potential of Robotic

Cystectomy” Department of Urology Grand Rounds. Duke University. October 22, 2006.

Durham, North Carolina.

“Promise and potential of COX-2 inhibitors in Urology.” Visiting Professor, Department of

Urology Grand Rounds. Medical College of Georgia. June 22, 2006. Augusta, Georgia.

“Modern Approaches to the Treatment of Prostate Cancer.” Oncology Grand Rounds,

Spartanburg Regional Medical Center. May 3, 2006, Spartanburg, North Carolina.

“Prostate Cancer Clinical Trials and the Evolving Area of Prostate Cancer Therapy.” Oncology

Rounds, New Hanover Regional Medical Center. March 21, 2006, Wilmington, North Carolina.

“Prostate Cancer Clinical Trials at The University of North Carolina at Chapel Hill.” Duke

Prostate Cancer Symposium. April 9, 2005, Durham, North Carolina.

“ Modern approaches to the Treatment of Prostate Cancer.” Legends Annual Meeting. The

University of North Carolina at Chapel Hill. April 3, 2005, Chapel Hill, North Carolina.

“ Robotics, laparoscopy, and other novel surgical approaches to the treatment of prostate

cancer.” Annual Oncology Nursing Forum at the University of North Carolina. The University

of North Carolina at Chapel Hill. March 15, 2005, Chapel Hill, North Carolina.

74

“The role of COX-2 inhibitors in urologic oncology.” Urologic Oncology Research Disease

Group Rounds, Department of Urology. University of Iowa. November 19, 2004. Iowa City,

Iowa.

“Promise and potential of COX-2 inhibitors in urology.” Visiting Professor, Department of

Urology. University of Iowa. November 18, 2004. Iowa City, Iowa.

“The role of COX-2 inhibitors in urologic oncology.” Piedmont Urological Society. August 9,

2004. Winston-Salem, North Carolina.

“The role of COX-2 inhibitors in urologic oncology.” Eastern Shore Medical Society. April 21,

2004. Baltimore, Maryland.

“The role of COX-2 inhibitors in urologic oncology.” Department of Urology Grand Rounds.

Hopkins-Bayview Medical Center. April 20, 2004. Baltimore, Maryland.

“The role of COX-2 inhibitors in urologic oncology.” Department of Urology Grand Rounds.

University of Maryland. April 19, 2004. Baltimore, Maryland.

“Urology Review”: American Academy of Physicians Assistants Annual Review Course.

February 24, 2004.

“Modern concepts in the treatment of prostate cancer.” Oncology Grand Rounds. Watauga

Memorial Hospital. October 17, 2003.

“Modern concepts in the treatment of prostate cancer.” Medical Grand Rounds. Gastonia

Memorial Hospital. August 17, 2003.

“The role of COX-2 inhibitors in urologic oncology.” Making a Difference in Oncology.

Sponsored by Moffitt Cancer Center, The University of South Florida. April 26, 2003. Phoenix,

Arizona.

“The Role of Laparoscopy in Urologic Oncology”: Tri-County Urology Meeting. Fayetteville,

North Carolina. March 11, 2003.

“The role of COX-2 inhibitors in urologic oncology.” Oncology Grand Rounds. The University

of Maryland. March 6, 2003. Baltimore, Maryland.

“The role of COX-2 inhibitors in urologic oncology.” Eastern Shore Medical Society. March 6,

2003. Baltimore, Maryland.

“The role of COX-2 inhibitors in urologic oncology.” Grand Rounds. Saint Josephs Hospital.

March 5, 2003. Baltimore, Maryland

“Concepts and Controversies in the Management of Invasive Bladder Cancer”: Eastern Carolina

Urological Association. September 17, 2002. Greenville, North Carolina.

“Laparoscopic Nephrectomy, Partial Nephrectomy and Renal Cyst Marsupialization: Surgical

Technique”: Invited Lecturer, Carolinas Laparoscopy & Advanced Surgery Program. September

6, 2002. Charlotte, North Carolina.

“Current Controversies in the Management of Invasive Bladder Cancer”: Carolina Urological

Association 72nd Annual Meeting. August 30-September 1, 2002. Wrightsville Beach, North

Carolina.

75

“Laparoscopic Nephrectomy and Renal Cyst Marsupialization: Surgical Technique”: Urology

Grand Rounds. June 29, 2002. Wilmington, North Carolina.

“ Laparoscopic Nephrectomy: History and Contemporary Applications”: Urology Grand Rounds.

Dartmouth-Hitchcock Medical Center. June 11, 2002. Hanover, New Hampshire.

“Current Concepts in Urinary Diversion”: Society of University Urological Residents 37th Annual

Meeting. May 23-24, 2002. Orlando, Florida.

“The Role of Laparoscopy in Urologic Oncology”: Wake County Urology Meeting. May 15,

2002. Raleigh, North Carolina.

“Urology Review”: American Academy of Physicians Assistants Annual Review Course.

February 24, 2002.

“PSA and Prostate Cancer”: Randolph County Medical Association. January 22, 2001. Asheboro,

North Carolina.

“Surgical Treatment of Renal Cell Carcinoma: Past, Present, and Future”: National Kidney

Cancer Association. October 14, 2000. Research Triangle Park, North Carolina.

“The Role of Laparoscopy in Urologic Oncology”: Triad Urological Society. August 9, 2000.

Winston-Salem, North Carolina.

“Prostate Cancer Update”: Pender County Medical Association. April 3, 2000. Burgaw, North

Carolina.

“PSA doubling times in patients who fail radical prostatectomy: correlation with histology of the

primary cancer”: Department of Urology Grand Rounds, Louisiana State University. March 30,

1999. Shreveport, Louisiana.

“PSA doubling times and times to PSA recurrence in patients who fail radical prostatectomy”:

Division of Urology Grand Rounds, Dartmouth-Hitchcock Medical Center. February 27, 1999.

Hanover, New Hampshire.

Clinical Teaching

Clinical Teaching - urology residents. UNC School of Medicine. 4/00 - present

Clinical Teaching - urology residents. LSU School of Medicine, 7/99 – 4/00

Preceptor for Student/Resident Research Projects

Residents

James A. McBride- Identifying Incidence and Risk Factors for VTE among Partial and Radical

(2014-2015)

Maxim J. McKibben, MD- Identifying Incidence and Risk Factors for VTE among Partial and

Radical Nephrectomy Patients. (2014-2015)

76

Maxi J. McKibben, MD -Operative Times Predict Length of Stay Following Radical Cystectomy

and Nephrectomy. (2014-2015)

Maxim J. McKibben, MD- Predictors of 30-day Readmissions following Radical Cystectomy for

Bladder Cancer. (2014-2015)

Josip Vukina, MD- Identifying Incidence and Risk Factors for VTE Among Radical

Prostatectomy Patients for Prostate Cancer. (2014-2015).

James A. McBride, MD- Predictors of 30-Day Readmission following Partial and Radical

Nephrectomy for Kidney Cancer. (2013-2014)

Josip Vukina, MD- Identifying Incidence and Risk Factors for VTE among Cystectomy Patients

for Bladder Cancer. (2013-2014)

James A. McBride, MD - Longer operative times predict increased length of stay following

cystectomy. (2013-2014)

Gordon Luke Fifer, MD - Robotic Ureteral Reconstruction Distal to the Ureteropelvic Junction:

Clinical Series with short term follow up. (2013-2014)

Maxim J. McKibben, MD - Predictors of 30-Day Readmission following Radical Cystectomy for

Bladder Cancer. (2013-2014)

Josip Vukina, MD - Longer operative times predict increased length of stay following

prostatectomy for prostate cancer. (2013-2014)

Gordon Luke Fifer, MD- Initial Operative Experience with Robotic Ureteral Reconstruction

Distal to the Ureteropelvic Junction. (2013-2014)

E. Will Kirby, MD -Economic Impact of Training and Career Choices in Urologic Surgery.

(2013-2014)

James Ferguson, MD - Practice Type and Employment of Urologists in the United States: An

Analysis of Changes over the Past Decade (2012-2013)

Joshua Langston, MD - Economic Impact of Training and Career choices in Urologic Surgery

(2012-2013)

E. Will Kirby, MD - Trends in the Geographic Structure of the Urology Workforce in The United

States. (2012-2013)

E. Will Kirby, MD - Trends in the Age and Gender of the Urology Workforce in The United

States. (2012-2013)

James Ferguson, MD - An Analysis of the Supply of Urologic Surgeons in the United Sates.

(2012-2013)

David Johnson, MD - . Projection Models Evaluating the Future Supply of Urologists in the

United States. (2012-2013)

77

Ian Udell, MD - Cost Analysis of Robotic-Assisted Radical Cystectomy Versos Open Radical

Cystectomy Utilizing A Prospective, Randomized Cohort. (2012-2013)

Ian Udell, MD - Prospective Randomized Controlled Trial of Robotic Versus Open Radical

Cystectomy for Bladder Cancer: Median 3-Year Follow-Up Results (2012-2013)

Rajesh Kurpad, MD - The Evolving Role and Age Structure of International Medical Graduates

(IMGs) on the Urology Workforce in the United States1981-2009. (2012-2013)

Rajesh Kurpad, MD - Trends in the Age and Gender of the Urology Workforce in the United

States: 1981-2009. (2012-2013)

Ian Udell, MD - An evaluation of Neoadjuvant chemotherapy eligibility rates among patients

undergoing radical Cystectomy for bladder cancer. (2011-2012).

Ian Udell, MD- Long-Term Follow-Up of Patients Initially Managed with Active Surveillance for

Solid Renal Masses. (2011-2012)

Ian Udell, MD- The Quality of Prostate Cryotherapy Information on the Internet. (2011-2012)

Ian Udell, MD - Robotic-Assisted Laparoscopic Intracorporeal Urinary Diversion: Combined

Initial Experience. (2011-2012)

Ian Udell, MD- Robotic Partial Nephrectomy and the Internet: Is the Information Evidenced –

Based? (2011-2012)

Rajesh Kurpad, MD - The Impact of Radical Cystectomy on Renal Function: An Analysis of

Variance Based on Age, Gender, Race and Diversion Technique. (2011-2012)

Rajesh Kurpad, MD - An Evaluation of Neoadjuvant Chemotherapy Eligibility Rates among

Patients Undergoing Radical Cystectomy for Bladder Cancer. (2011-2012)

Rajesh Kurpad, MD- Outcomes with Intravesical Therapy in Patients with Initial T1 Bladder

Cancer. (2011-2012)

Rajesh Kurpad, MD- An Evaluation of Adjuvant Chemotherapy Eligibility Rates among Patients

Undergoing Radical Cystectomy. (2011-2012)

Ian Udell The Cost Impact of Addition of NMP22 Bladderchek to Non-Invasive Bladder Cancer

Surveillance. (2011-2012)

Rajesh Kurpad, MD - Defining the Molecular Determinants of Sensitivity to EGFR Inhibition in

Urothelial Carcinoma. (2011-2012)

John Patrick Selph, MD - The stepwise approach to robotic-assisted laparoscopic intracorporeal

urinary diversion. (2010-2011)

John Patrick Selph, MD- Initial experience with robotic-assisted approaches to partial

cystectomy. (2010-2011).

78

Joshua Langston, MD- The evaluation of the learning curve associated with robotic radical

cystectomy: Initial 100 cases. (2010-2011)

Joshua Langston,MD - Robotic-assisted laparoscopic intracorporeal urinary diversion: Combined

initial experience. (2010-2011)

Joshua Langston, MD - . Cost analysis of robotic-assisted radical cystectomy versus open radical

cystectomy utilizing a prospective, randomized cohort. (2010-2011)

Joshua Langston, MD- Cost analysis of robotic-assisted versus laparoscopic versus open partial

nephrectomy. (2010-2011)

John Patrick Selph, MD- Re-secting T1 bladder tumors: Single-institution analysis in a modern

cohort of patients. (2010-2011)

John Patrick Selph, MD- Oncologic outcomes for node-positive patients undergoing robotic

radical cystectomy. (2010-2011)

Joshua Langston, MD- Robotic-assisted laparoscopic radical prostatectomy: Evaluation o f the

functional and oncologic learning curve. (2010-2011)

John Patrick Selph, MD- Robotic radical cystectomy: Medium-term oncologic follow-up. (2010-

2011)

John Patrick Selph, MD- Does robotic radical cystectomy for bladder cancer affect long-term

health-related quality of life? (2010-2011)

Joshua Langston,MD - Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or

external beam radiotherapy in high risk localized prostate cancer: A phase II trial. (2010-2011)

Johhua Langston, MD- Clinical and pathologic differences between patients undergoing TURBT

for newly-diagnosed versus recurrent bladder lesions detected by cystoscopy. (2010-2011)

John Patrick Selph, MD - The fate of men with incidental prostate cancer diagnosed at the time of

radical cystectomy. (2010-2011)

Joshua Langston, MD- HIFU and the internet: A quality control study of online information.

(2010-2011)

Stephen McKim, MD- Robotic cystectomy and the internet: Fact or fiction? (2009-2010)

Stephen McKim, MD- Preliminary experience with prostate-sparing cystectomy for urothelial

carcinoma of the bladder. (2009-2010)

Mathew C. Raynor, MD- Does obesity impact outcomes in patients undergoing robotic

cystectomy for bladder cancer: a multi-institutional analysis. (2009-2010)

Eugene Simopoulos, MD- The impact of race and gender in patients undergoing radical

cystectomy for bladder cancer. (2009-2010)

79

Stephen McKim, MD- The impact of radical cystectomy on renal function: An analysis of

variance based on age, gender, race, and diversion technique. (2009-2010)

Mathew C. Raynor,MD- Multi-institutional analysis of robotic radical cystectomy for bladder

cancer: Peri-operative outcomes in 227 patients. (2009-2010)

Eugene Simopoulos, MD -Long-term follow-up of patients initially managed with active

surveillance for solid renal masses. (2009-2010)

Mathew C. Raynor, MD- Feasibility and outcomes of robotic-assisted laparoscopic radical

cystectomy for bladder cancer in the elderly. (2009-2010)

Stephen McKim, MD- Robotic-assisted laparoscopic intracorporeal urinary diversion. (2009-

2010)

Stephen McKim, MD- Prospective, randomized trial of robotic versus open radical cystectomy

for bladder cancer: peri-operative and pathological results. (2009-2010)

Mathew C. Raynor, MD - Complications associated with robotic radical cystectomy for bladder

cancer: A multi-institutional analysis. (2009-2010)

Mathew C. Raynor, MD- Multi-institutional analysis of robotic radical cystectomy for bladder

cancer: Peri-operative outcomes in 227 patients. (2009-2010)

Eugene Simopoulos, MD – Does age affect presentation and outcomes in patients undergoing

radical cystectomy for bladder cancer? (2009-2010)

Eugene Simopoulos, MD – A neoadjuvant clinical trial with sorafenib for patients with Stage II

or greater renal cell carcinoma. (2009-2010)

Stephen McKim, MD – Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or

external beam radiotherapy in high risk localized prostate cancer: A Phase II trial. (2009 – 2010)

Stephen McKim, MD – A neoadjuvant clinical trial with sorafenib for patients with Stage II or

greater renal cell carcinoma. (2009 – 2010)

Eugene Simopoulos, MD – Elimination of bowel preparation in patients undergoing cystectomy

and urinary diversion. (2009 – 2010)

Angela Smith, MD – Multi-institutional analysis of robotic radical cystectomy for bladder cancer:

perioperative outcomes in 227 patients. (2009 – 2010)

Eugene Simopoulos, MD – Fast track program in patients undergoing radical cystectomy:

experience in 362 consecutive cases. (2009 – 2010)

Angela Smith, MD – Robotic-assisted laparoscopic radical cystectomy: evaluation of the

learning curve. (2009 – 2010)

R Matt Coward, MD – Cost analysis of robotic-assisted laparoscopic radical cystectomy for

bladder cancer. (2009 – 2010)

80

R Matt Coward, MD – A Phase II study of neoadjuvant erlotinib (Tarceva) in patients with

muscle-invasive bladder cancer undergoing radical cystectomy: preliminary results. (2009 –

2010)

J Slade Hubbard, MD – Robotic anterior pelvic exenteration for bladder cancer in the female:

outcomes and comparisons to their male counterparts. (2008 – 2009)

Kelly Swords, MD – The impact of obesity on the diagnosis of prostate cancer using a modern

extended biopsy scheme. (2008 – 2009)

Aaron Lentz, MD – Impact of marital status in patients undergoing radical cystectomy for bladder

cancer. (2008 – 2009)

Kelly Swords, MD – The impact of race on prostate cancer detection and choice of treatment in

men undergoing a contemporary extended biopsy approach. (2008 – 2009)

Angela Smith, MD – Evaluating the learning curve for robotic-assisted laparoscopic radical

cystectomy. (2008 – 2009)

Matt Pearson, MD - Robotic-assisted laparoscopic radical cystectomy. (2007 - 2008)

Jeff Nix, MD - Relationship of obesity and incidental prostate cancer detection in men

undergoing radical cystoprostatectomy for bladder cancer. (2007 - 2008)

Matt Pearson, MD - A Phase II study of neoadjuvant erlotinib (Tarceva) in patients with muscle-

invasive bladder cancer undergoing radical cystectomy. (2007 - 2008)

Jeff Nix, MD - Partial cystectomy for bladder cancer: analysis of recent trends in its use and

misuse. (2007 - 2008)

Jeff Nix, MD - Robotic-assisted laparoscopic radical cystectomy: evaluation of the learning

curve. (2007 - 2008)

Matt Pearson, MD - Robotic-assisted laparoscopic versus open radical cystectomy: comparisons

of a simultaneous experience. (2007 - 2008)

Jeff Nix, MD - The impact of bladder neck sparing modification on surgical and functional

outcomes after robotic-assisted laparoscopic radical prostatectomy? (2007 - 2008)

Matt Pearson, MD - Effect of neoadjuvant tyrosine kinase inhibitors on patients undergoing

radical nephrectomy. (2007 - 2008)

Jeff Nix, MD - Impact of obesity on operative, pathologic, and functional outcomes after robotic-

assisted laparoscopic radical prostatectomy. (2007 - 2008)

Matt Pearson, MD - The impact of bladder neck sparing modification on surgical and functional

outcomes after robotic-assisted laparoscopic radical prostatectomy. (2006 - 2008)

Vishal Bhalani, MD - Expectant management of patients with low-risk superficial bladder cancer.

(2007 - 2008)

81

Javier Miller, MD - Prospective evaluation of short-term impact and recovery of health related

quality of life (HRQOL) in ment undergoing robotic-assisted laparoscopic radical prostatectomy

vs open radical prostatectomy (ORP). (2005 - 2007)

Aaron Lentz, MD - A comparison of the Bricker versus Wallace ureteroileal anastomosis in

patients undergoing urinary diversion for bladder cancer. (2005 - 2007)

Aaron Lentz, MD - Stomal complications in patients undergoing radical cystectomy and ileal

conduit urinary diversion for bladder cancer. (2005 - 2007)

Javier Miller, MD - Accuracy of MR and CT cross sectional imaging in the staging of invasive

bladder cancer: a prospective study blinded to clinical outcome. (2005 - 2007)

Aaron Lentz, MD - Robotic-assisted laparoscopic radical cystectomy: initial experience and

operative outcomes. (2005-2006)

Adam Hickerson, MD - The impact of race and gender in patients undergoing radical cystectomy

for bladder cancer. (2006 - 2007)

Daniel McRackan, MD - Expectant management of small renal masses: does a delay in therapy

pose a clinical or pathological risk to the patient. (2006 - 007)

Joseph Molitierno, MD - Incidental finding of prostate cancer at cystoprostatectomy: changes in

incidence in the PSA era. (2004 - 2006)

Adam Hickerson , MD - Laparoscopic retroperitoneal lymph node dissection for low-stage

testicular cancer: challenges and benefits. (2004 - 2006)

Daniel McRackan, MD - Recent experience of surgical management of renal masses: the

evolution of laparoscopic approaches in clinical practice. (2004 - 2006)

Adam Hickerson, MD - Evaluation of the routine use of metocloperamide in patients undergoing

radical cystectomy and urinary diversion. (2004 - 2006)

Daniel McRackan, MD - An evaluation of prostate cancer knowledge in patients with prostate

cancer and their partners. (2004 - 2006)

Daniel McRackan, MD - An evaluation of prostate cancer knowledge in patients with prostate

cancer: impact of demographic and socioeconomic variables. (2004 - 2006)

Adam Hickerson, MD - Impact of race on treatment selection and disease progression in men

who choose observation for clinically-localized prostate cancer. (2004 - 2006)

Adam Hickerson, MD - Watchful waiting for patients with locally-advanced and node-positive

prostate cancer: biochemical and clinical outcomes. (2004 - 2006)

J Slade Hubbard, MD - Hand assisted laparoscopic nephrectomy for large renal masses. (2003 -

2005)

Heather Stefaniak, MD - Neoadjuvant docetaxel and estramustine followed by radical

prostatectomy or radiation therapy for patients with high-risk prostate cancer. (2003 - 2005)

82

J Slade Hubbard, MD - Prospective evaluation of short-term impact and recovery of health-

related quality of life (HRQOL) in men undergoing radical prostatectomy (RP). (2003 - 2005)

J Eric Derksen, MD - Efficacy and safety of en bloc ligation of the renal hilum at the time of

laparoscopic nephrectomy: review of 62 consecutive cases. (2003 - 2005)

J Eric Derksen, MD - Phase II trial of celecoxib in PSA recurrent prostate cancer after definitive

radiation therapy or radical prostatectomy. (2003 - 2005)

Joseph Molitierno, MD - Incidental finding of prostate cancer at cystoprostatectomy: changes in

incidence in the PSA era. (2002 - 2004)

J Eric Derksen, MD - Safe and effective application of laparoscopic partial nephrectomy for small

renal masses: duplication of open principles and practices. (2002 - 2004)

J Eric Derksen, MD - Hand assisted laparoscopic nephrectomy for large renal masses. (2002 -

2005)

Aubrey Evans, MD - Complications and reasons for prolonged stay in patients undergoing radical

cystectomy utilizing a perioperative pathway. (2002 - 2005)

Aubrey Evans, MD - Costs and surgical outcomes associated with radical cystectomy: changes

over the past decade. (2002 - 2005)

Heather Stefaniak, MD - The use of the COX-2 inhibitor celecoxib to reduce perioperative pain

associated with radical retropubic prostatectomy (RRP). (2002 - 2005)

Sean McLaughlin, MD - Potential role of initial incision of the lateral pelvic fascia, development

of a perirectal pocket, and early ligation of the vascular pedicles in reducing positive margins

during radical prostatectomy. (2002 - 2004)

Chris Tornehl, MD - Initial experience with fibrin tissue sealants during laparoscopic partial

nephrectomy. (2002 - 2004)

John Kang, MD - Comparison of grade and stage in African American and Caucasian patients

with prostate cancer: evaluation of clinical, biopsy, and surgical pathology. (2002 - 2004)

Kris Gaston, MD - Impact of race, age, income, and residence on prostate cancer: evaluation of

clinical, biopsy, and surgical pathology. (2002 - 2004)

Chris Tornehl, MD - Partial nephrectomy with fibrin glue repair: measurement of vascular and

pelvicaliceal bond integrity in a live porcine animal model. (2002 - 2004)

Sean McLaughlin, MD - Expression of cyclooxygenase-2 in human renal cell carcinoma. (2002 -

2004)

Sean McLaughlin, MD - Comparison of clinical and pathological staging in patients undergoing

primary versus delayed radical cystectomy for bladder cancer. (2002 - 2004)

83

Sean McLaughlin, MD - Potential role of initial incision of the lateral pelvic fascia, development

of a perirectal pocket, and early ligation of the vascular pedicles in reducing positive margins

during radical prostatectomy. (2002 - 2004)

Sean McLaughlin, MD - Reducing time to oral diet and hospital discharge in patients undergoing

radical cystectomy. (2002 - 2004)

Kris Gaston, MD - Impact of race, age, income, and residence on prostate cancer (CaP)

knowledge, screening behavior, and health maintenance in siblings of patients with CaP. (2001 -

2003)

Kris Gaston, MD - Impact of a sibling’s diagnosis of prostate cancer (CaP) on prostate cancer

knowledge, screening behavior and other health-related activities. (2001 - 2003)

J Eric Derksen, MD - The use of the COX-2 inhibitor celeceoxib in PSA-recurrent prostate cancer

(CaP) after radiation therapy or radical prostatectomy: 12 month follow-up. (2001 - 2003)

J Eric Derksen, MD - Early urethral catheter removal after radical retropubic prostatectomy.

(2001 - 2003)

Joseph Molitierno, MD - Incidental finding of prostate cancer at cystoprostatectomy. (2001 -

2003)

J Eric Derksen, MD - Factors affecting length of stay after radical retropubic prostatectomy.

(2001 - 2003)

Judy Chun, MD - The use of fibrin tissue sealants during laparoscopic partial nephrectomy.

(2001 - 2003)

Joseph Molitierno, MD - Characterization of PSA doubling time in patients who have failed

radical prostatectomy. (2001 - 2003)

Kris Gaston, MD - The use of erythropoietin in patients undergoing prostatectomy: effects of

hematocrit, transfusion rates, and quality of life. (2000 - 2002)

J Eric Derksen, MD - COX-2 inhibitors in PSA-recurrent prostate cancer: a pilot study. (2000 -

2002)

Kris Gaston, MD - Hand-assisted laparoscopic nephrectomy: prospective evaluation of the

learning curve. (2000 - 2002)

John Kang, MD - Impact of positive biopsy location on final tumor extent and unfavorable

pathological outcomes in prostate cancer. (1999 - 2001)

John Kang, MD - Comparison of grade and stage in African American and Caucasian patients

with prostate cancer: evaluation of clinical, biopsy, and surgical pathology. (1999 - 2001)

John Kang, MD - Impact of positive apical biopsies on unfavorable pathological outcomes in

prostate cancer. (1999 - 2001)

84

John Kang, MD - Unilaterally-positive sextent biopsies useful for predicting final pathology.

(1999 - 2001)

Students

Benjamin Waldorf – Long-term follow up of patients initially managed with active surveillance

for solid renal masses. (2009 – 2010)

Elizabeth Dray – Use and outcomes of adjuvant chemotherapy in PT3-4 or node positive bladder

cancer: analysis of a modern surgical cohort. (2009 – 2010)

Raj Kurpad – Robotic-assisted laparoscopic pelvic lymphadenectomy. (2009 – 2010)

Matthew Sand – Impact of marital status in patients undergoing radical cystectomy for bladder

cancer. (2009 – 2010)

Ashley Brandon – Ror2, a developmentally regulated kinase, promotes tumor growth potential in

renal cell carcinoma. (2008 – 2009)

Jim Belsante – Robotic cystectomy and the internet: separating fact from fiction. (2008 – 2009)

Raj Kurpad – A multidisciplinary approach to the management of urologic malignancies: does it

influence diagnostic and treatment decisions? (2008 – 2009)

Erik Kouba - Characterization of pT3A renal carcinoma in tumors less than 4.0 cm in size. (2006

- 2008)

Stephen McKim - Trends of length of stay in patients undergoing radical cystectomy. (2007 -

2008)

Stephen McKim - Trends of cystectomy use in octogenarians with bladder cancer. (2007 - 2008)

Erik Kouba - Clinical usefulness of serum Ca 125 levels in patients undergoing radical

cystectomy for transitional cell carcinoma of the bladder. (2006 - 2008)

Kelly Swords - Diagnostic rates and other outcomes based on initial versus repeat biopsy in a

cohort of men undergoing a modern biopsy (10-12 cored) scheme. (2006 - 2007)

Angela Smith - Impact of surgical treatment of renal carcinoma on renal function and blood

pressure: a race- and age-dependent association. (2006-2007)

Angela Smith - Gender-dependent associations between body composition in patients with renal

cell carcinoma (RCC). (2006 - 2007)

Erik Kouba - Impact of marital status in patients undergoing radical cystectomy for bladder

cancer. (2006 - 2007)

Eric Kouba - Characterization of acute phase inflammation in men undergoing robotic-assisted

laparoscopic radical prostatectomy (RALRP). (2006 - 2007)

85

Kelly Swords - Diagnostic rates and other outcomes based on initial versus repeat biopsy in a

modern cohort of men undergoing an extended biopsy (10-12 core) scheme. (2006 - 2007)

James Thomasch - Impact of race on time to androgen independence and subsequent biochemical

progression in men with advanced prostate cancer. (2004 - 2006)

N Hawke - Phosphorylated serine 536 as an indicator of NF (B activity in prostate Cancer).

(2003 - 2004)

Erik Kouba - Partial nephrectomy with fibrin glue repair: measurement of vascular and

pelvicaliceal bond integrity n a live porcine animal model. (2003 - 2004)

Attending on Clinical Service

Attending - urology clinical service. UNC School of Medicine, 4/00 - present

Attending - urology clinical service. LSU School of Medicine, 7/99 - 4/00

Grants

Submitted, Pending Review

Pragmatic Clinical Studies to Evaluate Patient-Centered Outcomes 10/2018-12/23

Patient-Centered Outcomes Research Institute (PCORI) $1,374,230

Role: Co-investigator (Angela Smith, PI)

“CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder

Cancer” CISTO is a prospective observational cohort study of patients with non-muscle invasive bladder

cancer (NMIBC) that have failed first-line BCG, and their caregivers. In this study, patient-

reported outcomes and patient-centered clinical outcomes will be compared between patients

undergoing radical cystectomy and those receiving bladder-sparing intravesical therapies for

NMIBC. Additional aims include evaluating the heterogeneity of treatments received and

corresponding patient/caregiver preferences as well as comparing the impact of treatment on

caregivers.

Current

1K08HS024134-01A1 (PI: Angela Smith) 4/2016-3/2019

AHRQ $464,759

Role: co-PI (Angela Smith, PI)

“Developing an Interactive, Patient-Centered mHealth Tool to Enhance Post-Cystectomy Care”

The goal of this award is to support the PI in becoming an independently funded physician-

scientist who is actively engaged in health information technology (HIT) interventions that

improve the process and outcomes of care of surgical patients following discharge. Using radical

cystectomy as a model, the proposed research seeks to develop and pilot test an electronic,

internet-based mHealth tool that prospectively collects patient centered outcome data on key

symptoms, functional status, and medication adherence.

PCORI Engagement Award (PI: Angela Smith) 7/2017-6/2019

Knowledge Award $249,000

86

Role: Co-investigator (Angela Smith, PI)

“Patient Empowerment through Engagement Research Training in Bladder Cancer PCOR

(PEER)”

This award involves development of a bladder cancer research training module supplemented

with existing training materials available through the PCORI-funded web-based portal (INSPIRE)

and a workshop at a BCAN leadership conference. The effectiveness of this training tool (PEER –

Patient Empowerment in Engagement Research) will be tested through patient engagement in

identifying and refining a patient-centered research question and involvement in an existing

PCOR project. Ultimately, trained patients will serve as mentors for future cohorts, creating a

sustainable method for continued patient engagement in bladder cancer research.

Recent Completed

R01CA174453 (supplement) (PI: Reeve and Chen) 09/2016 – 072017

PROMIS Validation in Prospective Population-based Prostate Cancer Research Study

Role: Supplement Lead, co-investigator

This supplement investigates (1) whether routine use of PROMIS and other patient-reported

measures in clinical practice is feasible and valuable for clinical management of symptoms

among Black and White prostate and bladder cancer patients; and (2) whether feasibility and

perceived value differ by race.

PCORI Engagement Award (PI: Angela Smith) 12/2014-12/2016

Knowledge Award $121,237

Role: Co-investigator

“Bladder Cancer Patient Survey Network for Research Prioritization

This knowledge award involves development of a survey network of bladder cancer patients by

engaging patients and caregivers involved with Bladder Cancer Advocacy Network and conduct

research prioritization activities. In this project, we aim to recruit users to participate in the

Patient Survey Network, generate research questions, and prioritize research questions with the

ultimate goal to create a sustainable method for conducting research prioritization with bladder

cancer patients on an iterative and ongoing basis

University Cancer Research Fund (PI: Ron Chen) 8/2013-8/2015

Innovation Award $175,000

Role: Co-investigator

"Building and Characterizing the North Carolina Bladder Cancer Cohort: Defining Quality of Life and

Potential Health Care Needs During Survivorship"

Role: Co-investigator

Adolor Corporation (PI: Pruthi) 1/7/10 – 1/6/13

Clinical Trial $12,240.00

Role: PI

14CL403 A Phase 4, Multicenter, Double-Blind, Placebo-Controlled, Parallel Study of

Alvimopan for the Management of Postoperative Ileus in Subjects Undergoing Radical

Cystectomy.

The primary objective of this study is to determine that alvimopan accelerates recovery of

gastrointestinal (GI) function in subjects undergoing radical cystectomy.

U.S. Department of Defense (PI: Davis) 9/30/11 – 9/29/14

Role: Co-investigator (PI: Davis) $134,068.00

87

Classifying Human Kidney Cancers by Comprehensive Analysis of Chromatin

Organization.

We have developed a new method to examine the structure of DNA in tumor cells. This test can

identify important differences between tumors that look identical under the microscope. These

differences have direct implications for the treatment of the cancer. We propose applying this

method to study kidney cancer.

University of Texas at San Antonio 7/1/11 – 6/30/16

Role: co_investigator (PI:Parekh) $25,000.00

Robot Assisted Versus Open Radical Cystectomy: A Randomized Clinical Trial.

To evaluate and compare long term measures of recovery outcomes and functional independence

between RARC and ORC.

National Institutes of Health 7/1/11 – 6/30/13

Role: Co-PI (PI: Nielsen) $54,212.00

Complexities of Decision Making in Older Adults with Low Risk Bladder Cancer.

This proposal aims to explore patient knowledge and information needs in this setting and

preferences regarding invasive surveillance practices contextualized as such.

National Institutes of Health 4/1/11 – 3/31/16

Co-investigator (PI:Rathmell) $602,711.00

Dissecting Complex Signatures from Renal Cell Carcinoma.

This proposal describes a broad based collaboration between experts in fields of biomarker

development using transcribtional, non-coding RNA, and chromatin analysis for the

establishment of a comprehensive set of multianalyte biomarkers for renal cell carcinoma that can

be assessed with a single clinical tool.

Lineberger Comprehensive Cancer Center 1/1/11 – 12/31/13

Co-investigator (PI:Rathmell) $499,000.00

LCCC 1028: Neoadjuvant Pazopanib: A Phase II Study to Evaluate the Effect on Disease

Response and Recurrence and to Establish Biomarkers of Drug Activity in Renal Cell

Carcinoma.

National Institutes of Health 12/1/09-11/30/11

Role: co-PI (PI:Satia) $125,000.00

Effect of supplemental omega-3 fatty acids in patients with superficial bladder cancer after

transurethral resection: a randomized trial

The primary specific aim is to evaluate whether dietary supplementation of two doses of omega-3

fatty acids (1800 mg and 3600 mg daily) for 9 months can reduce one-year (post initiation of the

intervention) recurrence rates in patients with low-risk, superficial bladder cancer after

transurethral endoscopic resection. OVERLAP NONE (Note: Submitted but delayed due to

death of Principal Investigator)

Past

Co Investigator; Satia J, Principal Investigator. Supplemental Omega-3 Fatty Acids, Serum PSA,

and Inflammation in Men with Prostate Cancer. NIH. 12/1/08 – 11/30/10.

Co-Investigator; Satia J, Principal Investigator. Inflammation, Oxidative DNA Damage, and

Nutrient Biomarkers in Prostate Cancer Patients. NIH. 12/1/08 – 11/30/10.

88

Prostate Cancer: Transition To Androgen-Independence: Core B. National Cancer Institute.

4/1/05 – 6/30/10.

Phase III Trial of Selenium for Prostate Cancer - Subcontract with the University of Arizona.

National Cancer Institute. 11/1/98 – 4/30/10.

Co-Principal Investigator; Smith M, Principal Investigator. A randomized Double Blind Placebo-

Controlled Phase III Study of Early vs Standard Zolodronic Acid to Prevent Skeletal Related

Events in Men with PCa –Metastatic to Bone. CALGB. 3/05 – 12/09.

Co-Investigator; Rathmell W.K., Principal Investigator. Phase II trial of Novel Vaccine in

Patients with Metastatic Renal Cell Carcinoma. Merix Inc. 6/04 – 12/09.

Co-Investigator; Rathmell W.K., Principal Investigator. Phase II trial of BAY-046 in Patients

with Metastatic Renal Cell Carcinoma. Bayer Inc. 10/04 – 12/09.

A Multi-Center, Randomized, Double Blind, Placebo Controlled Study to Investigate the Efficacy

and Safety of Aprotinin on Transfusion Requirements in Patients with Bladder Cancer

Undergoing Radical or Total Cystectomy. Kendle International Inc. 9/28/06 – 9/27/09.

Principal Investigator. A Phase II Trial of Plenaxis as Intermittent Therapy in Advanced Prostate

Cancer. Lineberger Comprehensive Cancer Center / Praecis Inc. 3/05 – 6/09.

Co-Investigator. Rathmell W.K., Principal Investigator. A Phase II Trial of neoadjuvant

sorafanib in patients with high risk renal cell carcinoma undergoing radical nephrectomy.

Lineberger Comprehensive Cancer Center / Bayer / Onyx Inc. 11/06 – 12/09.

Co-investigator; Wallen EM., Principal Investigator GST-Pi – 002 Quantitative GST-Pi

Methylation BX tissue testing to Improve the Accuracy of Ca Detection in Men with High Risk

Localized PCa Lineberger Comprehensive Cancer Center / Oncomethylone. 2/05 – 12/09.

Co-Investigator. Meshel M., Principal Investigator. Decision-making and Uncertainty in Men

Diagnosed with Prostate Cancer. National Institutes of Health. 6/03 – 12/09.

Co-investigator; Whang Y., Principal Investigator. A phase II study of Oral Once daily

GW572016 (Lapatinib) in pts. With Hormone Refractory PCa (LCCC0505). Lineberger

Comprehensive Cancer Center / GlaxoSmithKline. 3/05 – 12/08.

Co-Investigator. Mohler JM., Principal Investigator. Understanding Racial Differences in

Prostate Cancer. U.S. Department of Defense Prostate Cancer Research Program Consortium (3-

year, $9.9M) 8/1/04 – 12/07.

Principal Investigator. Partial nephrectomy with fibrin glue repair: measurement of vascular and

pelvicaliceal bond integrity in a live porcine and isolated abbatoir animal model utilizing Tisseel

fibrin tissue sealant. Baxter, Inc. 6/03 – 1/04.

Co-Principal Investigator; Droller M., Principal Investigator. An open comparative within-patient

controlled phase III multicenter study of Hexvix fluorescence cystoscopy and standard

cystoscopy in the detection of carcinoma-in-situ in patients with bladder cancer. Photocure Inc.

8/15/00 – 1/1/04.

89

Co-investigator; Whang Y., Principal Investigator. A phase II trial of Atrasentin in men with

metastatic, hormone-refractory prostate cancer. Abbott Laboratories. 6/02 – 6/03.

Co-investigator. A phase II randomized-discontinuation study of oral CEP-701 in prostate cancer

patients who have failed first-line hormonal therapy. TAP Holdings, Inc. 11/1/00 – 6/1/03.

Co- Investigator; Ornstein DK, Principal Investigator. SELDI analysis of serum proteins: a novel

approach to improve early prostate cancer detection. Lineberger Comprehensive Cancer Center,

UNC. 10/15/00 – 8/1/03.

Co-Principal Investigator; Lewis J, Principal Investigator. A multi-center randomized phase III

study of adjuvant Oncophage( versus observation in patients with high risk of recurrence after

surgical treatment for renal cell carcinoma. Antigenics Inc. 5/15/00 – 8/1/03.

Co-Principal Investigator; Cote RJ, Principal Investigator. MVAC in organ-confined bladder

cancer based on p53 status. National Cancer Institute. 11/1/97 – 12/00.

Co-investigator; Schroeder J, Principal Investigator. Estimation of risks of development of renal

cell carcinoma: evaluation of the effect of genetic polymorphisms in conjunction with

environmental factors. National Institutes of Health. (submitted 10/04)

Professional Service

Discipline

Reviewer, New England Journal of Medicine, July 2017-Present

Editorial Board Member-Urology: Research and Therapeutics Journal October 2016-Present

Editorial Board Member-Urology Updates October 2016- Present

Member, American Association of Genitourinary Surgeons April 2016 - present

American College of Surgeons Board of Regents October 2015 - Present

Chief Editor of Urology, C Surgeries, 06/2015-Present.

Member at Large, AUA Committee on Education and Science. May 2015-2018.

AUA Bladder Cancer Guidelines Committee January 2015 - present

Board Member, The Society of Urology Chairpersons and Program Directors Southeastern

Section, 2015- 2017

Board Member, The Society of Urology Chairpersons and Program Directors Representative to

The American College of Surgeons, 2015-2016

Member, AUA Workforce Working Group August 2014 - present

90

Member, The Society of Pelvic Surgeons, 11/2014-Present.

Head, Program Committee for Urology, American College of Surgeons 2015 - present

Urology Chair, American College of Surgeons, Committee on Video-based Education 2014 -

present

AUA Representative at Capitol Hill Advocacy Conference, 07/07/2014-07/09/2014, Washington,

DC. Met with congressional leaders on issues related to urology and other specialty medicine

concerns including GME, SGR, and tort reform.

Abstract Review Team Member 2AUA Abstract Review Process (2013, 2014, 2015)

Team Editorial Board, Conference Papers in Medicine, 09/2012- present.

Editorial Board, World Journal of Clinical Urology, 07/2012-present.

Chair of the Surgical Forum for Urology, American College of Surgeons, 1/12-10/15

Member American College of Surgeons, Committee on Video-based Education, 10/2011-10/2014

ABU/AUA Examination Committee Member, 08/2011-07/2014

Editorial Board, Archivos Espanoles De Urologia, 11/10 - present

Charter Member, Society of Robotic Surgery, 9/10 - present

Editorial Board, The Annals of Urology, 9/10 - present

Reviewer, Tumor Biology, 9/10 - present

Member, Bladder Cancer Guidelines Committee, International Consultation on Urological

Diseases, 5/10 – present.

Vice Chair, Scientific Committee, Indian American Urological Association, 2010-2014

Editorial Board, World Journal of Clinical Oncology, 1/10 - present

Vice Chair, Young Urologists Committee, American Urological Association, 5/09 – 5/10.

Committee Member, American Urological Associations Editorial Board. 5/2009-2013.

Editorial Board, Journal of Urology, 4/09 – present

Member, American College of Surgeons Advisory Council for Urology, 10/08 – present

Member, Scientific Program Committee, Indian American Urological Association Meeting, 2009

Member, Planning Committee, Indian American Urological Association Meeting, 2008

Editorial Board, The Open Surgical Oncology Journal, 10/08 – present

Editorial Board, Open Access Journal of Urology, 10/08 – present

Editorial Board, Case Reports in Medicine, 7/08 – present

Member, Board of Directors (NC alternate representatives), Southeastern Section of the

American Urological Association, 5/08 – 2014.

91

Editorial Board, World Journal of Urology, 11/07 – present

Consultant Journal of Women’s Health, 9/07 – present

Consultant Expert Review of Anticancer Therapy, 9/07 – present

Member, Young Urologists Committee, American Urological Association, 6/07 - present

Member, American College of Surgeons Committee on Young Surgeons, 05-07-2009

Member, Young Urologists Leadership Committee, Southeastern Section of the American

Urological Association, 2006-2009.F

Consultant Issues in Urology, 3/07 – present

Consultant Lancet Oncology, 3/07 – present

Consultant Expert Opinion on Pharmacotherapy, 3/07 – present

Consultant International Brazilian Journal of Urology, 3/07 – present

Consultant Indian Journal of Urology, 2/07 – present

Consultant TSW Urology, 11/06 – present

Consultant Cancer, 3/06 – present

Consultant Archives of Medical Research, 3/06 – present

Consultant Journal of Endourology, 1/06 – present

Invited Member, Urological Research Society, 11/05 – present

Surgical Principal Investigator, University of North Carolina -- Cancer and Leukemia Group B

(CALGB), 7/05 - present

Consultant, European Urology, 6/05 – present

Editorial Board, Prostate Cancer and Prostatic Diseases, 3/05 – present

Consultant, British Journal of Urology, 1/05 – present

Consultant, Apoptosis, 10/04 – present

Panel Member, Bladder Cancer Clinical Guidelines, American Urological Association, 6/04 -

present

Consultant, Urology, 6/03 – present

Consultant, Urologic Oncology, 1/03 - present

American College of Surgeons, 2003-present

Consultant, Journal of Urology, 1/02 – present

92

Editorial Advisory Board, Contemporary Urology, 1/02 – present

Society of Urologic Oncology, 2002 – present

Core Member, Genitourinary Committee – Cancer and Leukemia Group B (CALGB), 10/00 -

present

Triangle Urological Society, 2000 – present

American College of Surgeons Oncology Group, 2000 – present

Cancer and Leukemia Group B – genitourinary core member, 2000 – present

Southeast Section - American Urological Association, 1998 – present

American Urological Association, 1996 – present

Within UNC

Board Member, UNC Health Alliance (Clinically integrated Network) May 2015-Present.

Board Member, UNC Senior Alliance (Medicare ACO) July 2016 - present

UNC Clinically-integrated Network Strategic Planning Committee August, 2014 - May 2015

Member, Perioperative Leadership Group, UNC Healthcare, 09/2013- present

Co-Director of Urologic Oncology Group, Lineberger Comprehensive Cancer Center- UNC

School of Medicine, 11/11- present.

Faculty Leadership Initiative – UNC – 9/10 – 11/10

Urology Service Leader – UNC – 6/09 - present

Member, Regional Strategies Working Group - North Carolina Cancer Hospital - UNC School of

Medicine, 1/07 – present.

Disease Group Leader, Urologic Oncology, Lineberger Comprehensive Cancer Center - UNC

School of Medicine, 1/03 – 1/07

Member, Executive Committee - North Carolina Cancer Hospital - UNC School of Medicine,

11/06 – present.

Head, Section of Urologic Oncology; Division of Urologic Surgery - UNC School of Medicine,

2/03 – present

Director of Ambulatory Care, Department of Surgery UNC School of Medicine, 11/02 – present

Member, Compensation Task Force, Department of Surgery - UNC School of Medicine, 7/02 –

present

Member, Surgery Quality Assurance Committee, UNC School of Medicine, 1/02 - present

Member, Multidisciplinary Team Evaluating Medication Errors - UNC School of Medicine,

10/02 – 2/03

93

Director of Urologic Resident Education - UNC School of Medicine, 1/01 – present

Member, Operating Room Advisory Committee, UNC School of Medicine, 1/01 - present

Unit Chief, Urology Inpatient Service - UNC School of Medicine, 12/00 – present

Co-director, Multidisciplinary Clinic in Genitourinary Oncology - UNC School of Medicine,

10/00 – present

Team leader, Clinical Research Team, Division of Urology - UNC School of Medicine, 8/00 –

present

Member, Lineberger Comprehensive Cancer Center - UNC School of Medicine, 7/00 – present

Member, Protocol Review Committee, Lineberger Comprehensive Cancer Center - UNC School

of Medicine, 7/00 – 06/08.

Member, Surgical Endoscopy Committee, UNC School of Medicine, 7/00 – present

Member, Laparoscopic Institute of North Carolina, UNC School of Medicine, 7/00 – present

Lecturer - medical students, urology residents on urologic surgery, retroperitoneal/pelvic anatomy

(UNC School of Medicine, 4/00 – present); (LSU School of Medicine, 7/99 – 4/00)

Attending - urology clinical service (UNC School of Medicine, 4/00 – present); (LSU School of

Medicine, 7/99 – 4/00)

Visiting Scholar Supervisor:

Tong Zhang, MD

09/2010-3/2011

Dongbin Bi, MD

Shandong Provincial Hospital affiliated to Shandong University, China

11/2011-05/2012

Seung- Ju Lee, MD

The Catholic University of Korea

02/2012-02/2013

Jun Sung Koh, MD

The Catholic University of Korea

02/2014-02/2015

Hong Tao Jiang, MD, PhD

Second Clinic Medical College of Jinan University, China

09/2016-08/2017

94

Leadership Courses

Career Development Conversations

Leadership Development Learning Sessions

George Watts Alumni Center

Carolina Club

Chapel Hill, North Carolina

February 1, 2011

Leadership Development for Physicians in Academic Health Centers

Harvard School of Public Health

Center for Continuing Professional Education

Boston, Massachusetts

10/17 – 10/29/2010